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The goal of this dissertation is to better understand the complex relationship between 
the stresses encountered by U.S .  service personnel during the Gulf War and eventual 
physical and psychological health outcomes among its veterans. By developing and 
validating a stress model using structural equation modeling techniques, it is hoped that 
knowledge regarding wartime stress and its potential impact on the health of veterans will 
be gained. This knowledge can be used to guide future policy decisions on how to minimize 
the deleterious health consequences associated with deployment and combat, as well as 
furnishing a basis for future studies that examine the l ink between stress and health 
outcomes. 
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A structural equation model is developed to test a number of hypotheses concerning 
the relationship between stress and eventual psychological health and physical health 
outcomes among Gulf War veterans. A core model is first created to test whether or not 
physical health is a function of psychological health without stress in the equation. This 
model then expands to test whether or not physical health is a function of psychological 
health in light of differences in stressful exposures/experiences encountered by Gulf War 
veterans. The model finally further expands to test whether or not physical health is a 
function of psychological health and stressful wartime experiences/exposures adjusting for 
differences in veterans' age, gender, race, and marital status. 
The models theoretical foundation centers on the "Stimulus-based Model of Stress," 
developed by Drs. Thomas Holmes and Richard Rahe in the late 1 960's. Holmes and Rahe 
viewed stressful l ife events as additive in nature and that the more stress an individual 
experienced in a period of time, the more likely they were to suffer from a variety of 
physical and psychological i l lnesses. They developed a stress scale to measure the stressful 
l ife experience so as to predict heath outcomes. This study likewise quantified stressful 
wartime exposures/experiences by creating a stress scale that could measure the stress level 
of individual veterans. This stress scale was then used to create stress scores of veterans 
based upon their wartime experiences/exposures. These stress scores were then 
incorporated into the above structural equation model to determine the effect of wartime 
stress on veterans' physical and psychological health outcomes. 
The dissertation has drawn upon prior research regarding stress and health outcomes 
in the creation of its stress model. Goodness-of-Fit tests were preformed to determine 
XIV 
whether the pattern of variances and covariances in the data is consistent with the structural 
(path) model specified. The model was respecified to obtain a better fit by adding correlated 
error terms based upon the modification indices and theoretical considerations. 
CHAPTER 1 :  INTRODUCTION 
Introduction 
Nearly 700,000 American military personnel were deployed to the Persian Gulf 
between August 1 990 and April 1 99 1  in support of Operations Desert Shield and Desert 
Storm (see Appendix I). These troops, together with those from a coalition of other 
nations (see Appendix II), were sent to enforce United Nations (U.N.) resolutions (see 
Appendix III) calling for an immediate withdrawal of the Iraqi army, which had just 
invaded Kuwait. The ensuing mobilization of men and equipment to the Persian Gulf 
was the largest mass military deployment since the Vietnam War (Leyden, 1 997) and one 
that proceeded at a pace unprecedented in military history (Ursano, Norwood, 1 996, 
Marshall, G.N., 1 999). After months of negotiations failed to bring about a peaceful 
resolution to the conflict, in January 1 99 1  United States (U.S . )  and coalition forces 
launched a devastating air campaign against Iraqi mil itary targets in Kuwait and southern 
Iraq in what would soon become known as the Gulf War (see Appendix IV for timeline). 
For five weeks the U.S .  and its Coalition partners staged an unrelenting air bombardment 
over the Iraqi positions. This gave way to a quick and decisive ground assault that 
overwhelmed the overmatched Iraqi army, which in less than a week was routed. The 
war soon ended with Iraqi forces withdrawing from Kuwait and renouncing any claim 
they had to that nation. 
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Statement of the Problem 
Upon their return home, approximately 80,000 of the nearly 700,000 American 
men and women who were stationed in southwest Asia during the Gulf War (some 1 1 .4 
% of all veterans who fought in that war) reported a variety of unexplained il lnesses that 
they attributed to their participation in the war (Fulco, 2000). That number of il l  veterans 
is staggering, especially in light of the fact that the war was hailed as an extraordinary 
successful military operation with very few battle-related casualties (see Appendix V). 
Veterans of the Gulf War nonetheless reported a wide array of health problems consisting 
of symptoms including persistent fatigue, cognitive difficulties, memory loss, diffuse 
muscle and joint pain, gastrointestinal symptoms, skin lesions, and respiratory problems 
(Spencer, 1 998). Since no immediate explanation was presented for such health 
problems among the large number of veterans, the media soon labeled all unidentified 
il lnesses associated with the Gulf War as "Gulf War Syndrome" (Sartin, 2000). 
Department of Defense (DoD) and Veterans Administration (V A) officials, well 
aware of the health problems that some Vietnam era veterans had suffered upon their 
return home, immediately provided counseling services ranging from family therapy to 
treatment of post-traumatic stress disorder (PTSD) to any Gulf War veteran who 
requested those services. Officials also arranged for sick veterans to be given physical 
examinations and an array of medical tests to try to determine the nature of their i l lnesses. 
Despite these efforts, many men and women returning from the Gulf continued to suffer 
debilitating il lnesses that often confounded medical experts (PACGWI, 1 996). 
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Pressed by of veterans and their advocates, Congress and President Clinton in 
early 1 993 authorized the Secretary of Veterans Affairs (V A) to coordinate research 
funded by the Executive Branch of the federal government into the health consequences 
of service in the Gulf War (FSRGWVI, 200 1 )  (see Appendix VI, for Purpose of Research 
on Gulf War Veterans). The principal charge of this research was 1 )  to determine the 
nature and prevalence of symptoms, diseases, and other conditions among Gulf War 
veterans; 2) to identify the risk factors for those symptoms, diseases, and other 
conditions; and 3) to identify diagnostic tools, treatment methods, and possible 
prevention/intervention strategies (FSRGWVI, 200 1 ) . In response to this charge, the 
Veterans Administration and Department of Defense performed and contracted out 
research programs to study possible causes and treatments for the Gulf War veterans' 
health problems. Medical evaluation programs: the V A Gulf War Registry (see 
Appendix VIlA) and the Department of Defense's Comprehensive Clinical Evaluation 
Program (CCEP) (see Appendix VII B) were established to gather information on Gulf 
War veterans and their health problems. 
Specific Aims of the Study 
The primary goal of this epidemiological study is to examine the relationship 
between Gulf War Stress (GWS) and the mental and physical health outcomes of 
veterans of the Gulf War. Structural equation modeling techniques are used to test three 
models that describe that relationship. A core model (see Chapter 3 for model 
development) is first created based on theoretical considerations that describe the 
relationship between psychological and physical health among Gulf War veterans. This 
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model centers on two latent (non-observable) variables, physical and psychological 
health, and includes 1 5  measures of health outcome data from the Comprehensive 
Clinical Evaluation Program survey (see Figure I ) . A second model, based on the core 
model but taking into account the differences in stress that veterans had faced while 
serving in the Gulf War, is then created (see Figure 2). It incorporates data derived from 
a Gulf War Stress scale that is  based upon survey data as well as on exposure data 
contained in the Comprehensive Clinical Evaluation Program survey. Finally, a third 
model, based upon the second model but taking into account differences in veterans' age, 
gender, race, and marital status is created (see Figure 3) .  This model is used to see 
whether those variables have any bearing upon physical and psychological health 
outcomes among Gulf War veterans. 
For the three figures below, Psychological Health and Physical Health are both 
latent variables (non-observed) and thus are drawn as ell ipses according to structural 
equation modeling guidelines. The terms e I  -e I 5 represent the error terms for the 1 5  
health outcome indicators. Since measurement errors are estimated and not measured 
directly, they are drawn as circles. The term fI in all figures represents the error in the 
prediction of the endogenous latent variable Physical Health from the exogenous latent 
variable Psychological Health. As an error value, it is also drawn as a circle. The 1 5  
health outcome indicators are derived from the Comprehensive Clinical Evaluation 
Program Survey. They are from observed (measured) variables and are therefore drawn 
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Figure 1 :  A proposed structural equation model showing how physical health outcomes 
are affected by psychological health outcomes in a cohort of Gulf War veterans. 
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Figure 2 :  A proposed structural equation model based upon the core model in figure I ,  
showing how Gulf War Stress affects both physical and psychological health outcomes in 
a cohort of Gul f War veterans. 
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Figure 3: A proposed structural equation model based upon the model in figure 2, 
showing how the descriptive variables age, gender, race, and marital status affect 
physical and psychological health in a cohort of Gulf War veterans. 
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as rectangles. The coded health measures for the above three figures are translated in 
Table 1 below. 
Table 1 :  Coded Health Measures 
Code Text Code Text 
1 .  ABD PAIN Abdominal Pain 1 1 . WEIGHT C Weight Change 
2 .  BLE GUMS Bleeding Gums 1 2 .  DEP MOOD Depressed Mood 
3 .  DIARRHEA Diarrhea 1 3 .  DIF CONC Difficulty Concentrating 
4 .  FATIGUE Fatigue 1 4. MEM PROB Memory Problems 
5 .  HAIR LOS Hair Loss 1 5 . SLEEP DI Sleep Disturbances 
6. HEADACHE Headache 1 6. PERS AGE Veteran Age 
7.  JOINT PA Joint Pain 1 7. PERS SEX Veteran Gender 
8. MUS PAIN Muscle Pain 1 8 . RACE Veteran Race 
9. RASH Rash 1 9. MARITAL Veteran Marital Status 
1 0. SHORT BR Shortness of Breath 20. STRESS S Veteran Stress Score 
The Gulf War Stress score is derived from a weighted stress scale developed 
through a survey of veterans and health professionals as well as through exposure data 
from Comprehensive Clinical Evaluation Program survey. Since a measured stress score 
is developed for each veteran, the variable is drawn as a rectangle. Data for the four 
additional descriptive variables (age, gender, race, and marital status) are taken from the 
Comprehensive Clinical Evaluation Survey. Since these variables are observed 
(measured) variables, they are drawn as rectangles. In figures 2 and 3, the latent variable 
Psychological Health is transformed from an exogenous (independent) variable to an 
endogenous (dependent) variable due to the influence of the descriptive indicators. As an 
endogenous variable, Psychological Health must now have an error term associated with 
it. The error term f2 is thus added to the model. As an error value, f2 l ike fl is drawn as 
a circle. 
The three hypotheses of this study, which are tested by structural equation 
modeling techniques using the primary data from the Gulf War veteran stress survey and 
the secondary data from the Comprehensive Clinical Evaluation Program survey are as 
follows: 
Hypothesis 1 :  Ho = physical health = f (psychological health). 
HA= physical health f. f (psychological health). 
Hypothesis 2 :  Ho = physical health = f (psychological health, Gulf War Stress). 
HA= physical health f. f (psychological health, Gulf War Stress). 
Hypothesis 3:  Ho = physical health = f (psychological health, Gulf War Stress, age, 
gender, race, and marital status). 
HA= physical health f. f (psychological health, Gulf War Stress, age, 
gender, race, and marital status). 
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The hypothesized models are tested statistically in simultaneous analysis of the 
entire system of variables to determine the extent to which they are consistent with the 
data. If the goodness-of-fit tests are adequate, the model argues for the plausibility of the 
postulated relations among variables; if inadequate, the tenability of such relations should 
be rejected. Respecification of the model, based on theoretical lines, such as adding 
correlations among errors to improve model fit is performed if necessary. 
Significance 
This study has significance in that it uses both primary and secondary data in 
setting up structural equation models that analyze the impact of Gulf War service on 
those personnel who have reported unexplained health problems. The models tested 
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examine the relationship that psychological health has on  physical health among Gulf 
War veterans; the effect of wartime stress on that relationship; and how the variables age, 
gender, race, and marital status may affect that relationship. The importance of this 
study lies in the fact that it can clarify our understanding of how wartime stress affects 
the health outcomes of our veterans .  This increased understanding of the role of wartime 
stress will hopefully lead to preventative measures that will reduce the number of 
veterans who come down with mysterious health problems after serving their country. 
This study is also significant in that it employs structural equation modeling 
techniques in its analysis of the health outcomes of Gulf War veterans. Very few 
federally funded studies on Gulf War veterans' i l lnesses have used structural equation 
modeling techniques in their analysis and none of them have used the large 
Comprehensive Clinical Evaluation Program data (FSRGWVI, 2000). The use of 
structural equation modeling, a very powerful analytical tool that describes relationships 
between variables, allows the researcher to show causal relationships among both 
measurable and non-measurable variables. This capacity is important when looking at 
topics such as stress, psychological health, and physical health. 
This research, by developing structural equation models that correlate varying 
levels of stress with subsequent health outcomes, will aid Veterans Administration and 
Department of Defense efforts to promote veterans '  health by: I )  facil itating symptom 
recognition and diagnosis in areas of growing concern (physical and mental stress during 
war); 2) presenting an examination of the complex relationships that exist among health 
symptoms, hazardous environmental exposure, and war-zone stressor experiences; 3)  
comparing the prevalence of certain symptoms, medical conditions, and unexplained 
il lnesses among differing groups of veterans of the Gulf War. 
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This study finally has significance in light of the current deployment of U.S. 
soldiers around the world who are waging the war on terrorism. The troops now 
fighting to protect our lives face similar circumstances to those encountered during the 
Gulf War, namely being in a highly stressful environment, far from home, and under the 
constant threat of attack. Since there is a strong possibility that many of these troops will 
return home with health problems simi lar to those faced by many of Gulf War veterans, it 
is important to apply any lessons learned from the Gulf War to help the troops in current 
military operations. The more knowledge that can be gained through continued research 
into the health problems of veterans of the Gulf War, the more likely it is that 
preventative action can be taken, and thus the less likely that similar problems will beset 
the veterans of current and future deployments. 
Theoretical Framework 
The theoretical framework for this study is the "Stimulus-based Model of Stress," 
which is based upon the work of the psychologists Thomas Holmes and Richard Rahe, 
who during the 1 960s proposed it while studying the effects of life changes on an 
individual. Holmes and Rahe postulated that l ife changes act as stressors on individuals, 
and that too many l ife changes increase a person's  vulnerability to il lness (Rice, V.H. ,  
2000). They developed tools such as the Social Readjustment Rating Scale (SRRS) (see 
Appendix VIII) and the Schedule of Recent Experiences (Holmes T.H. ;  Rahe, R; 1 967) to 
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measure stress defined and operationalized as the adjustment required by selected major 
life changes or events. The Social Readjustment Rating Scale consists of 43 l ife events 
(e.g., marriage, loss of a loved one, pregnancy, vacation, divorce, retirement, and change 
in residence) that were assigned a priori weights derived from the mean ratings of the 
estimated amount of adjustment each life event would require (Holmes, T.H. ;  Rahe, R., 
1 967). In testing an individual using this scale, each of the 43 l ife events experienced 
within the last two years are be added up (using the a priori weights) to come up with a 
numerically assigned overall stress score value. Holmes and Rahe believed that the 
higher the stress score, the more likely that individual would become il l  within the next 
year. 
In their Stimulus-based Model of Stress, Holmes and Rahe viewed stress as an 
aggregate of the forces that together weigh upon a person. The greater these forces, the 
more likely a person will suffer from a variety of physical and/or psychological i l lnesses. 
Some stresses weigh heavily on a person, such as death in the family or the person's  
divorce. Other stresses such as  a minor traffic violation or  even going on vacation do not 
weigh as much, but stil l  contribute to the overall stress an individual faces. In the 
Stimulus-based Model of Stress it is not only the number of stressful l ife events 
experienced in a year that predicts the health status of an individual, but rather the 
number of those stressful events in combination with the weight each event carries. This 
type of model has been very useful in understanding the effects of major events upon 
people involved in them. It is the intention of this study to apply the Stimulus-based 
Model of Stress to those involved in the Gulf War and to attempt to understand how 
stressful events during the war may have affected their overall health. 
Methodology 
Source of Data 
Data for this study come from the Department of Defense's  Comprehensive 
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Clinical Evaluation Program maintained by Electronic Data Systems (EDS), as well as a 
Gulf War Stress Survey sent out to Gulf War veterans and experts in the field of stress. 
The Comprehensive Clinical Evaluation Program is a voluntary program that has 
collected data on active duty Gul f War veterans since 1 994, with oversight from the 
National Academy of Sciences and the Institute of Medicine. Data from the 
Comprehensive Clinical Evaluation Program include both exposure data and health 
outcome data. The Gulf War Stress Survey likewise is a voluntary survey sent out to 
Gulf War veterans and stress experts to gain their opinions on how stressful varying 
exposures were during the Gulf War. These data are compiled here to create a stress 
scale similar to the Holmes and Rahe Social Readjustment Rating Scale. 
(Data collection, formatting, and cleansing as well as scale development are covered in 
greater detail in the Methodology section). 
Structural Equation Modeling 
This study employs Structural Equation Modeling (SEM) techniques to test how 
Gulf War stress exposure affected the mental and physical health of Gulf War veterans. 
Structural Equation Modeling techniques, which encompass path analysis, confirmatory 
factor analysis, multiple regression analysis, and causal modeling with latent variables, 
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describe relationships between variables using a graphical modeling interface so as  to 
allow a pictorial presentation of the complex path diagrams that are hypothesized (Kline 
R.B.,  1 998). Structural Equation Modeling techniques are usually viewed as 
confirmatory rather than exploratory procedures, meaning that the researchers' 
hypotheses are presented first and then evaluated during analysis. Goodness-of-Fit tests 
are used to determine whether the pattern of variances and covariances in the data is 
consistent with the structural (path) model specified. The main question to be answered 
in using this technique is whether or not the hypothesized models are supported by the 
data. If the data are consistent with the theoretical model, then the model is supported. If  
the data and the model are off by a small amount, an exploratory approach may be used 
to "tweak" the model for better fit. If, however, the data show that the theoretical model 
is implausible, it is recommended that the researcher abandon the model or modify the 
hypotheses upon which it is based (Kline, R.B. ,  1 998). 
When conducting Structural Equation Modeling analysis, it is important to follow 
a basic sequence of events, which are listed and briefly described below: 
1 .  Specify the model - That is, put the researcher's hypothesis i n  graphical (or text i f  
so  desired) form, using the standard symbols (see Appendix IX) for creating a 
structural equation model. The defined variables are eventually linked to the data 
they represent, with the presumed relations between them being analyzed by the 
statistical software. 
2. Determine whether the model is identified - A model is identified if it is 
theoretically possible for the computer to derive a unique estimate of every model 
parameter. The types of structural equation models must each meet certain 
requirements in order to be identified. If a model fails to meet the requirements 
for its identification, attempts to estimate it may not be successful (Kl ine, R.B. ,  
1 998) .  
3 .  Select measures - The variables represented in the model should have 
standardized numerical representation (e.g., Male = I ,  Female = 0; age rounded 
off to the nearest year for all subjects, etc . ) .  
4. Analyze the model - A model fitting program such as AMOS, EQS, or LISREL 
should be used to derive estimates of the model 's parameters. 
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5. Evaluate model fit - Determine how adequately the hypothesized model accounts 
for the data, using goodness-of-fit measures. 
6. Respecify the model - Revise of the model, guided by the theoretical 
underpinnings of the research and the results of the initial analysis if necessary. 
The Amos Program 
The statistical software used in this study to conduct the Structural Equation 
Modeling analysis is the AMOS (Analysis of Moment Structures) 4.0 program. This 
program, developed within the Microsoft Windows interface, allows the user to work 
within either a graphical interface or a more traditional programming interface. This 
study uses the AMOS graphical interface, for a pictorial presentation of the structural 
equation models being analyzed. AMOS 4.0 has the ability to handle large data sets such 
as the secondary data from the Comprehensive Clinical Evaluation Program being used in 
this study, and it can take data from a variety of sources, such as EXCEL or SPSS. It also 
allows the researcher to choose among a wide variety of analytic processes to test the 
models. 
Statistical Analysis 
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Descriptive statistics are calculated for all variables in the study, using SPSS in 
order to provide simple quantitative descriptions of the data in a manageable form. The 
descriptive statistics include tests for mean, median, range, standard deviation, and 
frequency for all variables under consideration. They provide an overview of the sample 
population under consideration. If any flaws in the data may have occurred during the 
data collection and/or cleansing process, the descriptive statistics should point them out. 
This safeguard is useful when looking at large data sets like the Comprehensive Clinical 
Evaluation data, where there is a high likelihood of incorrect data being entered, due 
simply to the sheer volume. 
The main focus of the statistical analysis, however, lies within the goodness-of-fit 
tests used in structural equation modeling. AMOS 4.0 is util ized to develop and test 
causal models of mental and physical health outcomes among Gulf War veterans. By 
specifying the particular types of analysis to be performed, AMOS 4.0 can take the data, 
plug them into the model under question, and perform desired statistical procedures. In 
Structural Equation Modeling, no single test determines whether or not a model fits the 
data; rather, multiple statistical procedures together provide information on how well the 
hypothesized model fits with the data. The goodness-of-fit tests performed in this study 
are the statistical procedures most commonly used in Structural Equation Modeling. 
They include tests for chi-square, chi-square/degrees of freedom, goodness-of-fit index, 
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adjusted-goodness-of-fit index, root mean square error of approximation, and the test for 
Hoelter's critical N. Modification Indexes, which show areas of model misfit, are also 
used in this study, especially with regard to model respecification. (For more 
information on the goodness-of-fit tests and modification indexes, please see Appendix 
X. )  
Organization of the Study 
Chapter One provides a brief overview of the Gulf War, a description of the 
problems that some veterans are having because of their service in that war, and the 
theoretical framework of the study. It presents the study' s  specific aims, the hypotheses 
that are considered, and the models that are analyzed. It introduces background 
information on Structural Equation modeling and the AMOS program, the methodology 
employed, and the statistical procedures utilized. 
Chapter Two reviews the relevant scientific l iterature on the stressful exposures 
and the subsequent mental and physical health problems associated with service in the 
Gulf War. It describes how the literature review was conducted, and presents areas of 
prior research on Gulf War il lnesses, and the results thus far of that research. The 
chapter's focus is stress and how stressful exposures are associated with mental and 
physical health problems. It reviews the literature regarding the effects that wartime 
stress have on soldiers; in particular, it looks at how stressors during the Gulf War may 
have affected the troops who fought it. The findings of a number of studies on stress are 
listed in tables. Chapter Two, also reports what the scientific literature has to say about 
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how age, gender, race, and social support may affect an individual 's response to stressful 
experiences. 
Chapter Three presents the methodology used in this dissertation. It details the 
development of the proposed structural equation models used to test the three hypotheses 
under consideration. Specifically, the derivation of outcome variables in the model is 
presented as well as how they and the remaining variables were developed, measured, 
and positioned. The chapter also shows how the data for this study were collected, 
cleaned, and made ready for analysis by the AMOS 4.0 program. It traces the 
development of the Gulf War Stress Survey that was sent out to veterans and other health 
experts and how the results of that survey were compiled to set up a Gulf War Stress 
Scale, similar to the Holmes and Rahe Social Readjustment Rating Scale. Finally, 
chapter three shows the process of respecification of the models, based on theoretical 
considerations, to obtain better fit with the data. 
Chapter Four presents the results for all statistical analyses performed here: both 
the results of the Gulf War stress survey sent out to veterans and health professionals that 
were used to develop a stress scale, and the results of the factor and correlational analysis 
used to derive health outcome variables. This chapter also provides the descriptive 
statistics for all variables in the proposed structural equation model, and the results of the 
goodness-of-fit tests that are part of the statistical analysis described in the methodology 
chapter. Model respecification results for better fit are included, as wel l .  
Chapter Five evaluates the findings from the results section and draws 
conclusions from the overall work. The chapter discusses in detail the meaning of the 
results and how they support or reject the proposed hypotheses. It wil l  cover the 
theoretical, methodological, practical, and policy implications of the results; the 
l imitations of the overall work; and offer suggestions for future study in this area. 
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Finally, the Appendices at the end o f  the dissertation provide background 
information and more in-depth coverage of certain topics discussed only briefly in the 
body of the text. Greater detail on many of the topics relevant to the dissertation is 
offered in the Appendices in order not to sidetrack the reader from the dissertation's main 
topics. Both the Gulf War stress survey sent out to veterans and health experts and the 
portions of the Comprehensive Clinical Evaluation Program survey used in this 
dissertation are included in the Appendices. 
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CHAPTER 2 :  LITERATURE REVIEW 
Introduction 
This chapter reviews the scientific literature pertinent to stressful exposures and 
the subsequent mental and physical health problems associated with service in the Gulf 
War. It begins by examining the major studies showing that Gulf War have higher rates 
of physical and mental health problems than do their military counterparts who did not 
serve in the Gulf. It then gives an overview of the major areas of research that have been 
conducted and are ongoing with regard to the health status of Gulf War veterans. The 
l iterature review next focuses on the overall link between stress and health outcomes 
found in the general scientific literature - specifically, how stress affects both 
psychological and physical health outcomes and why the relationship between 
psychological and physical health outcomes is a recursive (unidirectional flow), not a 
reciprocal one. The review then examines the effects of stress on health outcomes as 
shown in the mil itary l iterature, including how stress relates to post-traumatic stress 
disorder (PTSD). The Gulf War l iterature is surveyed to see how the many stressful 
exposures that veterans encountered may have predisposed them to health problems upon 
their return home. Finally, the review delves into the existing l iterature on how stress 
affects differing groups of individuals such as older persons, females, minorities, and 
individuals who lack social support systems. 
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Conduct o f  the Literature Review 
The literature reviewed for this dissertation came from a variety of sources, all of 
which are publicly available and unclassified. A variety of literature sources were used 
in order to avoid bias in the background information. Articles on Gulf War veteran's 
il lnesses were found and researched through medical search engines such as medline, 
pubmed, and embase. The search terms used most often were Gulf War, stress, i l lness, 
and health outcomes. Articles were also found at the Veterans Administration internal 
l ibrary and through generic search engines such as www.yahoo.com and 
www.google.com. Other, published materials came from the Institute of Medicine, 
which is part of the National Academy of Sciences, and from the Rand Corporation, a 
nonprofit institution that helps improve policy and decision-making through research and 
analysis. 
Specific study information came from the Research Working Group of the Gulf 
War Coordinating Board's Annual Report to Congress on Federally Sponsored Research 
on Gulf War Veterans i l lnesses (FSRGWVI, 2000) as well as from Rand reports. 
Information on stressful exposures that troops encountered came from a variety of online 
web pages: the Department of Veterans Affairs Gulf War web page at 
http://www.va.gov/gulfwar/. the Department of Defense page regarding Gulf War 
Il lnesses at http://www.gulflink.osd.mill. and the United Kingdom·s Ministry of Defence 
Gulf Veterans '  il lness page at http://www.mod.uklissues/gulfwarlindex.html. 
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Health Problems in Gulf War Veterans 
Although the majority of veterans of the Gulf War returned to an active and 
normal l ife after the war, many veterans found that they had unexplained mental and 
physical health problems that they attributed to the war. The Departments of Defense 
(DoD), Health and Human Services (HHS), and Veterans Affairs (V A) have sponsored 
numerous studies to investigate the health concerns of these veterans and the etiologic 
causes of their il lnesses. The most compelling of these studies compare the health status 
of veterans who served in the Gulf War with those who did not. Table 2 reviews the 
major studies that directly compare the health status of Gulf War veterans and same era 
control groups who were not deployed. Those studies offer sufficient evidence that Gulf 
War veterans are indeed more likely to have mental and/or physical health problems than 
are those veterans who did not serve there. 
Possible Causes of Health Problems among Gulf War Veterans 
In 1 995, the Presidential Advisory Committee on Gulf War Veterans' Il lnesses, in 
consultation with the Department of Defense, Veterans Administration, and Veteran 
Services Organizations (VSOs) came up with a list of suspected risk factors for il lnesses 
associated with the Gulf War. The Committee advised the President and Congress that 
federal funds should be provided for research in the following areas: 
• Chemical warfare agents (See Appendix XI and Appendix XIX survey links 1 0, 
1 1 . )  
• Biological warfare agents (See Appendix XII . )  
Vaccines against chemical and biological weapons (See Appendix XII I  and 
Table 2 :  Major studies comparing the health status of Gulf War deployed vs. non­
deployed veterans 
Study: Iowa Persian Gulf Study Group, 1 997 
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Objectives: Compared deployed and non-deployed veterans' self-report of symptoms 
and il lness 5 yrs fol lowing the Gulf War. 
Sample: 
Control: 
Time of 
Stratified sample drawn from 4 study groups (Gulf War regular military, 
National GuardlReserve, non-Gulf War regular military, and non-Gulf 
War National Guard/reserve). Sample stratified for age, race, sex, rank, 
and branch. N=3695, male=9 1 %, White=9 1 %, Age < 25=9 1 %  
Yes, N= 1 799. 
Assessment: 5 yrs post-Gulf War 
Exposure 
Assessment: Military Exposure Questionnaire; deployment as proxy 
Methodology: Between-group study comparing deployed versus non-deployed military 
personnel on post-Gulf War psychological symptoms. Not deployed to 
Gulf War as a control group. Stratified random sample with proportional 
allocations. 
Relevant 
Findings: 
Study: 
Objectives: 
Sample: 
Control: 
Time of 
Assessment: 
Exposure 
Assessment: 
Methodology: 
Relevant 
Findings: 
Gulf War military personnel had significantly more PTSD, depression, 
chronic fatigue, cognitive dysfunction, bronchitis, asthma, fibromyalgia, 
alcohol abuse, sex discomfort than non-deployed Gulf War military 
personnel. National Guard/reserve reported more chronic fatigue and 
general health problems than regular military. 
Iowa Persian Gulf Study Group, 1 997 
To compare prevalence of self-reported problems in deployed and non­
deployed veterans 
Stratified random sample of 3695 active, reserve, and Guard troops: 
male=9 1 %, white=9 1 %, age <25=9 1 %, response rate=76%, all from Iowa 
Yes, N= 1 799, male=9 l %, female=9%. 
5 yrs post-Gulf War 
Deployment; mil itary exposure questionnaires 
Epidemiologic study; self-reported 
Deployed had higher prevalence of selected mental and physical health 
symptoms and syndromes; reservists more chronic fatigue and alcohol 
abuse than regular mil itary; most Gulf War exposures related to medical 
and psychiatric conditions. 
Table 2 continued: Major studies comparing the health status of Gulf War deployed vs. 
non-deployed veterans 
Study: 
Objectives: 
Sample: 
Control: 
Time of 
Sohler, 1 992 
To assess the psychological sequelae of Gulf War service; 
examined gender, deployment, and pre-Gulf  War exposure. 
N=507; Reserve and Guard troops: female=2 1 %, N=288 Gulf War 
deployed 
N= 1 99 not activated 
Yes 
Assessment: 7/9 1 -9/9 1 ,  6 months post-Gulf War 
Exposure 
Assessment: Deployed versus non-deployed; CES 
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Methodology: Between-group design comparing deployed and non-deployed veterans on 
health and self-reported psych./physical health symptoms. 
Relevant 
Findings: 
Study: 
Objectives: 
Sample: 
Control: 
Time of 
Deployed reported higher IES than not deployed did. 
Stretch et aI . ,  1 996 
Examined the prevalence of PTSD symptoms in active and reserve 
deployed Gulf War veterans and active and reserve non-deployed Gulf 
War veterans following Gulf War 
Active duty and reservists from Pennsylvania and Hawaii who were 
assigned to Army, Navy, Air Force & Marines. Subjects were either 
deployed ( 1 524; active 7 1 5 ; reserve 766) or not deployed (25 1 2 ; active 
1 576; reserve 948) to ODS. Gender not specified. 
Yes, N=25 1 2 . 
Assessment: Mail survey; 2 years post-Gulf  War 
Exposure 
Assessment: Deployed versus non-deployed; self-report of stressors. 
Methodology: Between-group design examining prevalence rates of PTSD symptoms in 
active versus reservists, and deployed versus non-deployed to Gulf War. 
Relevant 
Findings: Active duty=57 deployed subjects PTSD positive (8%) /2 1 of non­
deployed PTSD positive ( 1 .3%). Reservists=70 deployed PTSD positive 
(9.2%)/20 non-deployed PTSD positive (2 . 1  %). Significant correlation 
between stressors and PTSD symptoms. 
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Table 2 continued: Major studies comparing the health status of Gulf War deployed vs. 
non-deployed veterans 
Study: 
Objectives: 
Sample: 
Control: 
Time of 
Sutker et aI . ,  1 993 
Examined the relationship between war stress and physical and 
psychological symptoms following Gulf War in activated deployed and 
non-deployed troops. 
Army National Guard and Army Reserve. Troops were distributed across 
air reserve, medical, and infantry support specialist, air ambulance, tactical 
fighters, maintenance, and quartermaster. N=2 1 5 , male=82%, 
female= 1 8%. 
Yes, N=60. 
Assessment: 4- 1 0  months post-ODS 
Exposure 
Assessment: ODS-SES (divided groups into high and low exposure). 
Methodology: Between-group design comparing deployed (high and low exposure) with 
non-deployed (no exposure) on variables of post-ODS psychological 
sequelae. Compared PTSD positive with PTSD negative on personal 
characteristics. 
Relevant 
Findings: 
Study: 
Objectives: 
Sample: 
Control: 
Time of 
Assessment: 
Exposure 
Assessment: 
High exposure group reported significantly higher MISS, PTSD Scale, 
BDI, anxiety and anger scores than did low and no exposure groups. High­
exposed had group significantly more difficulties sleeping, concentrating, 
nervousness. Gender and race significant correlation with PTSD.  
Stuart et  aI., 1 998 
To study assessed factors related to the long term psychological health of a 
sample of U .S .  Army National Guard and Reserve Unit veterans who 
served during ODS. 
N= 1 , 1 56 Army National Guard and 739 Army Reserve Subjects, 
male=90%, Average Age= 3 1  years. 
Yes, N=279, No Deployment history. 
I year post Gul f War 
Hierarchical Regression used to conduct reported symptom levels of 
psychological distress 
Methodology: Interview assessing wartime stressors 
Relevant 
Findings: This subset of Gulf War reserve veterans had elevated levels of distress in 
comparison to the control group. 
Table 2 continued: Major studies comparing the health status of Gulf War deployed vs. 
non-deployed veterans 
Study: 
Objectives: 
Sutker et aI. , 1 995 
Examined and compared the prevalence of psychological symptoms 
among military participants in war-zone exposed and stateside duty. 
Examined gender and ethnicity between exposed and non-exposed. 
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Sample: Gulf War war-zone exposed (n=653) and stateside duty troops (n=259). 
Included Army, Air Force, Marine, National Guard, and reserve units who 
underwent psychological debriefing post-Gulf  War. N=9 1 2, female= 1 3%, 
White=63%. 
Control: Yes, N=259, male=83%, female= 1 7%. 
Time of 
Assessment: Within 1 2  months post-Gulf War 
Exposure 
Assessment: ODS-SES 
Methodology: Between-group study comparing war-zone exposed and stateside duty on 
psychological symptoms post-Gulf War. Examined gender and ethnicity. 
Relevant 
Findings: 
Study: 
Objectives: 
Sample: 
Control: 
Time of 
Assessment: 
Exposure 
Significantly more depression, anxiety, and somatic complaints for 
deployed; Minority significantly more symptoms of depression; female 
significantly more somatic complaints. No main effect for gender and 
PTSD; interaction effect gender by ethnicity for PTSD. 1 0- 1 2% deployed 
PTSD positive. 
Unger et aI., 1 992, VA Report, Chap 8 
Examined physical and psych. symptoms in deployed and non-deployed 
troops. 
N=85 ; Reserve and Guard veterans; no demographics provided. 
Yes, N=5 1 of 85 .  
Upon return to Rhode Island; time not specified 
Assessment: CES; deployment as proxy for stress exposure 
Methodology: Between-group design comparing deployed and non-deployed troops. 
Relevant 
Findings: Deployed troops had significantly higher physical and psychological 
symptoms except for depression (somatization not clear). 
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Appendix XIX survey links 1 5 , 1 6. )  
• Pyridostigmine bromide (See Appendix XIV and Appendix XIX survey link 1 3 . )  
• Various occupational exposures, such as petroleum products and paints (See 
Appendix XIX survey links 4, 5, 6, 7, 8 . )  
• Psychological and physical stress 
• Insecticides and repel lents (See Appendix XIX survey Iink I 4. )  
• Depleted Uranium (See Appendix XIX survey link 9 . )  
• Smoke from Kuwait oil fires (See Appendix XIX survey link 2 . )  
• Endemic infectious diseases (See Appendix XIX survey link 1 7 . )  
(Source: PACGVI, 1 995) 
Since that time numerous studies of both large and smal l populations of veterans have 
been conducted that focused on these areas (see Appendix XV for a review of Federal 
research on Gulf War veterans Il lnesses). 
Although significant progress has been made in determining a cause and effect 
relationship between certain exposures and the subsequent development of health 
problems, no single exposure has yet been definitively linked to the many types of health 
problems experienced by veterans of the Gulf War upon their return home (10M, 1 999). 
Part of the problem in coming up with specific causes for to the wide variety of il l  health 
effects is the lack of information available to researchers about troop exposures during 
and shortly after the Gulf War. The lack of credible exposure information has stymied 
investigators in their quest to answer fundamental health questions. One of the major 
lessons learned during the Gulf War with regard to preventing potential health problems 
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in returning veterans is that more effort should be made to collect data before, during, and 
after future deployments. That lesson learned has been evident during the current U.S .  
deployments in Afghanistan and Iraq, where troops are much more closely monitored to 
try to prevent potential deployment-related health problems. 
Despite the problems inherent in conducting Gulf War research, the Veterans 
Administration, the Department of Health and Human Services, and the Department of 
Defense remain steadfastly committed to improving the lot of i l l  veterans by continuing 
their research. As new information is discovered and new modeling techniques become 
available, new research will be funded. Solving the mysteries behind Gulf War i llnesses 
remains a top priority, not only to help the veterans still suffering today, but also to 
safeguard future generations of veterans who may be asked in times of war to serve their 
country. 
Focus on Stress 
Although there are many potential areas to consider when looking at possible 
causes for the health problems veterans faced returning from the Gulf War, this 
dissertation focuses on the stress of deployment and the mental and physical health of 
returning veterans. Stress is considered here because there are data available to be mined 
on the subject (the Comprehensive Cl inical Evaluation Program database) and also 
because there is an abundance of evidence from previous mil itary conflicts that stress can 
adversely affect mental and physical health. Stress is likewise be considered because 
unlike other areas of Gulf War research, with the possible exception of exposure to oil 
well fires, no one risk factor has had as great an effect on as high a percentage of Gulf 
War veterans as has the stress of deployment and eventual combat. 
Stress Definition 
29 
The literature provides several definitions of stress that are all fundamentally the 
same regardless of who is doing the defining. Webster's  dictionary defines stress as "a 
physical, chemical or emotional factor that causes bodily or mental tension resulting from 
factors that tend to alter an existing equilibrium." (New Merriam-Webster Dictionary, 
1 989) The American Medical Association (AMA) defines stress as "any interference that 
disturbs a person's mental and physical well-being" (American Medical Association 
Family Medical Guide). In physics, stress is defined as the internal resistance, or 
counterforce, of a material to the distorting effects of an external force or load given by 
the equation Stress (cr) = FIA, where F = force and A = cross sectional area (Giancoli, 
2000). Several psychologists define stress as "a real or perceived imbalance between 
environmental demands required for survival and an individual ' s  capacity to adapt to 
these requirements" (Lazerus and Folkman, 1 984; Chrousos and Gold, 1 992; Lovallo, 
1 997; PearIin, Lieberman, Menaghan and Mul len, 1 98 1 ;  Weiner, 1 992). In all, stress is a 
term that covers a number of emotional and physical responses, ranging from anxiety, 
panic, unhappiness, fatigue, tension, and strain, to excitement, stimulation, and a feeling 
of challenge. It is a personal response to situations, so what may be stressful to one 
person may not be to another. 
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Stress and Its Relationship to Health 
In the general scientific literature there is ample evidence of a connection between 
an individual experiencing stress and the development of subsequent health problems. 
Stress has been linked to the onset of diseases such as cardiovascular conditions 
(Benschop et al . ,  1 998; Pashkow, 1 999; Omish, 1 983), cancer (Cohen, 1 998; Siegel, 
1 986) and colds (Cohen et al., 1 998; Cohen 1 99 1 ), as well as to the exacerbation of 
symptoms such as asthma (Wright, 1 998), irritable bowel syndrome (Bennett, 1 998; 
Dancey, 1 998), ulcerative conditions (Whitehead, 1 985), arthritis (Crofford, 1 999), skin 
disorders (Lebowohl, 1 998) and diabetes (Inui; 1 998; Surwit, 1 992). In addition, stress 
has been linked to symptomatic experiences such as headaches (Davis, 1 998; 
Fanciullacci, 1 998; Holm, 1 997; Holroyd, 1 99 1 ), musculoskeletal pain (Dyrehag et al . ,  
1 998; Stacy, 1 992) gastrointestinal upset (Whitehead, 1 995), hyperventilation 
(Ringsberg, 1 999), insomnia (V gontzas, 1 998), and fatigue (Glaser, 1 998). 
Some of the characteristics that influence the stressful ness of an event include its 
intensity, chronicity, and complexity (Patterson, 1 987), as well as its novelty, ambiguity, 
unpredictability, and uncontrollability (Averill , 1 973; Mineka, 1 975,  Thompson, 1 98 1 ). 
At the same time, whether or not individuals perceive a given set of circumstances as 
stressful depends upon their own life experiences as well as their personal, social, and 
biological resources and vulnerabilities (Marshall, 1 999). Health care util ization research 
has repeatedly demonstrated that from 30% to 60% of all physician office visits are for 
il lness experiences that are non-disease-based, with stress as the common contributor 
(Cummings, 1 98 1 ;  Sobel, 1 995) .  
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Stress Exposure and Psychological Health Outcomes 
A large body of literature has examined the psychological morbidity associated 
with exposure to stressful life events. The aftermath of exposure to significant stressors 
ranges from moderate elevations of psychological complaints - including depression, 
anxiety, hostility, fatigue, appetite disturbance, headaches, back and neck aches, 
breathing difficulty, gastrointestinal complaints, and sleep problems - to severe forms of 
psychopathology meeting diagnostic criteria for psychiatric disorders (Adams, 1 984; 
Gregg, 1 995; Shore, 1 989). Common psychiatric diagnoses reportedly stemming from 
war zone or other trauma exposure as well as other l ife events include PTSD, anxiety 
disorders, depression, and somatization (Bremmer, 1 996; McFarlane, 1 992; van der Kolk, 
1 996). 
Most research suggests that psychiatric reactions to stressful l ife events (e.g., 
accidents and natural disasters) are short-lived, generally disappearing within 8- 1 6  
months (Fairly, 1 986; Keane, 1 990; Tranah, 1 994) .  Numerous studies, however, attest 
that stress reactions can persist long after the stressful circumstances have subsided. 
Studies of persons exposed to traumatic l ife events, including combat veterans, prisoners 
of war, and holocaust survivors, indicate that symptoms of stress exposure can persist for 
decades (Beebe, 1 975 ;  Goldstein, 1 987; Soloman, 1 996). 
A number of studies have examined the relationship between stress exposure 
during the Gulf War and subsequent psychological health problems. Table 3 is a 
summary of some of the major federally funded studies that examine the relationship 
between Gulf War stress and psychological health outcomes. For the most part these 
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Table 3: Major federally funded studies that examine the relationship between Gulf War 
stress and psychological health 
Study: 
Objectives: 
Sample: 
Control: 
Time of 
Assessment: 
Exposure 
Assessment: 
Methodology: 
Relevant 
Findings: 
Study: 
Objectives: 
Sample: 
Control: 
Time of 
Assessment: 
Exposure 
Haley & Kurt, 1 997 
Examined the psychological and physical symptoms reported by veterans 
following the Gulf War. 
Members of the 24th Reserve Naval Mobile Construction Battalion. 58% 
retired from service; 42% still active. N=249. 
No 
3 yrs/7 months post-Gulf War 
Booklet measuring war-time exposure 
Descriptive study examining the prevalence of health problems in Gulf 
War veterans. Factor analyzed reported symptoms. 
70% reported serious health problems attributed to war; six medical 
syndromes surfaced, explaining 70% of variance. Traumatic stress 
subscale was not elevated in any group of veterans with the reported 
medical syndromes. 
Iowa Persian Gulf Study Group, 1 997 
To compare prevalence of self-reported problems in deployed and non­
deployed veterans 
Stratified random sample of 3695 active, reserve, and Guard troops: 
male=9 1 %, white=9 1 %, age <25=9 1 %, response rate=76%; all from Iowa. 
Yes, N= 1 799, male=9 1 %, female=9%. 
5 years, post-Gulf War 
Assessment: Deployment; Military Exposure Questionnaire 
Methodology: Epidemiologic study; self-reported 
Relevant 
Findings: Deployed had higher prevalence of selected mental and physical health 
symptoms and syndromes; Reservists had more chronic fatigue and 
alcohol abuse than did regular military; most Gulf War exposures related 
to medical and psychiatric conditions. 
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Table 3 continued: Major federally funded studies that examine the relationship between 
Gulf War stress and psychological health 
Study: 
Objectives: 
Sample: 
Control: 
Time of 
Perconte, 1 993 
To examine level of psychological distress among Gulf War veterans 
Convenience sample; N=58 1 ;  Army, Navy, Marine Reservists: 
male=88%, white=9 1 %, response rate=95%, 1 26 activated but not 
deployed; 26 deployed to Europe; 429 deployed to Gulf War 
Yes 
Assessment: I I  months post-Gulf War 
Exposure 
Assessment: Military History Questionnaire units rank ordered by war-stress exposure 
Methodology: Comparison of deployed and non-deployed troops 
Relevant 
Findings: 
Study: 
Objectives: 
Sample: 
Control: 
Time of 
Assessment: 
Exposure 
Assessment: 
Methodology: 
Relevant 
Findings: 
Distress higher among deployed. Among deployed, distress higher among 
females; No race effects; GSI and MISS; but not BDl, scores increased 
with war stress rank order (units with more combat stress). 
Perconte et aI. , 1 993 
Examined war-related psychological distress among Gulf War veterans 
fol lowing Gulf War. 
Community sample of Army, Navy, and Marine Reservists. 1 26 activated 
but not deployed; 26 deployed to Europe; 439 deployed to Persian Gulf 
combat theater. N=58 1 ,  male=88%, White=9 1 %. 
Yes, N= 1 52. 
I I  months post-Gulf War 
Deployed versus not deployed 
Between-group design comparing deployed Gulf War veterans with non­
deployed Gulf War veterans on psychological symptoms following trauma 
exposure. Examined variables of gender, race, and prior combat exposure. 
Significant effect of deployment. Gender effect significant for MISS & 
BDI. Significant interaction effect for gender by deployment. Female 
significantly higher scores on MISS. No significant effect of prior combat. 
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Table 3 continued: Major federally funded studies that examine the relationship between 
Gulf War stress and psychological health 
Study: 
Objectives: 
Sample: 
Control: 
Time of 
Sutker et a\ . ,  1 993 
Examined relationship between war stress and physical/psychological 
symptoms following Gulf War in activated deployed and non-deployed 
troops. 
Convenience sample; N=2 1 5 ; Army National Guard/reserve troops 
Yes, N=60. 
Assessment: 4- 1 0  months post-Gulf War 
Exposure 
Assessment: ODS-SES 
Methodology: Between-group design comparing deployed (high and low) with non­
deployed on psych. and physical health measures 
Relevant 
Findings: 
Study: 
Objectives: 
Sample: 
Control: 
Time of 
Deployed with high exposure had higher depression, anxiety, and physical 
health complaints than did non-deployed. Deployed with low exposure 
reported symptom levels more comparable to those of non-deployed. 
Sutker et a\ . ,  1 995 
Examined and compared the prevalence of psychological symptoms 
among military participants in war-zone exposed and stateside duty. 
Examined gender and ethnicity between exposed and non-exposed. 
Gulf war-zone exposed (n=653) and stateside duty troops (n=259). 
Included Anny, Air Force, Marine, National Guard, and reserve units who 
underwent psychological debriefing post-Gulf War. N=9 1 2, female= 1 3%, 
White=63% 
Yes, N=259, male=83%, female= 1 7%. 
Assessment: Within 1 2  months post-Gulf War 
Exposure 
Assessment: ODS-SES 
Methodology: Between-group study comparing war-zone exposed and stateside duty on 
psychological symptoms post-Gulf War. Examined gender and ethnicity. 
Relevant 
Findings: Significantly more depression, anxiety, and somatic complaints for 
deployed; minority with significantly more symptoms of depression; 
females with significantly more somatic complaints. No main effect for 
gender and PTSD; interaction effect of gender by ethnicity for PTSD. 1 0-
1 2% deployed PTSD positive. 
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Table 3 continued: Major federally funded studies that examine the relationship between 
Gulf War stress and psychological health 
Study: 
Objectives: 
Sample: 
Control: 
Time of 
Sutker et aI . ,  1 994 
Examined and compared psychological and physical symptoms post-Gulf 
War in Gulf War veterans who were deployed to graves registry with Gulf 
War veterans who remained stateside. 
Army Reservists assigned to 3 quartermaster companies that provided 
supplies and logistic support; 40 were deployed to graves registry. N=60, 
female=8%, Hispanic=98%. 
Yes, N=20, male=95%. 
Assessment: 1 2  months post-Gulf War 
Exposure 
Assessment: Graves Registry Duty Scale; deployed versus non-deployed 
Methodology: Between-group design comparing Gulf War veterans deployed to graves 
Relevant 
Findings: 
Study: 
Objectives: 
Sample: 
Control: 
Time of 
Assessment: 
Exposure 
Assessment: 
registry with Gulf War veterans remaining stateside on post-Gulf War 
psychological sequelae. 
Exposure group reported more current and l ifetime psychiatric disorders 
than non-exposure group did. Exposure group had more PTSD symptoms, 
higher BDl, ST AS, ST AI, & physical symptoms checklist scores. 53% of 
PTSD cases had concurrent psychological disorder. 
Stuart et aI . ,  1 998 
To study assessed factors related to the long-term psychological health of 
a sample of U.S .  Army National Guard Reserve Unit veterans who served 
during ODS. 
N= 1 , 1 56 Army National Guard and 739 Army Reserve subjects. 
male=90%, Ave. age = 3 I years 
Yes, N = 279, No deployment history 
I year post-Gulf War 
Hierarchical Regression used to conduct reported symptom levels of 
psychological distress. 
Methodology: Interview assessing wartime stressors 
Relevant 
Findings: This subset of Gulf War reserve veterans had elevated levels of distress in 
comparison to the control group. 
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Table 3 continued: Major federally funded studies that examine the relationship between 
Gulf War stress and psychological health 
Study: 
Objectives: 
Sample: 
Control: 
Time of 
Unger et aI . ,  1 992 
Examined and compared Gulf War veterans with National Guard veterans 
who remained in U.S . ,  on post-Gulf War psychological symptoms. 
Gulf War veterans following return to Rhode Island from deployment to 
Persian Gulf and National Guard Servicemen (NGS) who remained in 
U .S . ,  N=85 .  
Yes, N=5 1 .  
Assessment: Upon return to Rhode Island from Persian Gulf; time not specified 
Exposure 
Assessment: CES; deployment as proxy 
Methodology: Between-group design comparing deployed and non-deployed reserve 
personnel on post-Gulf War psychological sequelae 
Relevant 
Findings: 
Study: 
Objectives: 
Sample: 
Control: 
Time of 
Differences between NGS and Gulf War veterans on CES, MISS, SCL-90-
R (7 of 9 scales). Of the Gulf War veterans, 50% under enemy fire saw 
someone kil led; 75% felt in danger of being killed. Of Gulf War veterans, 
50% had moderate-severe intrusive thoughts and avoidance and 35% had 
nightmares. 
Unger et aI . ,  1 993 
Examined physical and psychological symptoms in deployed and non­
deployed troops. 
N=85;  Reserve and Guard veterans; no demographics provided. 
Yes, N=5 1 .  
Assessment: Upon return to Rhode Island; time not specified 
Exposure 
Assessment: CES; Deployment as proxy for stress exposure 
Methodology: Between-group design comparing deployed and non-deployed troops 
Relevant 
Findings: Deployed troops had significantly higher physical and psychological 
symptoms except for depression. 
studies show a positive correlation between service in the Gulf and the onset of 
psychological disorders. 
Stress Exposure and Physical Health Outcomes 
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There is an abundance of literature addressing the link between stress exposure 
and physical health outcomes. Stress has been shown to adversely affect the autonomic 
nervous system and neuroendocrine system, thereby causing problems with the immune, 
gastrointestinal, neuromuscular, and cardiovascular systems among others (de la Torre, 
1 994; McEwen, 1 998). Stress has also been shown to activate short-term adaptive 
physiological changes as well as a whole range of somatic symptoms (e.g., rapid heart 
rate, increased perspiration, gastrointestinal motility) that may be experienced as 
symptomatic of i l l  health (Chrousos, 1 992). Although there are short-term adaptive 
benefits to the body from these physiological responses, their chronic activation is 
believed to enhance vulnerabi lity to cardiovascular, metabolic, immune-related, and other 
diseases (Chrousos, 1 992; McEwen, 1 998) as well as changes in the central nervous 
system and the structure of the brain itself (Sapolsky, 1 996). Evidence in both animals 
and humans also suggests that exposure to stressful events may increase the permeabil ity 
of the blood brain barrier, thus rendering the central nervous system susceptible to drugs 
that typically act only on peripheral mechanisms (Friedman, 1 996). Table 4 summarizes 
some of the major federally funded studies that examine the relationship between stress 
in the Gulf and physical health outcomes. There appears to be sufficient evidence from 
these studies of is a positive correlation between Gulf War stress and some of the 
physical health problems experienced by returning veterans. 
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Table 4 :  Major federally funded studies that examine the relationship between Gulf War 
stress and physical health. 
Study: 
Objectives: 
Sample: 
Control: 
Time of 
Haley & Kurt, 1 997 
Examined the psychological and physical symptoms reported by veterans 
following the Gulf War. 
Members of the 24th Reserve Naval Mobile Construction Battalion. 58% 
retired from service; 42% stil l  active. N=249. 
No 
Assessment: 3 yrsl7 months post-Gulf War 
Exposure 
Assessment: Booklet measuring war-time exposure 
Methodology: Descriptive study examining the prevalence of health problems in Gulf 
War veterans. Factor analyzed reported symptoms. 
Relevant 
Findings: 
Study: 
Objectives: 
Sample: 
Control: 
Time of 
70% reported serious health problems attributed to war; six medical 
syndromes surfaced, explaining 70% of variance. Traumatic stress 
subscale was not elevated in any group of veterans with the reported 
medical syndromes. 
Iowa Persian Gulf Study Group, 1 997 
Compared deployed and non-deployed veterans' self-report of symptoms 
and il lness 5 yrs following Gulf War. 
Stratified sample drawn from 4 study groups (Gulf War regular military, 
National Guard/Reserve, non-Gulf War regular military, and non-Gulf 
War National Guard/reserve). Sample stratified for age, race, sex, rank, 
and branch. N=3695, male=9 1 %, White=9 1 %, Age < 25=9 1 %. 
Yes, N= 1 799. 
Assessment: 5 yrs post-Gulf War 
Exposure 
Assessment: Military Exposure Questionnaire; deployment as proxy 
Methodology: Between-group study comparing deployed versus non-deployed military 
personnel on post-Gulf War psychological symptoms. Not deployed to 
Gulf War as a control group. Stratified random sample with proportional 
allocations. 
Relevant 
Findings: Gulf War military personnel had significantly more PTSD, depression, 
chronic fatigue, cognitive dysfunction, bronchitis, asthma, fibromyalgia, 
alcohol abuse, sex discomfort than did non-deployed Gulf War military 
personnel. National Guard/reserve reported more chronic fatigue and 
general health problems than regular military did. 
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Table 4 continued: Major federally funded studies that examine the relationship between 
Gulf War stress and physical health 
Study: 
Objectives: 
Sample: 
Control: 
Time of 
Iowa Persian Gulf Study Group, 1 997 
To compare prevalence of self-reported problems in deployed and non­
deployed veterans. 
Stratified random sample of 3695 active, reserve, and Guard troops: 
male=9 1 %, white=9 1 %, age <25=9 1 %, response rate=76%, all from Iowa 
Yes, N= 1 799, male=9 1 %, female=9%. 
Assessment: 5 years post-Gulf War 
Exposure 
Assessment: Deployment; Mi litary Exposure Questionnaire. 
Methodology: Epidemiologic study; self-reported. 
Relevant 
Findings: Deployed had higher prevalence of selected mental and physical health 
symptoms and syndromes; Reservists had more chronic fatigue and 
alcohol abuse than did regular military; most Gulf War exposures related 
to medical and psychiatric conditions. 
Study: 
Objectives: 
Sample: 
Control: 
Time of 
Stretch et aI., 1 995 
Examined self-assessed physical health of Gulf War veterans. 
Active duty and reservists from Pennsylvania and Hawaii; included all 
services: deployed= 1 524, non-deployed=25 1 2. 
Yes 
Assessment: 2/93-8/93 
Exposure 
Assessment: Deployment; sel f-report of stressors 
Methodology: Cross-sectional survey; self-report 
Relevant 
Findings: Deployed troops reported more physical health complaints even after 
adjustment for demographics. 
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Table 4 continued: Major federally funded studies that examine the relationship between 
Gul f War stress and physical health 
Study: 
Objectives: 
Sample: 
Control: 
Time of 
Sutker et aI . ,  1 993 
Examined relationship between war stress and physical/psychological 
symptoms following Gulf War in activated deployed and non-deployed 
troops. 
Convenience sample; N=2 1 5 ;  Anny National Guard/reserve troops 
Yes, N=60 of 2 1 5 .  
Assessment: 4- 1 0  months post-Gulf War 
Exposure 
Assessment: ODS-SES 
Methodology: Between-group design comparing deployed (high and low) w/non­
deployed on psych. and physical health measures. 
Relevant 
Findings: 
Study: 
Objectives: 
Sample: 
Deployed with high exposure had higher depression, anxiety, and physical 
health complaints than did non-deployed; deployed with low exposure 
reported symptom levels more comparable to non-deployed. 
Sutker et aI . ,  1 994 
Examined psychological, physical, and psychiatric disorders in Anny 
Reservists who served grave registry duty in Gulf War. 
N=24; Anny Reservists assigned to Quartennaster unit: male=2 1 ,  
female=3 . 
Control: No 
Time of 
Assessment: 8 months post-Gulf War 
Exposure 
Assessment: ODS-SES 
Methodology: Descriptive study examining prevalence of self-reported health problems 
and diagnosed psychiatric disorders. 
Relevant 
Findings: Body handlers had elevated physical and psychological symptoms relative 
to civilian nonns; 55% diagnosed w/current Axis I disorder. 
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Table 4 continued: Major federally funded studies that examine the relationship between 
Gulf War stress and physical health 
Study: 
Objectives: 
Sample: 
Control: 
Time of 
Sutker et a! . ,  1 994 
Examined and compared psychological and physical symptoms post-Gulf 
War in Gulf War veterans who were deployed to graves registry with Gulf 
War veterans who remained stateside. 
Army Reservists assigned to 3 quartermaster company that provided 
supplies and logistic support; 40 were deployed to graves registry. N=60, 
female=8%, Hispanic=98%. 
Yes, N=20, male=95%. 
Assessment: 1 2  months post-ODS 
Exposure 
Assessment: Graves Registry Duty Scale; deployed versus non-deployed. 
Methodology: Between-group design comparing Gulf War veterans deployed to graves 
Relevant 
Findings: 
registry with Gulf War veterans remaining stateside on post-Gulf War 
psychological sequelae. 
Exposure group reported more current and l ifetime psychiatric disorders 
than non-exposure group did. Exposure group had more PTSD symptoms, 
higher BDI, ST AS, ST AI, and physical symptoms checklist scores. 53% 
of PTSD cases had concurrent psychological disorders. 
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The Relationship between Psychological Health and Physical Health 
Considerable evidence in the scientific literature suggests that an individual ' s  
physical health is partly dependent upon their psychological well-being. Numerous 
studies have shown that when an individual develops a psychological disorder, he or she 
they often develops physical health problems as a result of that disorder. Studies on 
common psychological disorders such as depression, for example, show that suffering 
individuals often develop muscle pains, digestive problems, and respiratory ailments as a 
result of their depression (Spi lane, 2002). Other studies indicate that individuals who 
have had long-term depression are more likely to develop heart disease (Linden, 2003, 
Carney, 200 1 ), cancer ( Spiegel, 2003), osteoporosis (Vrkljan, 2003) and immune system 
problems (Scanlan, 200 I ), in comparison to persons who do not suffer from long-term 
depression. Anxiety, which is another common psychological disorder, has been known 
to cause dizziness, chest pain, abdominal discomfort, frequent urination, and shortness of 
breath (BUPA, 2003 ) .  Simi larly eating and sleeping disorders, which often have a 
psychological basis, have been implicated in physical health problems. Anorexia and 
bul imia, for example, can lead to malnutrition, dehydration, electrolyte imbalances, 
edema, muscle atrophy, acid reflux, kidney failure, osteoporosis, dental problems, liver 
failure, infertil ity, stomach ulcers, and even death if not treated (Zerbe, 1 996) .  Sleep 
disorders such as insomnia, obstructive sleep apnea, and parasomnias (disruptive sleep 
disorders, which include sleep walking, sleep eating, and sleep terror), have also been 
shown to cause physical health problems such as drowsiness, irritabil ity, and 
hypertension (Schubert, 2002). 
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Although there is evidence in the scientific literature suggesting that physical 
health problems cause psychological health problems, the evidence for this relationship is 
not as convincing as that for the reverse relationship. Evidence from the scientific 
l iterature shows that most psychological disorders are a causal effect arising not from 
physical health problems, but rather from something else. Psychological conditions such 
as social phobia (Ramsay, 200 1 ), schizophrenia (Maguire, 2002), panic attacks (lnada, 
2003), depression (Wong, 200 1 ), and attention deficit disorder (Doyle, 2002), for 
example, all have genetic components that play a large role. These conditions may have 
physical components as well ;  however, the scientific l iterature suggests that these are 
minor and are overshadowed by the genetic components. Many other common 
psychological health problems such as post-traumatic stress disorder, conduct disorder, 
and oppositional defiant disorder are thought to have been initiated by an upsetting 
extemal l ife experience, not a physical health problem (Quyen, 200 I ) . Still other 
psychological disorders such as delusional disorder (Mullen, 2003) and obsessive­
compulsive disorder (AAFP, 2002) have unknown etiologies. These disorders may have 
physical components, but as of yet the scientific community has not agreed upon their 
causes. 
For the purposes of this dissertation, a recursive model postulates that 
psychological health problems cause physical health problems. This step is founded 
strictly upon theoretical grounds supported by the findings from the literature search. 
Although there is some evidence that a reciprocal relationship exists between 
psychological health and physical health, there is not enough to warrant a causal effect 
from physical health problems to psychological health problems. 
War Zone Stress 
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The war zone is replete with hardships and dangers, including many that are only 
secondarily related to combat itself (Grinker, 1 945; Hobfoll, 1 99 1 ) . Classic discussions 
of war-related stress have long recognized that exposure to combat can lead to mental and 
physical health problems (Carroll, 1 985;  Foy, 1 987). In general, the literature describes a 
dose response relationship between combat exposure and increased risk of subsequent 
mental and physical health problems (Fairbank, 1 990; O'Toole, 1 996). Recent research 
on war zone stress has studied the possibility that war zone deployment may be 
associated with a wide range of potential stressors, some of high magnitude and others of 
low magnitude (King, 1 995). High magnitude war zone stressors such as direct combat 
exposure and the witnessing of wartime atrocities have long been documented as 
potentially causing health problems (Litz, 1 997). It is only recently, however that the 
same has potential been found for low magnitude stressors such as harsh living 
conditions, lack of privacy, long work hours, and difficult climatic conditions (Litz, King 
1 995).  These low magnitude stressors often foster a sense of disheartenment, discomfort, 
or demoralization that, like high magnitude stressors, can lead to long-term adverse 
health effects (Litz, King 1 997). 
Stress in Past Military Conflicts 
The association between war zone stress and subsequent health problems among 
soldiers is not a new phenomenon. War-related il lnesses simi lar to those encountered by 
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veterans of the Gulf War have been reported as far back as the Civil War, when records 
of such occurrences were first kept. During the Civil War, many soldiers on both sides 
complained of fatigue, shortness of breath, headaches, sleep disorders, memory problems, 
and difficulty in concentrating, which they blamed on the stress of battle (Hyams, 1 996). 
Likewise, during World War I many soldiers were diagnosed with shelI shock or trench 
neurosis, an acute il Iness attributed to combat stress. These soldiers became dazed or 
detached, exhibited an exaggerated or startled response to stimuli ,  and often had severe 
anxiety problems that caused them to break down in battIe (Hyams, 1 996). During World 
War II and the Korean War, also many soldiers reported health problems with 
concentration, sleeplessness, anxiety and physical and emotional exhaustion. Many 
described the onset of their symptoms as occurring even before they actualIy saw combat 
(Bramsen, 1 999, Elder, 1 995) .  As in other wars, some veterans of the Vietnam War 
experienced symptoms that included sleep problems, difficulty concentrating, and general 
anxiety. Many of these veterans attributed their health problems to the overalI stress of 
deployment, preparation for combat, and actual combat (Kulka, 1 990). In alI, the stress 
of combat and the stress involved in preparing for combat have played a significant role 
throughout our military history in terms of the health outcomes of our veterans. 
Although the symptoms of these health problems are welI documented, the causes and 
means of prevention are stilI not welI understood. 
Post-Traumatic Stress Disorder (PTSD) 
Post Traumatic Stress Disorder (PTSD) is a stress disorder that deserves special 
attention due to the severity of its symptoms and the lasting effects it has. Although only 
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recently ( 1 980) added as a new diagnostic category to DSM (Diagnostic and Statistical 
Manual ) by the American Psychiatric Association, PTSD is not a new disorder. There 
are written accounts of simi lar symptoms that go back to ancient times, describing 
soldiers having severe stress symptoms after experiencing traumatic battlefield events 
(Horowitz, 1 999). Soldiers in many wars have often complained of health problems, 
lasting many years, that were the result of life-threatening experiences and witnessing 
and engaging in terrifying, gruesome acts of violence on the battlefield (Horowitz, 1 999). 
The diagnosis of PTSD describes the adverse health responses that some experience after 
exposure to such l ife threatening or horrific events (APA, 1 980). Some of the more 
prevalent symptoms associated with PTSD include 1 )  reexperiencing the event in varying 
sensory forms ( flashbacks), 2) avoiding reminders associated with this trauma, and 3)  
chronic hyperarousal in the Autonomic Nervous System (ANS) (APA, 1 994.). These 
symptoms are often accompanied by loss of function in jobs or social relationships. The 
effects of PTSD may last a l ifetime if untreated. Even with treatment, trauma memories 
usually do not go away entirely. They become more manageable, however, as new 
therapies are given and coping ski lls are learned (Davidson, 1 993) .  
Stress Exposures during the Gulf War 
There is an abundance of literature citing potential sources of stress that U .S .  
troops may have encountered while serving in the Gulf. Much of i t  focuses on high 
magnitude stressors such as direct combat exposure, the witnessing of horrific carnage on 
the battlefield, or the fear of being wounded or killed. Such intense types of stress have 
often been associated in the literature with the symptoms of PTSD as defined by the 
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DSM manual of the American Psychological Association (event flashbacks, hyper 
arousal, etc . ) .  Table 5 gives examples of how high magnitude stressors affected exposed 
troops. In most cases, troops exposed to traumatic stressful events were much more 
prone to psychological and physical health problems than were the troops spared such 
exposure. 
To a lesser degree the literature on Gulf War stress examines low magnitude or 
day-to-day stressors that troops encountered while deployed. This l iterature looks at the 
relationship between such stress exposure and other mental and physical health problems 
not associated with the experience of a traumatic or l ife-threatening event. The research 
on low magnitude stress focuses on the factors of deployment that alter an individual 's 
equilibrium, such as separation from loved ones (Litz, Orsillo et aI . ,  1 997), exposure to 
harsh living conditions (King et ai, 1 995), lack of privacy, long work hours, and limited 
opportunity for recreation. Other factors examined are mandatory vaccinations (Hotopf, 
2000), the threat of biological or chemical attack (Fiedler, 2000), exposures to smoke 
from oil well fires (Smith, 2002), as well as many other low impact stressors that upset 
the balance of daily l ife. Like the troops exposed to traumatic events, the troops exposed 
to such low magnitude stressors were adversely affected in comparison to the troops who 
were not deployed to the Gulf. 
The Stimulus-Based Model of Stress 
The Stimulus-based Model of Stress views stressful l ife events such as loss of a 
job, marital difficulties, or the death of a close family member as additive phenomena 
that can be used to predict the health of an individual. The model 's central proposition is 
Table 5 :  High magnitude stressors 
Study: 
Objectives: 
Sample: 
Control: 
Time of 
Baker et aI . ,  1 997 
Examined relationship between combat exposure and subsequent 
symptoms of PTSD. 
N= 1 88 ;  50% were help-seeking, and 50% were non-treatment-seeking 
veterans on active duty. 
Yes, PTSD group (N=24. )  
Assessment: Unspecified, but perhaps up to 3 years following Gulf War 
Exposure 
Assessment: Combat Exposure Scale; self-report 
Methodology: Correlational study and between-group comparison of veterans with and 
without PTSD 
Relevant 
Findings: 
Study: 
Degree of combat exposure was positively associated with PTSD 
symptom severity scores. 
Iowa Persian Gulf Study Group, 1 997 
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Objectives: Compared deployed and non-deployed veterans' self-reports of symptoms 
and il lness 5 years following Gulf War 
Sample: 
Control: 
Time of 
Stratified sample drawn form 4 study groups (Gulf War regular military, 
National Guard/reserve, non-Gulf War regular military, and non-Gulf War 
National Guard/reserve). male=9 1 %, White=9 1 %, Age < 25=9 1 %.  
Yes; N= 1 799. 
Assessment: 5 years post-Gulf War 
Exposure 
Assessment: Mil itary Exposure Questionnaire; deployments as proxy 
Methodology: Between-group study comparing deployed versus non-deployed military 
personnel on post-Gulf War psychological symptoms. Not deployed to 
Gulf War as a control group. Stratified random sample with proportional 
allocations. 
Relevant 
Findings: Gulf War military personnel had significantly more PTSD, depression, 
chronic fatigue, cognitive dysfunction, bronchitis, asthma, fibromyalgia, 
alcohol abuse, sex discomfort, than non-deployed Gulf War military 
personnel did. 
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Table 5 continued: High magnitude stressors 
Study: 
Objectives: 
Sample: 
Control: 
Time of 
Assessment: 
Exposure 
Sutker et aI . ,  1 993 
Examined the relationship between war stress and physical and 
psychological symptoms following Gulf War, in activated deployed and 
non-deployed troops 
Army National Guard and Army Reserve. Troops were distributed across 
air reserve, medical, and infantry support specialist, air ambulance, tactical 
fighters, maintenance, and quartermaster. N=2 1 5 , male=82%, 
female= 1 8%. 
Yes; N=60. 
ODS-SES (divided groups in high and low exposure) 
Assessment: 4- 1 0  months post-Gulf War 
Methodology: Between-group design comparing deployed with non-deployed on 
variables of post-ODS psychological sequelae. 
Relevant 
Findings: 
Study: 
Objectives: 
Sample: 
Control: 
Time of 
High exposure group reported significantly higher MISS, PTSD Scale, 
BDI, anxiety and anger scores, than did low and no exposure groups. 
High exposure group had significantly more difficulties sleeping, 
concentrating, nervousness. Gender and race significant correlations with 
PTSD. 
Stretch et aI., 1 996 
Examined the prevalence of PTSD symptoms in active and reserve 
deployed Gulf War veterans and active and reserve non-deployed Gulf 
War veterans following the Gulf War 
Active duty and reservists from Pennsylvania and Hawaii who were 
assigned to Army, Navy, Air Force, and Marines. Subjects were either 
deployed ( 1 524) or not deployed (25 1 2 )  to Gul f War. 
Yes, 25 1 2  
Assessment: Mail Survey, 2 years post-Gulf War. 
Exposure 
Assessment: Deployed versus non-deployed. Self-report of stressors 
Methodology: Between-group design examining prevalence rates of PTSD symptoms in 
active versus reservists, and deployed versus non-deployed to Gulf War 
Relevant 
Findings: Significant correlation between stressors and PTSD symptoms 
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that too many stressful life events in a short time increase the probability that an 
individual will have disease or negative health consequences. The model is useful as a 
predictor of health for individuals who have numerous stressful life events. A researcher 
can pre-assign normative weights to stressful l ife events, using prior research, and then 
measure the likelihood of an individual suffering i l l  health by examining the individual 's 
scores on researcher-selected tests. At each of predetermined score levels, a researcher 
can estimate the likelihood of a serious il lness for that individual in the next few years. 
The most noted advocates of the Stimulus-based Model of Stress are the 
psychologists Thomas Holmes and Richard Rahe, who in 1 967 published the now famous 
Social Readjustment Rating Scale (SRRS) in the Journal of Psychosomatic Research. 
The scale used stress related life events to study and predict i l lness. Holmes and Rahe 
created the SRRS scale to attempt to quantify the impact of major life stressors on the 
health of individuals. They took 43 life events and scaled them from I (least stressful) to 
1 00 (most stressful) in order to determine how much a person would need to adjust his or 
her established l ifestyle to adapt to a particular situation. The l ife event of marriage was 
taken as the standard stimulus and given the value 50, and with other life events were 
assigned a proportion of that standard. Holmes and Rahe rated life events of a loss, such 
as the death of a spouse, divorce, and/or a serious personal injury or illness very high in 
terms of the effort it would take to adapt to such situations. Further down the scale are 
events such as change in financial state, vacation, and/or a minor traffic violation, which 
although disruptive are proportionally less stressful .  Individuals were asked in a survey 
to check off which events they had experienced in the preceding 24 months. Holmes and 
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Rahe found that people who had accumulated stress scores of 300 points or higher had 
significantly higher rates of il lness than did those who had scored lower (Holmes, Rahe, 
1 967). 
The Stimulus-based Model of Stress has become the dominant paradigm of stress 
research from the early 1 970s to the present (Rice, 2000). It has become important to 
many disciplines, including psychology, sociology, nursing, medicine, psychiatry, 
occupational therapy, and physiology. A large body of evidence has emerged since the 
initial Holmes and Rahe studies to support the additive nature of stressful l ife events and 
the onset of health problems. Multiple stressful events have been shown to influence the 
risk for a wide range of physical and emotional disorders, from colds and infections 
(Cohen, Tyrell, & Smith, 1 99 1 )  to major health crises such as myocardial infarction, 
sudden cardiac death (Rahe & Lind, 1 97 1 ), and PTSD (American Psychiatric 
Association, 1 994). 
Vulnerable Populations among Gulf War Veterans 
The military personnel who were deployed to the Gulf to take on the Iraqi army 
during Operations Desert Shield/Storm were by far the most diverse group of individuals 
assembled as a fighting force in U.S . ,  if not world, history (PACGWVI, 1 996). The force 
was composed of men and women of different ages, ethnic makeup, religious affiliations, 
social networks, and income levels. Some were married, some were single; some were 
full-time military, and others were reserves that served only when called upon. When 
looking at stress and how it affected the health of troops returning from the Gulf, it is 
important to look not only at the overall health outcomes of veterans who served, but also 
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those of the subpopulations of veterans. Some of the above subpopulations may or may 
not have been at increased risk of developing health problems stemming from stress. 
Among those who may have been more susceptible were older veterans, female veterans, 
minority veterans, and veterans who lacked social support networks. 
An individual is considered at risk, or vulnerable, for a particular disorder if the 
l ikelihood that he or she will meet diagnostic criteria for that disorder is greater than for 
the population at large (Ruskin, 1 996). Studies designed to test this vulnerability tend to 
involve attempts to identify characteristics of specific "at risk" individuals and 
differentiate them from those who are not "at risk." The fol lowing four sections in this 
review will look at the l iterature on the potential risk factors of age, gender, race, and 
social networks to see what role they may have played in an individual 's  vulnerability to 
stress-related health problems. The literature reviewed will look at both why these 
subpopulations may be considered vulnerable and the results of studies that have tested 
this potential vulnerability. 
Age, Stress, and Health Problems 
As one ages the overall decline in the structure and function of the body that can 
has widespread health implications. Some of the normal physical changes that occur 
during the aging process are decline in the senses (touch, taste, vision, olfactory function, 
and hearing), loss of muscle mass, drop in bone density, and slowing of the brain and 
central nervous system. These changes occur slowly, over time beginning for most adults 
during the mid-twenties and continuing unabated throughout l ife. Other physiological 
changes in individuals as they age include, but are not l imited to, changes in the skin, 
53 
musculoskeletal function, cardiovascular system, respiratory system, neurologic function, 
the immune system, renal function, and the genitourinary system. With increasing age, 
many organ systems lose some of the reserve capacity for regulating homeostatic 
capabilities. Thus older adults are more vulnerable to i l lness, trauma, and environmental 
changes such as stress (Porth, 1 994). 
Of particular concern with regard to stress are changes in the skin, cardiovascular, 
and immune systems. As one ages, one's  skin changes. Studies have shown that the 
number of active sweat glands and the amount of sweat produced per gland decreases 
with age (Juniper; 1 967, MacKinnon; 1 954, Silver, 1 964). This can impinge on many of 
the primary functions of the skin: protection from the environment, temperature 
regulation, maintenance of electrolyte fluid balance, and excretion of metabolic waste 
(Porth, C.M. ,  1 994). Thus an older individual is more likely than a younger person to 
have problems in a challenging environment. As one ages, the aorta and arteries tend to 
become stiffer and less distensible. Numerous epidemiological studies have shown that 
in industrialized nations, resting systolic and diastolic blood pressure increases 
substantially with age (Epstein; 1 967, Wheaton; 1 985) .  In studies using pharmacological 
challenges as well a variety of behavioral and cognitive challenges, it has been observed 
that older individuals show greater stress-induced blood pressure reactivity as compared 
to younger individuals (Barnes, 1 982; Gintner, 1 986; Matthews, 1 988;  Wagner, 1 98 1 ) . 
In short, older individuals may have elevated responses to stressful l ife situations, in 
comparison to younger persons. Older persons also tend to have weaker immune systems 
than younger persons and tend to be more susceptible to illness and/or health problems. 
54 
Although the number of T cells remains unchanged with advancing age, there are 
changes in the functioning of helper T cells that alter cellular immune response in older 
adults are (Porth, 1 994). This makes older adults more susceptible to urinary tract 
infections, respiratory tract infections, wound infections, and nosocomial infections than 
younger persons (Porth, 1 994). 
The literature is l imited with regard to how age is related to the stresses of 
deployment and combat. One of the few major studies in this area was a cross-sectional 
survey of four Air Force units (n= I 002) who served in the Gulf. The authors concluded 
that older age was significantly associated with a higher likelihood of being il l  
(Nisenbaum et aI . ,  2000). Another study used structured interviews, with the Medical 
Outcomes Short form 36, of both Gulf War and non-Gulf War veterans (n=3723). In this 
study, the odds ratio of becoming ill over the age of 30 was much greater than for 
becoming il l  under the age of 30 (Fukuda et aI. , 1 998). Much of the other information 
available in this area focuses specifically on PTSD and natural disasters, not combat or 
preparation for combat. A major PTSD study done in the early sixties concluded from a 
literature review on casualties from World War II and natural disasters that the elderly are 
a "special risk" group for both physical and psychological consequences (Freidson, 
1 96 1 ) . Another study, which examined the post-traumatic stress reaction of victims of 
the Mount St. Helen's  eruption, found that individuals in the 35-44-year old age range 
were much more likely to suffer symptoms of PTSD than were individuals 1 8-34 years 
old (Shore et aI . ,  1 989). 
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Gender, Stress, and Health Problems 
Throughout the history of combat, military service has been a male-dominated. 
Men would go off to fight battles while women would stay at home to care of family and 
practical affairs. This slowly but surely began to change during the late nineteenth and 
early twentieth century. Women first became active in wars as nurses caring for the sick 
and injured, and later took on administrative and other non-combat-related roles. As 
modem warfare has evolved to become much more technological and less individual 
combat, the role of women in military service has changed even further. By the time of 
Operations Desert Shield and Desert Storm, women were involved in almost every aspect 
of military service. Of the approximately 697,000 U.S. military personnel who served in 
the Gulf, 49,950 were female, accounting for 7% of the entire fighting force (Mil itary 
Medicine, 1 997) - by far the highest proportion that had served on any military mission 
in the history of the United States. 
The women who served in the Gulf did so side-by-side with their male 
counterparts in multiple tasks related to the war effort. They integrated into almost every 
mil itary unit and performed various war-related tasks: driving trucks, establishing 
communications systems, digging bunkers, refueling bombers and fighters, launching 
Patriot missi les, and guarding prisoners of war (POWs). Although theoretically they 
were not allowed to engage in ground combat, many of the women saw action during the 
war and faced many of the same l ife-threatening risks that the male soldiers did. Like the 
male soldiers in the Gulf, female soldiers were in range of Iraqi missiles that might 
contain biological or chemical warheads. They therefore underwent the same 
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preparations for chemical and biological weapons attacks that their male counterparts did, 
which included familiarization with the use of protective suits and masks as well as how 
to respond to chemical and missile alarms. In some instances women were given 
prophylactics such as Pyridostigmine Bromide (PB) or other vaccines intended to combat 
the effects of a chemical or biological weapons attack. Like the men, many women gave 
their l ives in the fight to free Kuwait from the Iraqi invaders. Of the 1 48 U.S .  battle 
deaths that occurred during the Gulf War, 1 5  were women. 
Female troops had many of the same deployment-and combat-related stressors 
that the male troops faced during the Gulf War; however, their reactions to those stressors 
may have been noticeably different that their male counterparts ' reactions, because of 
physiological differences between the sexes. Differences in hormones, particularly the 
reproductive hormones, may significantly affect how men and women respond to stress 
(Heitkemper et aI . ,  1 996). During the luteal phase of the menstrual cycle, for example, 
female heart rate and systolic blood pressure rise significantly as compared to other 
phases. These fluctuations, unique to women, may affect on their reactions to stressful 
situations (Manhem, 1 994). The average woman's  heart is 25 percent smaller than the 
average man's and women have, on average, a heart rate 5 to 8 beats per minute faster 
than that for a man, since heart size is inversely related to heart rate (Stein, 1 997). Many 
studies have shown that these faster, resting female heart rates show greater stress­
induced increases than those for males do (Bell et aI., 1 968; Collins, 1 978;  McAdoo et 
aI., 1 990). Thus the effects of changes in heart rate caused by stressors may be felt much 
more in females than in males, because the resting heart rate already is higher. Finally, a 
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woman's  response to heat stress differs somewhat from a man's. Women sweat less, lose 
less heat through evaporation, and reach higher body temperatures before sweating starts, 
as compared to men. This difference may also affect how women respond to stressful 
situations, which could help to predict physical and mental health outcomes. Table 6 l ists 
the major studies that have considered gender differences in health outcomes among Gulf 
War veterans. 
Race, Stress, and Health Problems 
Americans live in a multicultural society that draws strength and vitality from the 
diversity of its people. Persons from every comer of the earth have come to the United 
States with the dream of better lives for themselves and their fami lies, bringing with them 
global ideas and perspectives that have helped to shape and enrich the nation. Diversity 
of the U.S .  population has brought prosperity, energy, and optimism to the nation. The 
array of cultures, races, and ethnicities that make up the United States has helped it to 
become one of the most successful and affluent countries on the face of the earth. 
While diversity has helped this the United States achieve unprecedented wealth 
and prosperity, its multicultural society does have certain problems that may have 
adverse effects on health. Language barriers, for example, which exist in many 
immigrant communities, tend to prevent persons who need medical help from seeking 
treatment (Timmons, c.L., 2002) .  Poverty, which is far more prevalent in minority 
communities than in non-minority, has long been shown to have adverse effects on health 
(Gallo, 2003; Everson, 2002). In some communities, cultural differences, such as the 
distrust of modem medical techniques or the stigma associated with having a medical 
Table 6: Gender differences in Gulf War literature 
Study: 
Objectives: 
Sample: 
Control: 
Time of 
Perconte et a! . ,  1 993a 
Examined stress level in survivors of a missile attack before and after 
treatment intervention. Compared stress levels with a group of survivors 
who did not receive treatment intervention. 
Quartermaster unit hit by missile. N=25,  Reserve troops; male=84%. 
Yes, N=8. 
Assessment: During Gulf War (2 months post-missile attack 4/9 1 )  
Exposure 
Assessment: Missile attack (on site; guard duty; non-deployed) 
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Methodology: Pretest and posttest between -group design comparing Gulf War veterans 
receiving debriefing with Gulf War veterans not receiving debriefing in a 
unit-based program. 
Relevant 
Findings: 
Study: 
Objectives: 
Sample: 
Control: 
Time of 
On-site group had significantly higher MISS and SCL-90-R scores; 
females had significantly higher BDl, MISS, and SCL-90-R at pre­
treatment than males. Significant reduction in symptoms post-treatment. 
No change in symptoms for non-deployed, post-treatment. 
Sohler et a! . ,  1 992 
Interim report of ongoing study examining the psychological sequelae on 
Gulf War veterans following the Gulf War. 
National Guard/Reserve units in North Central Florida. Branch not 
specified. M=397, F= 1 1 0. 
Yes 
Assessment: 6 months post-Gulf War 
Exposure 
Assessment: Deployed versus non-deployed; CES 
Methodology: Between-group design comparing Gulf War veterans deployed on 
psychological sequelae post-Gulf War. Gender, unit, and combat exposure 
were also assessed. 
Relevant 
Findings: Deployed had higher IES scores than non-deployed; females had higher 
IES scores; Significant interaction effect for gender by deployment (i .e. 
higher IES scores for deployed females than males); experienced veterans 
reported significantly fewer intrusive thoughts. 
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Table 6 continued: Gender differences in Gulf War literature 
Study: 
Objectives: 
Sample: 
Control: 
Time of 
Assessment: 
Exposure 
Sutker et aI . ,  1 993 
Examined the relationship between war stress and physical and 
psychological symptoms following Gulf War in activated deployed and 
non-deployed troops. 
Army National Guard and Army Reserve. Troops were distributed across 
air reserve, medical, and infantry support specialist, air ambulance, tactical 
fighters, maintenance, and quartermaster. N=2 I S , male=82%, 
female= 1 8%. 
Yes, N=60. 
4- 1 0  months post-ODS 
Assessment: ODS-SES (divided groups into high and low exposure) 
Methodology: Between-group design comparing deployed (high and low exposure) with 
non-deployed (no exposure) on variables of post-ODS psychological 
sequelae 
Relevant 
Findings: 
Study: 
Objectives: 
Sample: 
Control: 
Time of 
Assessment: 
Exposure 
High exposure group reported significantly higher MISS, PTSD Scale, 
BDI, anxiety and anger scores than did low and no exposure groups. 
High-exposed group had significantly more difficulties sleeping, 
concentrating, nervousness. Gender and race are significantly correlated 
with PTSD. 
Wagner et aI . ,  2000 
Investigated the impact of PTSD on physical health of veterans 1 8-24 
months after returning from the Gulf; gender differences observed. 
N=230 1 ;  Gulf War veterans 
No 
Immediately after returning home from the Gulf and a follow-up 1 8-24 
months later. 
Assessment: Self-report of health problems. 
Methodology: Time scale differential in self-report data. 
Relevant 
Findings: Overall, female veterans reported significantly more health problems than 
their male counterparts did; not much difference in terms of time 
differential . 
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Table 6 continued: Gender differences in Gulf War literature 
Study: 
Objectives: 
Sample: 
Control: 
Time of 
Sutker et aI. , 1 995a 
Examined and compared the prevalence of psychological symptoms 
among military participants in war zone exposed and stateside duty. 
Examined gender and ethnicity between exposed and non-exposed. 
War-zone exposed (n=653) and stateside duty troops (n=259). Included 
Army, Air Force, Marine, National Guard, and reserve units who 
underwent psychological debriefing post-Gulf War. N=9 1 2, female= 1 3%, 
White=63%.  
Yes; N=259, male=83%, female= 1 7%. 
Assessment: within 1 2  months post-Gulf War 
Exposure 
Assessment: ODS-SES 
Methodology: Between-group study comparing war-zone exposed and stateside duty on 
psychological symptoms post-Gulf War. Examined gender and ethnicity. 
Relevant 
Findings: 
Study: 
Objectives: 
Sample: 
Control: 
Time of 
Significantly more amount of depression, anxiety, and somatic complaints 
for deployed; minority had significantly more symptoms of depression. 
Females had significantly more somatic complaints. No main effect for 
gender and PTSD.  Interaction effect gender by ethnicity for PTSD. 1 0-
1 2% deployed PTSD positive. 
Wolfe et aI., 2002 
Examined the prevalence of symptoms and identified risk factors for 
reported symptoms among a group of Army Gulf War veterans. Study 
objectives: to look at multi-symptom il lnesses and gender differences. 
Mail survey to 2949 U.S .  Army soldiers deployed to the Gulf; total of 
1 290 subjects responded to the mail survey; aggressive follow-up methods 
were employed. 
No 
Assessment: 5 days after return from Gulf War. 
Exposure 
Assessment: Self-report 
Methodology: Correlational design examining relationship between exposure 
demographics and symptoms. 
Relevant 
Findings: Female gender, lower levels of education, ingestion of anti-nerve gas pills, 
anthrax vaccination, and exposure to oil smoke were significantly related 
to multi-symptom il lness in logistic regression analysis. 
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problem are critical deterrents t o  use of  health care util ization (Kelleher, 1 996). Finally, 
there is racism, which pits one group of individuals against another. The distrust, fear, 
and often outright anger directed at a person of another racial group simply because of 
the person's  race does also adversely affect the overall health of our society (Boulware, 
2003) .  
Epidemiological studies have shown that for a variety of reasons there are racial 
and ethnic differences in the causes, expression, and prevalence of various diseases 
(Burchard, 2003 ). Some of these differences, e.g., those mentioned above, are the result 
of environment. Others are based on genetics. An example of an environmental factor 
that affects health is dietary intake, which often reflects cultural eating habits. Eastern 
diets, which general ly have high salt content, predispose people to stomach and 
pancreatic cancer. Western diets, which contain less salt but more fat, are associated with 
lower rates stomach and pancreatic cancer but higher rates of colo-rectal and hormone­
related cancers (WCRF, 1 997). Genetic factors also play a role in whether or not an 
individual is susceptible to a particular type of il lness. Hemophilia, sickle cell anemia, 
and cystic fibrosis all have genetic components that make individuals of certain races or 
ethnic groups vulnerable to acquiring them. Regardless of whether or not an individual is 
predisposed to a certain health problem by environmental or by genetic factors, apparent 
differences in vulnerabilities among ethnic or racial groups can be seen. 
A review of the literature suggests that as with other ailments, responses to stress 
during wartime may vary with ethnicity or race. Studies from the Vietnam era show that 
during a military conflict, members of ethnic or racial minorities are more likely to have 
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stress-related health problems attributed to that conflict (Loo, 1 994). According to the 
National Vietnam Veterans Readjustment Study, both Hispanic and African-American 
male veterans of the Vietnam theater had higher rates of PTSD than did Whites. (Kulka, 
1 990). One reason for this discrepancy may have been that during the Vietnam War 
minorities were more exposed to war zone stresses (e.g., atrocities, violence, and combat) 
than their non-minority counterparts were (Loo, 1 994). Another reason may have been 
the added stress of being a minority far away from cultural support systems. Whatever 
the reason, the literature on previous conflicts shows a higher rate of stress-related 
problems among minorities as compared to non-minorities. It is thus important when 
looking at data from the Gulf War to take ethnicity/race into account so as to identify 
discrepancies and understand the variations among racial and ethnic groups. By 
identifying discrepancies and understanding why they exist, progress can be made in the 
developing of strategies to improve health outcomes for everyone. 
Social Support Networks, Stress, and Health Problems 
Numerous studies have demonstrated that social support through connections or 
bonds to other people can improve the mental and physical outcomes of adults. 
Individuals who have solid social support systems have a lower risk for depression and 
psychological distress than do those without such social supports (George, 1 989; 
Stansfe1d et aI., 1 997). Persons who have strong social support networks are much less 
likely than those with few social ties to indulge in unhealthy behaviors such as cigarette 
smoking, abusing alcohol, use of il licit drugs, eating poorly, and exercising too 
infrequently. They therefore are not as likely to suffer the physical health problems 
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stemming from such behaviors (Orley, 1 998). Studies conducted across a variety of 
populations indicate that people who are more socially integrated live longer (House, 
1 998; Berkman, 1 995), are more likely to survive a myocardial infarction (Berkman, 
1 995;  Seeman, 1 996), are less susceptible to upper respiratory infections and 
gastrointestinal problems (Cohen, 1 985)  and are less l ikely to suffer a recurrence of 
cancer (Helgeson, 1 998) than are their less integrated counterparts. There have also been 
studies that have shown that social integration is associated with endocrine function 
(Seeman, 1 994), cardiovascular function (Uchino, 1 996), and the immune system's  
abi lity to  fight off infections (Cohen, 1 997). 
Research has shown that individuals with strong social support networks are to 
some degree buffered from stressful l ife situations (Cohen, 1 985) .  Family and friends 
can provide both emotional support and physical assistance to individuals undergoing 
stressful l ife events. They can remind us to exercise, help us to quit smoking, allow us to 
talk through our problems, and drive us to a doctor or other health care provider if 
needed. Social support networks provide activities, a lternative viewpoints, and outlets 
for our emotional stress. They can provide a shoulder to lean on during rough times and 
help to moderate if not alleviate many of the life stressors. Studies have shown that 
young people reporting poor social connections - who have no one to talk to, no one to 
trust, no one to depend on, and no one who knows them well - are between two and three 
times more likely to experience depressive symptoms when compared to their peers 
(Glover, 1 998). Thus strong social support networks can provide coping mechanisms 
that may help to lessen the impact of stress on both one's  physical and one's  emotional 
health. 
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One of the strongest and most meaningful of all social support networks is the 
bond of marriage, a partnership unlike any other social bond. Marriage joins two people 
to share l ife in both good times and bad, and in both sickness and health. It commits two 
persons to each other above all others so that they can live together and support one 
another. It provides an individual someone with whom to share intimate thoughts as well 
as leisure time. Marriage may also greater financial independence and a wider social 
network of family, friends, and neighbors. Studies have shown that married persons live 
longer and healthier lives than do those who have never married or are divorced (Lil lard, 
1 995). Married people tend to eat and sleep more regularly, and live "a more "orderly 
l ifestyle" than non-married persons (Panis, 1 996). Research also has shown that being 
married ameliorates potentially stressful l ife events such as retirement (Wan, 1 982). 
Such reductions in stress may help to explain why married persons are generally healthier 
and have longer l ife spans than non-married persons do. 
Summary 
Chapter Two has presented a review of the literature pertinent to examining the 
how the effects of stresses encountered during the Gulf War may have led to 
psychological and physical health problems among some Gulf War veterans. The chapter 
has covered in detail how the l iterature review was conducted, the major health problems 
that some Gulf War veterans have been facing, and what the scientific community 
believes are their possible causes. The chapter also has given an overview of stress and 
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reviewed what the scientific literature says regarding how it can affect both one's  
psychological and physical one's  welI-being. It has gone into detail as  to  why the 
literature supports a recursive relationship whereby psychological health problems 
contribute to physical health problems and has shown why the reverse relationship is not 
supported. It has described the history of stress in military conflicts, and in particular has 
looked at how stressors during the Gulf War may have affected the troops. The chapter's 
conclusion provides an overview of what the scientific l iterature has to say about how 
stress affects potentialIy vulnerable populations such as the elderly, females, minorities, 
and those individuals who lack social support networks. 
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CHAPTER 3 :  METHODOLOGY 
Introduction 
The methodology chapter examines the proposed conceptual model that describes 
how stress during the Gulf War may have affected the mental and physical health of Gulf 
War veterans. I t  provides a detailed description of the Comprehensive Clinical 
Evaluation Program data source used in the proposed model, including a discussion on 
how that data was found and eventually acquired. I t  explains how the data from the 
Comprehensive Clinical Evaluation Program data was formatted into Access, cleaned of 
irrelevant material, and modified so that it would be usable for structural equation 
modeling. It then goes on to addresses important issues with regard to the data such as its 
reliability and validity. 
This chapter next discusses the steps taken in creating of the Gulf War Stress 
survey sent out to veterans and health experts. It details the recruitment of survey 
participants as wel l as show how the results of the survey were recorded and analyzed. It 
explains how a Gulf War Stress Scale modeled after that of Holmes and Rahe was 
developed and how stress levels of individual Gulf War veterans were measured via that 
scale. Survey data reliability and validity are discussed, followed by a description of 
how the cleaned data from the Comprehensive Clinical Evaluation Program and the stress 
survey data were attached to the AMOS modeling software in preparation for analysis. 
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Finally, this chapter describes the development of the structural equation model 
used to study the health outcomes of Gulf War veterans. It details the creation of the core 
model and then shows how and why additional parts of the model were added to take 
account of stress in the Gulf War as well as differences in age, gender, race, and marital 
status. A discussion will take place concerning the reasoning behind the derivation of the 
health outcomes variables followed by a detailed description of important issues with 
regard to the model such as its identification, variable measurement, its analysis, and 
respecification. 
The Comprehensive Clinical Evaluation Program Data Source Used in the Proposed 
Model 
The secondary data source used in the proposed structural equation model 
examining the effects of Gulf War stress on subsequent mental and physical health 
problems among Gulf War Veterans came from the Comprehensive Cl inical Evaluation 
Program. This voluntary program by the Department of Defense was created to provide a 
systematic and uniform medical evaluation of troops who served during the Persian Gulf 
War, to respond to the health concerns of veterans and the organizations representing 
them. It was set up, under oversight by the Institute of Medicine, to provide a two-phase 
cl inical evaluation of Gulf War veterans. In phase I, all Comprehensive Clinical 
Evaluation Program participants were to be examined by a board-certified physician in 
either family practice or internal medicine (Roy, 1 994). Participants were given a 
complete physical, which included a medical history, basic laboratory tests, and 
standardized provider-administered questionnaires (Joseph, 1 997). For individuals who 
were healthy or who had problems that could be satisfactorily explained after the Phase I 
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evaluation, no additional evaluation was conducted. Participants who felt they needed a 
more in-depth evaluation proceeded to Phase II at specialized Department of Defense 
regional medical centers, where additional tests were performed. Phase II tests included 
a structured clinical interview for DSM-III-R, a cl inician administered PTSD scale test, a 
chest X-ray, and additional blood tests (Joseph, 1 997). 
The portion of the Comprehensive Clinical Evaluation data used in this 
dissertation came from the Phase I provider-administered questionnaire regarding 
wartime exposure/experience and health outcome information (see Appendix XXII). 
Demographic information (gender, race, age, marital status etc.)  were obtained by 
connecting a relational database having this information to the Phase I provider­
administered questionnaire. To preserve confidentiality, no specific personnel identifiers 
were given out with the data: no names, social security numbers, home addresses, or 
specific unit l istings were given. Likewise, no information was given regarding lab 
work, medical histories, or physical examinations. Despite these limitations, the Phase I 
provider-administered questionnaire used in this study has been a valuable tool for 
analyzing the complex relationship between wartime exposures/experiences and veterans'  
health outcomes. 
Acquisition of the Comprehensive Clinical Evaluation Program Data 
Information about how to obtain a copy of the researcher-available data on the 
Comprehensive Cl inical Evaluation Program data was found at: 
http://www.defensel ink.mi llnews/SepI 996lb090496 btprescc.html. which is part of the 
official web site for the Department of Defense. The website provides directions for 
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contacting Electronic Data Systems, the contracting firm that maintains and archives the 
data. Although it is not required, Electronic Data Systems strongly encourages 
investigators who request a copy of the Comprehensive Clinical Evaluation Program data 
to submit an approved Institutional Review Board scientific protocol. That was done for 
this dissertation through the Virginia Commonwealth University Office of Research and 
Subject Protection. Since the research this dissertation posed no more than minimal risk 
to the subjects in the survey, an expedited review was requested and approved. 
Formatting of the Comprehensive Clinical Evaluation Program Data 
The Comprehensive Clinical Evaluation Program data used in this dissertation 
were acquired from Electronic Data Systems on August 1 2, 2002 . They were provided as 
an Informix relational database (designed to handle large amounts of structured and 
unstructured data) with ASCII text delimited files (standard fi les that are recognized by 
most word processors or spreadsheet programs). The drawback in receiving ASCII files 
for the dissertation was that it treated each question asked to each participant in the 
database as an individual record. With some 60,000 participants in the Comprehensive 
Cl inical Evaluation Program, responding to up to several hundred questions, the total 
number of records in the database easily exceeded the maximum capacity (65,000 
records) of Microsoft Excel, an AMOS-compatible spreadsheet program. In order to 
process this amount of data, it was necessary to transfer the data into a form that could 
handle them, and then cut the size down so that it could fit into a format that could be 
understood by the Structural Equation Modeling software AMOS. The Comprehensive 
Clinical Evaluation Program data was thus transferred from its original Informix database 
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into Microsoft Access 7 . 1 ,  which could handle the large amount of data. That was done 
with the Access import procedure, which allowed the relational data to be viewed as 
tables. Once in Access, the data were sorted so as to identify non-study related data, 
which could then be eliminated. 
Cleaning of the Comprehensive Clinical Evaluation Program Data 
After importing the Informix database into Access, the next step in getting the 
data ready for analysis was to clean them of all items not related to the study. The 
original data supplied by Electronic Data Systems Corporation contained numerous Phase 
I and Phase II specialty tests that had nothing to do with the aims of this dissertation. To 
reduce the overwhelming amount of data in the Access program, all irrelevant study 
material was removed. In addition, within the questionnaire about wartime 
exposure/experience and health outcomes were survey answers from others than Gulf 
War veterans. Those data came primarily from family members and/or civil ians who 
were in the Gulf during the war. To avoid introducing any data biases into the study, it 
was necessary to have those data records eliminated from the overall data set, as well. 
Removal of unwanted data in the Access database was a multi-step process that 
required a sorting of the data to that unwanted records could be found and then deleted. 
Since the data given by out by Electronic Data Systems were in numerous large tables 
that contained several variables, the first step in the data cleansing process was to pull up 
the tables that contained the variables needed for this study. The two tables needed were 
the wartime exposure/experience and health outcomes response table and a personal 
information table, which were linked to each other by a common identifier variable. 
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Once the tables were found, the next step i n  data cleansing was to query the needed 
variables in the Access design view. Since all variables had numerical representation 
assigned to them, (see numbers on Appendix XXII data), data could be sorted in a way 
that permitted needed data to be separated from unneeded data. Thus data that were non­
study-related could be deleted and kept out of the study. 
Several data sorts were made to identify and delete unnecessary data. The initial 
sorting separated those persons who took the survey regarding wartime 
exposure/experience and health outcomes from those who did not. Only the results and 
personal identifier information of persons who had taken this survey were saved for an 
updated data set. The results of all other, unrelated surveys were deleted. After that, 
another sort separated the records of Gulf War veterans and any records of non-veterans 
who may have participated in the survey. Only records of military personnel who served 
in the Gulf War were kept for an updated data set. The results of all other, non-Gulf War 
veteran records were deleted. A third sort looking at the birth year of the survey 
respondents was then done as a data set quality control measure. Since the Gulf War 
was in 1 99 1  and participants had to be at least eighteen years old to participate in the war, 
persons who stated that their year of birth was after 1 973 were excluded from the sample. 
Included within this deleted group were a number of veterans who mistakenly filled in 
the test completion year as the year of birth. In all, the result of this data cleaning process 
was a ridding of extraneous and potentially biasing material within the Access database. 
This reduction of extraneous material helped to solve the problem of transferring the data 
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into a spreadsheet program such as Microsoft Excel or SPSS that could be recognized by 
the AMOS. 
Modification of the Comprehensive Clinical Evaluation Program Data 
The next step in preparing the Comprehensive Clinical Evaluation Program data 
for structural equation modeling analysis was to have it modified to account for several 
problems inherent within the data: what to do with missing/incomplete data, how to 
handle duplicate data, how to transfer coded data into a recognizable form that could be 
util ized by the modeling software, and how to deal with do not know/do not recall 
responses to questions. Several data handling decisions were implemented to deal with 
these problems while at the same time upholding the integrity of the data set. 
For missing/incomplete data, it was decided to eliminate any record that did not 
contain responses to all variables needed for analysis. That was done both because the 
data set was large enough to be statistically relevant without these records, and because it 
would eliminate the records of individuals who might not have completed the survey, 
through a lack of interest or understanding. Most of the incomplete wartime 
exposure/experiences and health outcome data came from the same respondents. 
Approximately 400 records were eliminated from the final data set because of 
incomplete/missing response data. 
Duplicate data or multiple responses to the same question posed another problem. 
In order to have a single response to each item in the survey questionnaire, several 
decisions had to be made on what to do with duplicate or multiple survey responses. It 
was decided that if two answers that were simi lar were given to a single question, the 
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least extreme response would be kept in the data set and the more extreme response 
eliminated. If, for example, a participant checked off that they experienced a health 
problem all of the time and also checked most of the time, the data handling decision 
would be to go with "most of the time." This was done to keep such duplicate records in 
the survey while at the same time making sure that if an error were to be made, it would 
be made on the side of caution. If two answers to the same question were far apart such 
as when a participant had checked off that he or she never has experienced a particular 
health problem and also had checked off that they experience a health problem most of 
the time, the record would be eliminated. Finally, if three or more answers to the same 
question were given, the record was l ikewise eliminated from the data set. In all, about 
200 records were modified by data handling decisions about duplicate records, and 
another 1 00 records were eliminated. 
Another decision that had to be made about to the data was how to transfer the 
coded Comprehensive Clinical Evaluation Program data into a form that could be 
recognized by the AMOS software. The data acquired from Electronic Data Systems 
contained a very complicated code that was meant to encompass the whole 
Comprehensive Cl inical Evaluation Program. To analyze these data using the 
AMOS Structural Equation Modeling Software, it was necessary to simplify the code so 
that AMOS could make sense of them. Several data handling decisions thus had to be 
made in order for the data to be interpreted and then analyzed. One major initial decision 
was to code all "yes" answers as " I "  and all no answers as "0." Another was to code all 
responses that required a degree answer on a numerical scale. This meant that for 
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questions of onset, duration, frequency, and amount of impairment, a " 1 "  represented the 
minimal choice, followed by "2", "3", "4" and "5," representing ever increasing degree 
choices. Converting the coded answers of the Comprehensive Clinical Evaluation 
Program into more simplified scaled responses enabled the AMOS structural equation 
modeling software to make sense of the data and analyze it. 
Finally, there was the question of what to do with the "I don't  know" responses to 
wartime exposure/experiences questions in the Comprehensive Clinical Evaluation 
Program data. Since this dissertation is looking to differentiate definite 
exposures/experiences from non-exposures/experiences in its creating of a Gulf War 
stress scale, a data handling decision was made to treat all "I don' t  know" answers as 
"no" answers. Thus if a veteran was not sure whether he or she had been exposed to a 
particular event, the study treats that response as a non-exposure. In terms of data 
coding, this means that all "yes" answers to particular exposure/experiences questions 
were coded as a " I "  and that all "no" or "I don't know" answers were coded as "0." 
Reliability of Comprehensive Clinical Evaluation Program Data 
For the most part, data from the Comprehensive Clinical Evaluation Program may 
be considered a reliable reflection of the health status of veterans who served in the Gulf 
War. The demographic characteristics of those veterans who participated in the program 
are highly consistent with the actual characteristics of the veterans who participated in the 
war (see Table 7) .  Similarly, the total number of Comprehensive Clinical Evaluation 
Program participants, currently over 50,000, is roughly seven percent of the over 697,000 
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Table 7: A comparison of demographic characteristics of 20,000 Comprehensive Clinical 
Evaluation Program participants and those of all U.S .  veterans of the Persian Gulf War. 
Percent with the Characteristic 
Characteristic 
Gender 
Male 
Female 
A ·  b ge In years 
1 7-25 
26-30 
3 1 -35  
36-65 
Race / ethnicity 
White 
African-American 
Hispanic 
Other 
Rank 
Enl isted 
Officer 
Mi litary branch 
Army 
Navy 
Marines 
Air Force 
Military status 
Active duty 
ReserveslNational Guard 
Civilians 
CCEP All Gulf War 
Participants' Veterans 
(n=20,000) (n=697,000) 
88 % 93 % 
1 2 % 7 % 
32 % 55  % 
24 % 20 % 
23 % 1 2 % 
2 1  % 1 3  % 
57 % 70 % 
32 % 23 % 
5 % 5 % 
6 % 2 % 
92 % 90 % 
8 % 1 0 % 
82 % 50 % 
4 % 23 % 
4 % 1 5  % 
9 % 1 2 % 
84 % 83 % 
8 % 1 7 % 
8 % - % 
a. Among CCEP participants, val id data were not 
available for 3% of rank, 2% of age, and 1 % of military 
branch entries. 
b. Age was calculated as of August 1 990. The mean age 
of CCEP participants was 28 years (median 30 years) 
compared to a mean age of 27 years (median 25 years) 
for all Gul f War veterans. 
Source: Joseph, S.c. ( 1 997), A Comprehensive Clinical Evaluation of 
20,000 Persian Gulf War Veterans, Military Medicine, 1 62, 3 :  1 49. 
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U.S .  participants in the war, which is a highly representative sample. Since the veterans 
who went through the Comprehensive Clinical Evaluation Program were the ones who 
had the most at stake in terms of the knowledge to be gained from it, they had an 
incentive to give time and thought to their answers to the survey questionnaires. This 
likelihood should indirectly increase the consistency of the data and thus their reliability, 
by limiting the number of frivolous answers (due to lack of interest). Finally, the 
protocol of the Comprehensive Clinical Evaluation Program was designed by the Institute 
of Medicine in conjunction with medical and public health experts to produce 
standardized questions. The standardized questions keep investigator bias to a minimum, 
which also helps to increase the reliability of the results. 
Validity of Comprehensive Clinical Evaluation Program Data 
An extensive quality-control process was instituted during the development of the 
Comprehensive Clinical Evaluation Program to ensure the validity of the database (10M, 
1 996). Senior medical officials from all military services were consulted to guarantee the 
content validity (the degree to which content of a test or questionnaire covers the extent 
and depths of its subject). They along with representatives of the President's Advisory 
Committee on Gulf War Il lnesses, the General Accounting Office, and the Office of 
Technology Assessment (10M, 1 997) made sure that the Program's accurately reflected 
the experiences and health concerns of Gulf War veterans .  On top of this, a special 
outsourced committee of the Institute of Medicine independently reviewed and monitored 
the Comprehensive Clinical Evaluation Program process, including its design and 
implementation (10M, 1 996). That committee reported on how well the Comprehensive 
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Clinical Evaluation Program in met the health concerns of veterans. From its reports, the 
validity of the Comprehensive Clinical Evaluation Program data appears ensured. 
Creation of the Gulf War Stress Survey 
A primary source of data for this study was from a stress survey sent out to 
veterans of the Gulf War and to health professionals with expertise in the field of combat 
trauma and/or military stress. This survey was developed in order to quantify the 
potentially stressful exposures of Gulf War veterans so that a Gulf War stress scale could 
be created. The survey questionnaire asked veterans and health experts to rate, on a scale 
of 0 (least stressful) to 1 0  (most stressful), how stressful they thought 24 potentially 
harmful exposures that occurred during the Gulf War were to the veterans who 
experienced them. The 24 exposures veterans and health experts were asked to rate are 
listed in Table 8 .  
Table 8 :  Twenty-four potentially stressful exposures experienced by some veterans of  the 
Gulf War. 
I .  Passive cigarette smoke 1 3 . PB (pyridostigmine bromide pills) 
2. Oil fire smoke 1 4. Insect repellents 
3 .  Tent heater smoke 1 5 .  Botul ism immunization 
4. CARC paint 1 6. Anthrax immunization 
5 .  Other paints 1 7. Malaria prevention 
6. Solvents 1 8. Food contamination 
7. Diesel Fuel 1 9. Water contamination 
8. Other petrochemicals 20. Combat exposure 
9. Depleted uranium 2 1 .  Wounded in action 
1 0. Nerve gas 22.  Witnessing of casualties 
1 1 . Mustard gas 23 .  Scud attacks 
1 2 . Microwaves (strong radar) 24. Chemical alarms 
Each veteran and/or expert was instructed to give a single response for each of the 
24 above l isted exposures. Radio buttons were used on the emailed survey to ensure that 
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only one response would be recorded. A detailed explanation of each exposure was 
included in the questionnaire, so that respondents could make informed ratings. The e­
mailed version of the survey provided the explanations as a link that could be accessed by 
double clicking a listed exposure (see Appendix XXI for Survey Links). If  a veteran had 
not been exposed to a certain event listed, the survey asked the veteran to rate the stress at 
the level he or she thought most appropriate. Thus, for example, if a veteran had not been 
subject to botul ism immunization during the Gulf War, the survey asked the veteran to 
rate the stress at the level he or she thought such an exposure would have caused. 
The 24 potential exposures that this survey asked about were the same as those in 
the Comprehensive Clinical Evaluation Program exposure/experience questionnaire (see 
Appendix XX). The difference between the two questionnaires is that this survey is 
looking at the stress level caused by each particular exposure, while the Comprehensive 
Clinical Evaluation Program questionnaire is looking for a yes/no answer about a 
particular exposure. The same 24 exposures were used in this study's survey so that a 
stress scale score for each individual veteran who participated in the Comprehensive 
Clinical Evaluation Program could be calculated. (That scale is discussed in detail later 
in this chapter.) Once individual veteran stress scores were calculated, the results were 
then fitted into a structural equation model to examine how Gulf War stress exposure 
affects mental and physical health. 
Recruitment of Gulf War Stress Survey Participants 
Veteran participants in the Gulf War Stress Survey were recruited from veteran 
locater web sites such as http://www.gulfweb.org/locator/locator search.cfm and 
http://www.vetfriends.com/memberships.html. as well as through personal contacts. 
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From the veteran locater websites, approximately 2400 veterans'  e-mail addresses were 
obtained. Each of these veterans was sent a mass e-mail containing the Gulf War Veteran 
Stress Cover Letter (Appendix XIX) and a link to a Gulf War Veteran Stress Survey 
(Appendix XX). Another 50 Gulf War veterans were either mailed or personally given a 
Gulf War Stress Survey. Names and addresses of the veterans who were mailed the Gulf 
War Stress Survey were obtained through personal contacts. Most of the veterans who 
were personally given Gulf War Stress Surveys were given them during the 2003 
Veterans Day gatherings in Washington D.C. 
In addition to veterans, approximately 50 health experts in the field of stress were 
sent a Gulf War Stress Survey to fill  out, for another perspective on how exposures 
during military service in the Gulf may have contributed to the overall veterans' stress. 
The health experts were given the same survey that the veterans were, but were told to 
base the ratings on their professional opinion rather than on personal experience. The 
names and contact information for health experts in the field of stress were obtained 
through several Veterans Administration regional medical centers and also through the 
National Center for Post Traumatic Stress Disorders (NCPTSD), as well as through 
personal contacts. In many instances the health professionals who responded 
recommended other colleagues who were familiar with combat stress and associated 
health outcomes. These individuals, too, were e-mailed a stress survey. 
Handling of the Gulf War Stress Survey Results 
The results (see Appendix XXII) of the e-mailed Gulf War stress survey were sent 
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to a secure data site operated by Virginia Commonwealth University so as to keep the 
identity of all respondents confidential. Access to the site was password protected and 
l imited to the study investigator and the systems administrator at Virginia 
Commonwealth University in charge of handling secure data. When a respondent hit the 
submit button after completing their questionnaire, responses would go to this secure site 
at Virginia Commonwealth University and assigned a number according to the time that 
they came in. That assigned number was the only way to identify which responses 
belonged to which respondent and the total number of responses to the emailed survey. 
Once all response data had been received, the data and all associated survey responses 
were pulled up by this assigned number into an Access database. From Access, the 
survey results were transferred into Excel and then on to SPSS where they were used for 
analysis. 
The initial emailed survey was sent out to 1 600 veterans on Tuesday, October 28, 
2003 in the form of a group email .  Responses came in at a high pace initially and then 
staggered in through the rest of the week. A second email was then sent out on Thursday 
November 6, 2003 thanking all veterans who responded for doing so and requesting that 
persons who had not already responded and wished to do so to please go ahead and 
respond. After the first and reminder email. 1 1 8 responses to the Gulf War Stress survey 
were recorded at the secure data site. In order to increase the number of responses to this 
survey, an additional 800 veterans were sent the same email containing the Gulf War 
Stress survey on Monday November 1 7, 2003 . Again, there was an initial burst of 
responses fol lowed by a slow but steady drop off. A second follow-up emai l was sent to 
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this second group o f  veterans on Monday November 24, 2003 again thanking those 
veterans who had already responded and asking for additional responses. From this 
second mass emai l and follow up came an additional came another 60 responses bringing 
the total number of responses to the emailed survey up to l 78 . This was the total 
number of responses used in the email portion of the Gulf War Stress Survey. 
The Gulf War Stress Survey results that were acquired either by mail ing or by in 
person interview were added to the Access database that contained the emailed veteran 
responses. A total of 32 veterans responded to the Gulf War Stress survey in this way 
with 1 2  coming in by mail and another 20 via interview. Adding this total (32) to the 
total number of emailed respondents ( 1 78) gave a grand total of 2 1  0 veterans who 
responded to the Gulf War Stress Survey. Like the emailed survey, both mailed and 
interviewed respondents were assured that confidentiality concerns would be respected. 
All health professionals who responded to the Gulf War Stress Survey were 
contacted via email during the fall of 2003.  Unlike the mass mailings emailed to many 
veterans, emails sent out to health professionals were done mostly on an individual basis. 
Their email addresses were obtained through Veterans Administration regional medical 
centers, the National Center for Post Traumatic Stress Disorder, and through personal 
contacts. In many instances health professionals who responded to the Gulf War Survey 
recommended other colleagues who were familiar with combat stress and associated 
health outcomes. These individuals were l ikewise emailed a stress survey to take. As 
with the veterans, assurances were given to health professionals that personal identifiers 
would not be included in the study. Out of the 50 emails sent out to health professionals 
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containing the Gulf War Stress survey, 28 persons submitted responses. These responses 
were then manually transferred to an Access database similar to the one set up for veteran 
respondents. The results of all 
Development of a Gulf War Stress Scale 
A Gulf War Stress Scale, similar to the Holmes and Rahe Social Readjustment 
Rating Scale, was created using the data obtained through the stress survey sent out to 
Gulf War veterans and health experts. Veterans and health experts had been asked to 
rate from 0 (least stressful) to 1 0  (most stressful) the amount of stress involved in 24 
potentially stress inducing events. If  they had not experienced an event that was being 
rated, they were asked to estimate how stressful that event would be, in l ight of the 
experiences they had had during the Gulf War. Of the 2450 Gulf War veterans who were 
asked to participate in this survey, 2 1 0  responded. The results of their ratings of the 24 
potentially stress-inducing events were averaged to create a veteran stress scale, (see Vet 
Scale column in Table 9). A similar scale was created from the results of the Gulf War 
Stress Survey sent to health professionals who had expertise in the fields of stress, 
combat, and health outcomes. The only difference between the survey sent to health 
experts and that sent to veterans was that the health experts were asked for their 
professional opinions as to the ratings whereas the veterans were asked to base their 
ratings upon personal experience. Of the 50 stress surveys e-mailed to health experts, 22 
were returned. The averages of their ratings are shown in the Expert Scale column in 
Table 9. A Gulf War Stress Scale was then developed by averaging the veteran scale 
results and health expert scale results for the 24 items in the survey (see the Gulf War 
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stress scale column in Table 9). 
Table 9:  Development of a Gulf War Stress Scale 
Vet Scale Expert Scale Gulf War Stress Scale 
Q I  Passive cigarette smoke 2 .80 2.27 2 .54 
Q2 Oil fire smoke 6.20 5.95 6.08 
Q3 Tent heater smoke 2 .75 2.23 2 .49 
Q4 CARC paint 2 .46 1 .86 2. 1 6  
Q5 Other paints 2 .38 3 .09 2.74 
Q6 Solvents 3 .47 3 . 1 8  3 .33  
Q7 Diesel fuel 4.85 3 .55  4.20 
Q8 Other petrochemicals 4.20 3 .95 4.08 
Q9 Depleted uranium 3 .77 6. 1 4  4.96 
Q I O  Nerve gas 4.94 5 .45 5.20 
Q l l Mustard gas 4.08 5.23 4.66 
Q 1 2  Microwaves (strong radar) 3 .80 2.86 3.33 
Q 1 3  P B  (pyridostigmine bromide) 6.36 6.68 6.52 
Q 1 4  Insect repellents 4.3 1 3 . 1 8  3 .75 
Q 1 5  Botulism immunization 5 .04 4.32 4.68 
Q 1 6  Anthrax immunization 6. 1 5  6.23 6. 1 9  
Q 1 7  Malaria prevention 4.23 4.9 1 4.57 
Q 1 8  Food contamination 3 .6 1 3 . 1 4  3 .38  
Q 1 9  Water contamination 3 .96 3 .55  3 .76 
Q20 Combat exposure 6.52 6.95 6.74 
Q2 1 Wounded in action 3 .35  5.95 4.65 
Q22 Witnessing of casualties 5.29 5.77 5 .53 
Q23 SCUD attacks 6.35 6.9 1 6.63 
Q24 Chemical alarms 7 . 1 7  7.59 7 .38 
Procedure Used to Measure the Stress Score of Individual Veterans 
Both the data from the Comprehensive Clinical Evaluation Program and that from 
the Gulf War Stress Survey were used to determine stress scores for individual veterans. 
Stress scores were calculated with of the following formula: 
S; = L Q; W; 
where S; = Stress Score, Q;= Question number and Wi = Weight (Gulf War Stress Scale). 
The above fonnula calculated stress scores for all veterans who had filled out the 
exposure portion of the Comprehensive Clinical Evaluation program questionnaire. 
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The maximum possible stress score was 1 09.55, meaning that the veteran was exposed to 
all 24 listed items; the minimum score was 0, meaning that the veteran was not exposed 
to any of the 24 l isted items. The average veteran stress score for from the 1 2,205 
Comprehensive Clinical Evaluation Program participants was 47. 1 9. An example of 
how an individual veteran' s  stress score was calculated can be seen in Table 1 0. 
Gulf War Stress Survey Reliability 
The reliability of data refers to whether or not a measurement can be repeated 
over and over with consistent results. In short, it is the degree to which an instrument 
measures the same way each time it is used under the same condition with the same 
subjects. Since the Gulf War Stress Survey was e-mailed to veterans on two separate 
occasions (October 28, 2003, November 6, 2003) the results of each of those separate 
surveys can be compared for consistency and thus reliability. Simi larly, results of those 
surveys that were either mailed in or taken personally from veterans could be compared 
to survey results that were obtained via e-mail, to check for consistency. The results 
shown in Appendix XXIII show that the questionnaire responses to that were mailed to 
veterans were very similar to the responses that were e-mailed to veterans. Likewise the 
results of the Gulf War stress survey e-mailed to health experts were similar to both the 
mailed and e-mailed responses of veterans. The overall pattern of results thus appears to 
give evidence that the Gulf War Stress Survey sent out to veterans and to health experts is 
a reliable one. 
Table 1 0: Example of the procedure used to measure the stress level of an individual 
veteran 
Veteran # I Yes( I )/No(O) Gulf War Stress Scale Sum 
Q I  Passive cigarette smoke 0 2.54 0.00 
Q2 Oil fire smoke 0 6.08 0.00 
Q3 Tent heater smoke I 2.49 2 .49 
Q4 CARC paint 0 2. 1 6  0.00 
Q5 Other paints 0 2 .74 0.00 
Q6 Solvents I 3 .33  3 .33  
Q7 Diesel fuel I 4.20 4 .20 
Q8 Other petrochemicals I 4.08 4.08 
Q9 Depleted uranium I 4.96 4.96 
Q I O  Nerve gas I 5 .20 5 .20 
Q I I Mustard gas I 4 .66 4.66 
Q I 2  Microwaves (strong radar) 0 3 .33  0.00 
Q I 3  PB (pyridostigmine bromide) 6.52 6.52 
Q I 4  Insect repellents I 3 . 75 3 .75 
Q I 5  Botulism immunization 0 4.68 0.00 
Q I 6  Anthrax immunization 0 6. 1 9  0.00 
Q I 7  Malaria prevention 0 4 .57 0.00 
Q 1 8  Food contamination 0 3 .38 0.00 
Q I 9  Water contamination 0 3 .76 0.00 
Q20 Combat exposure I 6.74 6 .74 
Q2 1 Wounded in action 0 4.65 0.00 
Q22 Witnessing of casualties 5 .53 5 .53  
Q23 SCUD attacks 6.63 6 .63 
Q24 Chemical alarms 7 .38 7 .38 
Score 65 .44 
Gulf War Stress Survey Validity 
Validity is the degree to which the results of a study are likely to be true, 
believable and free of bias. It is a measure of the accuracy of a study's conclusions, 
inferences, and propositions, reflecting the strength of the research design. In 
considering validity in terms of the Gulf War Stress Survey, it is important to examine 
both survey design and how representative the respondents are of the population in 
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question. If the survey is designed wel l and representative of the population under 
consideration, it is more likely to be a valid one. 
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The Gulf War Stress Survey was designed to elicit the perceptions of veterans and 
health experts about 24 potentially stressful wartime exposures. Their responses were 
used to develop the Gulf War Stress Scale, which assesses the amount of stress 
experienced by an individual veteran. In order for the scale to be valid, the stress survey 
had to be an accurate reflection of the major stressors encountered by Gulf War veterans. 
That was ensured by taking questions about stress exposure that had been developed by 
military and civil ian health experts for the Comprehensive Clinical Evaluation Program 
survey and incorporating them into the Gulf War Stress Survey. Those questions dealt 
with the experiences that such experts thought to be most l ikely to cause stress in 
veterans. Using the same items in the survey supported the validity of the survey and 
thus of the stress scale. 
The target audience of the survey is the component relevant to whether or not the 
survey results are a valid representation of the views of the overall population under 
study. For the Gulf War Stress Survey, two audiences were targeted: veterans and health 
experts. To ensure that only the responses of targeted individuals would be included in 
the results, a question at the beginning of the survey questionnaires asked, "Are you a 
Gulf War veteran?" for those sent to veterans, and "Do you consider yourself an authority 
in the field of mil itary health and/or stress?" for those sent to health experts. If this 
question was answered "No" or left unanswered, the respondent 's responses were not 
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included in the final survey results. Ensuring that only targeted responses are included in 
the results supports the validity of the survey. 
Attaching Data to the AMOS Software 
The cleaned Comprehensive Clinical Evaluation Program data, which was in a 
M icrosoft Access database, was transferred into Microsoft Excel using a Stat Transfer 
program. Once in Excel, a formula (Si = L Qi Wi) was used that combined the 
Comprehensive Clinical Evaluation Program individual veteran question exposure data 
(Qi) with the Gulf War Stress Scale weights (Wi) from the results of the Gulf War Stress 
Survey, to create a stress score (Si) for each of the 1 2,205 veterans under study. This new 
stress score data as well as the cleaned Comprehensive Clinical Evaluation Program data 
were then transferred from Excel to SPSS, again using a Stat Transfer program. Once in 
SPSS, the data could be uploaded into the AMOS software and attached to a structural 
equation model. 
Creation of the Structural Equation Model Used in the Study 
Figures 4-8 show the development of the proposed structural equation model used 
to examine the effects in Gulf War Stress exposure to subsequent mental and physical 
health problems among Gulf War veterans. The core of that structural equation model 
focuses on the two latent variables, psychological health and physical health, and their 
effects upon the I S  health outcome indicator variables. The 1 5  health outcome measures 
emerge from a factor analysis of medical complaints/symptoms listed in the 
Comprehensive Clinical Evaluation Program data. (The derivation of the I S  health 
outcome measures is discussed later in this chapter). 
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Figure 4: Eleven medical complaints/symptoms associated with physical health problems. 
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Figure 5 :  Four medical complaints/symptoms associated with psychological health 
problems. 
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Figure 6: A proposed structural equation model showing the relationship between 
physical and psychological health. 
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Figure 7: A proposed structural equation model showing the effects of Gulf War stress 
on two latent variables, physical health and psychological health. 
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RACE 
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Figure 8: A proposed structural equation model showing the effects of age, gender, race, 
marital status, and Gulf War stress on two latent variables physical health and 
psychological health. 
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Since the medical complaints/symptoms are measured variables, they are shown in 
rectangles in accordance with the guidelines of structural equation model analysis. The 
error terms e l -e 1 5  associated with these measured variables cannot themselves be 
measured, and thus are shown as circles. The regression weights between the 1 5  health 
outcome variables and e l -e 1 5  are set to " 1 "  for model identification purposes. 
Of the 1 5  medical complaints/symptoms l isted, eleven (abdominal pain, bleeding 
gums, diarrhea, fatigue, hair loss, headaches, joint pain, muscle pain, rash, shortness of 
breath, and weight change) are physical health problems, and thus arrows emanating from 
the latent variable physical health go to them (Figure 4). The remaining four 
complaints/symptoms (depressed mood, difficulty concentrating, memory problem, and 
sleep disturbances) are psychological difficulties, and thus arrows emanating from the 
latent variable psychological health go to them (Figure 5) .  Two regression weights 
labeled " 1 "  are included in this model to scale the two factors, psychological and physical 
health, so that this model could achieve identification. (Model identification is discussed 
in detail later in this chapter). 
The literature review establishes that psychological health has a causal effect on 
physical health. That relationship is reflected in the proposed model (Figure 6) by the 
arrow emanating from psychological health and directed toward physical health. Since in 
the core model, psychological health is an independent (exogenous) variable, there is no 
error term associated with it. Physical health, on the other hand, is influenced by 
psychological health and is thus considered a dependent (endogenous) variable, which 
must have an error term associated with it. The error term fl is thus added to the model. 
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Since fl is an estimated and not measured value, it is drawn in a circle. 
The stress scores of Gulf War veterans (calculated by the Gulf War Stress Scale) 
are next added to the core model. Since a veteran' s  stress score is a measurable item, 
derived from the data on wartime exposure/experiences and the developed stress scale, it 
is represented by a rectangle in the proposed structural equation model. The l iterature 
review presents a significant amount of evidence that stress directly affects an 
individual 's physical as well as psychological well-being. This conclusion is reflected in 
the proposed model by arrows emanating from the stress scores to the latent variables, 
physical health and psychological health (Figure 7). The addition of a stress score 
indicator to the model causes the latent variable, psychological health, to change from an 
independent (exogenous variable) to a dependent (endogenous) variable. Since 
exogenous variables require error terms, a new error term, f2 is  attached to psychological 
health in the model. Like fl ,  which represents the error term for physical health, f2 is an 
estimated value and thus is drawn in a circle. 
Four additional indicators (age, gender, race, and marital status) were next added 
to the model (Figure 8) .  From the literature review, it is apparent that each of these 
indicators has an effect upon both physical and psychological health. This effect is 
reflected in the structural equation model by arrows emanating from each indicator 
variable toward both physical health and psychological health. 
Derivation of the Health Outcomes Variables 
Many Gulf War veterans returned home with a wide range of health problems similar to 
the 1 5  (abdominal pain, bleeding gums, depressed mood, diarrhea, difficulty 
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concentrating, fatigue, hair loss, headaches, joint pain, memory problem, muscle pain, 
rash, shortness of breath, sleep disturbance and weight change) l isted in the medical 
complaints/symptoms portion of the Comprehensive Clinical Evaluation Program survey 
(see Appendix XXII) .  For some veterans, these problems were a chronic source of pain 
and suffering that disrupted their l ives. For others they were minor nuisances that often 
just came and went. In order to derive health outcome variables that accurately reflected 
the health status of veterans who had fought in the Gulf War, it was necessary to 
incorporate not only yes/no data assessing the presence of health care problems in the 
veteran population, but also scaled data that could reflect the severity of those problems. 
In the medical complaints/symptoms portion of the Comprehensive Clinical 
Evaluation Program survey, veterans were asked yes/no questions as to whether or not 
they had experienced or were experiencing any of the listed 1 5  health problems. If they 
answered yes to either question, they were directed to fol low-up questions, which asked 
about the onset, duration, frequency, and level of impairment of that health problem. The 
follow-up questions had response choices scaled from lowest level impact on the veteran 
( I )  up to the greatest level of impact (5) .  Veterans were asked to identify the impact 
levels of their health problems in terms of onset, duration, frequency, and impairment 
level .  The results for that set of choices as well as the results of the yes/no experience 
questions were used together to come up with health outcome variables for the study. 
Table I I , as an example, shows how presence and follow-up data were recorded 
for abdominal pain (one of the I S  l isted health problems) for the first 20 of 1 2,205 Gulf 
War veterans who had responded to the medical complaints/symptoms portion of the 
Table I I : Examples of how past and current experiences with abdominal pain were 
combined to create abdominal pain presence scores. (n=20.) 
Veteran Past Abd. Current Presence Abd. Pain Abd. Pain Abd. Pain Abd. Pain 
Number Pain Abd. Pain Abd. Pain Onset Duration Frequency Impairment 
I 0 
2 0 
3 0 
4 I 
5 0 
6 I 
7 I 
8 0 
9 0 
1 0  0 
I I  I 
1 2  0 
1 3  0 
1 4  0 
1 5  I 
1 6  0 
1 7  0 
1 8  0 
1 9  0 
20 I 
Veteran Number: 
Past Abd. Pain: 
Current Abd. Pain: 
Presence of Abd. Pain: 
Abd. Pain Onset: 
Abd. Pain Duration: 
Abd. Pain Frequency: 
I I 2 5 2 I 
I I 5 5 2 2 
0 0 
0 I 5 3 I 2 
I I 3 5 2 2 
0 I 5 1 I 1 
0 I 5 3 3 I 
0 I 4 I 2 2 
0 0 
I I 3 5 2 2 
0 I 5 2 2 2 
I I 3 2 2 2 
0 0 
0 0 
0 I 5 4 2 I 
0 0 
0 0 
0 0 
0 0 
0 I 5 I 2 I 
These are the first 20 out of 1 2,205 veteran responses in the 
medical complaints/symptoms portion of the Comprehensive 
Cl inical Evaluation Program survey data. 
YeslNo response to the question about having experienced 
abdominal pain. 
YeslNo response to the question about currently experiencing 
abdominal pain. 
Combination of YeslNo responses for abdominal pain. 
Scaled score responses ( 1 -5 )  for abdominal pain onset ( I ,  
lowest impact, to 5,  greatest impact). 
Scaled score responses ( 1 -5 )  for abdominal pain duration 
( I ,  lowest impact, to 5, greatest impact). 
Scaled score responses ( 1 -4) for abdominal pain frequency ( I ,  
lowest impact, to 4, greatest impact). 
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Abd. Pain Impairment: Scaled score responses ( 1 -3 )  for abdominal pain impairment ( 1 ,  
lowest impact, to 3 ,  greatest impact). 
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Comprehensive Clinical Evaluation program survey. In this example, the results of the 
column for past abdominal pain (a yes/no response) were combined with the results of the 
column for current abdominal pain (also a yes/no response) to generate the column 
denoting presence of abdominal pain for the 20 veterans sampled. If a yes response " 1 "  
was l isted for either past abdominal pain or current abdominal pain, a " 1 "  was recorded 
for that veteran under the heading presence of abdominal pain column, and that veteran 
was directed to the follow-up questions about abdominal pain. If a no response "0" was 
given for both past abdominal pain and current abdominal pain, a "0" was recorded for 
that veteran for presence of abdominal pain, and no follow-up questions were used. 
Table I I , which records 20 veterans' responses to a single health problem, is simply a 
small sample of how the medical complaints/symptoms portion of the Comprehensive 
Clinical Evaluation were recorded. The actual data used in the study consisted of the 
1 2,205 veterans' responses to questions on 1 5  different health problems. 
In deriving health outcome variables for this study, it was important to 
incorporate not only the information about the presence or absence of a particular health 
problem, but also information on the severity of the problem if it existed. Describing 
health problems in terms of both presence and severity yields a more accurate accounting 
of the veterans' health status. As Table 1 1  illustrates, for each of the 1 5  health problems 
examined in this study, " I "  denoted the presence of a particular problem and "0" its 
absence. "0" l isted for the presence of a health problem generated "0" l isted in the health 
outcome variable, since the veteran had not experienced or was not experiencing that 
health problem. I f"  1 "were listed, meaning the presence of a health problem, the results 
of the follow-up questions about the problems' onset, duration, frequency, and level of 
impairment were used to numerically establish the severity of that problem. 
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Factor and correlation analyses were performed in SPSS on the results of those 
fol low-up questions for each of the 1 5  health problems listed in the study. The factor 
analysis procedure, which is a data reduction technique, was used to determine how many 
factors (common characteristics of the results of the questions) were needed to explain 
the underlying relationships among those questions. The results of the factor analysis 
(see Appendix XXIII) show that a single factor component for each of the 1 5  health 
problems is responsible for the majority of variance among the four follow-up questions: 
in each of the 1 5  health problems, over 75% of the variance among the questions could 
be explained by a single variable. In other words, the degree of uniformity among the 
four fol low-up questions was very strong. A correlation analysis was also performed in 
order to generate a correlation matrix to describe how the results of individual follow-up 
questions linearly relate to one another. Correlation coefficients can range from - 1 .00 
(perfect negative correlation) to + 1 .00 (perfect positive correlation), with a value of 0.00 
representing a lack of correlation. The results of the correlation analysis in this study (see 
Appendix XXIII) show a high degree of correlation ( .7  or greater) among the results of 
the four follow up questions in each of the 1 5  health problems. This high degree of 
correlation suggests that the follow-up questions were all very similar in terms of gauging 
the impact that a health problem had on the health status of a veteran. 
Since the results of the factor and correlation analysis revealed that similarity, it 
was decided to have one follow-up question represent all four in terms of deriving a 
health outcome variable. For veterans who had experienced or were experiencing a 
particular health problem, one follow-up question out of the four (onset, duration, 
frequency, and level of impairment), was chosen to serve as a scaled response. The 
frequency with which a veteran experienced a health problem seemed to best represent 
the degree to which a health problem had affected the veteran, since in the correlation 
matrix (see results section) the results of the frequency question consistently correlate 
highest with all four questions. 
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Thus yes/no responses from the presence of a particular health problem column 
and the scaled responses from the frequency column were thus used to create a health 
outcome variable for each of the 1 5  listed health problems. Where there was a no "0" 
response in the presence column for a particular health problem, there would likewise be 
a no "0" in the health outcome variable column for that problem. Where there was a yes 
" I "  response in the presence column, the corresponding scaled score from the frequency 
column would be transferred to the health outcome variable column. An example of how 
the health outcomes were derived can be seen in Table 1 2, which is an extension of Table 
I I . The health outcome variable to be used in the structural equation modeling analysis 
can be seen in bold. The procedure illustrated in Table 1 2  for deriving a scaled score for 
health outcomes was used for each of the 1 5  listed health problems, for 1 2,205 veterans. 
Identification of the Model 
Identification, a fundamental element in structural equation modeling, concerns 
the ability of a model to theoretically generate unique estimates for each of its 
parameters. The term "identified" describes a model that can generate unique parameter 
Table 1 2 :  Examples of how Presence of Abdominal Pain and Frequency of abdominal 
pain were combined to create an Abdominal Pain Outcome Variable (n=20.) 
1 00 
Veteran Past Abd. Current Presence Abd. Pain Abd. Pain Abd. Pain Abd. Pain Abd. Pain 
Number Pain Abd. Pain Abd. Pain Onset Duration Frequency Impairment Variable 
I 0 I I 2 5 2 I 2 
2 0 I I 5 5 2 2 2 
3 0 0 0 0 
4 1 0 1 5 3 1 2 1 
5 0 1 1 3 5 2 2 2 
6 1 0 1 5 I 1 1 1 
7 I 0 I 5 3 3 1 3 
8 0 0 I 4 1 2 2 2 
9 0 0 0 0 
1 0  0 1 1 3 5 2 2 2 
I I  I 0 1 5 2 2 2 2 
1 2  0 1 1 3 2 2 2 2 
1 3  0 0 0 0 
1 4  0 0 0 0 
1 5  1 0 1 5 4 2 I 2 
1 6  0 0 0 0 
1 7  0 0 0 0 
1 8  0 0 0 0 
1 9  0 0 0 0 
20 I 0 1 5 1 2 1 2 
estimates, and "not identified" describes models that cannot do so (Kenny, 1 987). Only 
"identified" models are of value in structural equation modeling. Those models that 
cannot produce unique estimates for its parameters do not provide much in terms of 
relevant information about the data in the model and are of l ittle value to the researcher. 
Therefore, researchers who use structural equation modeling techniques in their data 
analysis make sure that their models are "identified" prior to analysis. 
For a model to be "identified," it must meet two conditions: ( 1 )  the number of free 
1 0 1  
parameters i n  the model must be less than o r  equal to the number o f  observations i n  the 
model, and (2) every factor must have a scale (Kline, R.B. ,  1 998). The number of free 
parameters in a model consists of the total number of variances and covariances (i .e . ,  
unanalyzed associations) of the factors and measurement errors in the model, plus direct 
effects on the indicators from the factors (i .e. factor loadings) in the model (Kline R. B . ,  
1 998). The number of observations in a model is calculated using the formula: number of  
observations = v (v+ 1 )/2, where v is the number of observed values in the model. In 
order for a model to be identified, the number of free parameters thus must be less than or 
equal to the number of observations in the model, and every factor must be scaled 
(weighted by designating one factor loading as 1 .0) .  
The AMOS modeling software automatically determines whether or not a model 
is identified every time it is run with data. If a model is not identified, it will exhibit an 
error term stating so in the model output and setting the requirements for identification. 
If a model is  identified, AMOS will state this in the model output and proceed with 
model analysis. The AMOS program confirmed that identification was achieved for all 
parts of this study's  structural equation model. 
Variable Measurement 
The model in Figure 8 contains two latent variables physical and psychological 
health (shown at the center of the model), 1 5  health outcome variables (shown at the right 
side of the model) and five descriptive variables (shown at the left hand side of the 
model) along with associated error terms. Since the two latent variables and error terms 
by definition cannot be measured, they will be left out of this discussion. The derivation 
of the 1 5  outcome variables has already been discussed, which leaves this section to 
focus in on the measurement of the five descriptive variables in the model. 
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Four out of the five descriptive variables (age, race, gender, and social support 
systems) came directly from the personal identifier section of the Comprehensive Clinical 
Evaluation program data. The fifth descriptive variable (stress score) was derived though 
use of a stress survey results as wel l as exposure/experience information from the 
Comprehensive Clinical Evaluation Program data. Both age and stress score were 
normally distributed (see Results section) and thus treated as continuous data. The 
remaining three descriptive variables, gender, race, and social support systems were 
treated as discrete variables. 
The variable age was measured by taking the date that the Comprehensive 
Clinical Evaluation Program exposure/experiences form was filled out and subtracting 
from it the birth year of the veteran. Since only birth years were given with the 
Comprehensive Clinical Evaluation Program data, the variable age was rounded down to 
the age in years that person was at the time they took the survey. The variable stress 
score was also rounded, but to the nearest hundredths position. 
The discrete variables gender, race, and social support systems were each treated 
as binomial variables and measured as follows: gender was designated as " I "  for males 
and "0" for females; race was divided into " I "  for majority and "0" for minority; and 
social support systems was divided into " I "  for married veteran and "0" for not married 
veteran. The latter two variables were designated as binomial values so that the AMOS 
program could understand them. 
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Model Analysis 
Model analysis took place once all appropriate data was attached to the AMOS 
program, the model in question was connected to that data, and the settings on the 
analysis properties function were set to allow all the appropriate goodness-of-fit tests to 
run. The model analysis consisted of testing the three hypotheses set at the beginning of 
this dissertation, namely that: 1 )  physical health was a function of psychological health; 
2) that relationship between physical health and psychological health would remain the 
same after taking into account the varying stress levels of Gulf War veterans; and 3) that 
the overall relationship would not change when the variables age, gender, race, and social 
support networks were introduced into the equation. The parts of the structural equation 
model which were used to test these hypotheses were figure 6 for hypothesis 1 ,  figure 7 
for hypothesis 2, and figure 8 for hypothesis 3 .  Model analysis results testing the three 
above hypotheses are found in the Results section. 
Model Evaluation and Respecification 
Once the model is run using the AMOS program, it can be evaluated to see how 
wel l it fits with the data using goodness-of-fit measures. The major goodness-of-fit 
measures used to determine model fit were the chi-square value, chi-square/degrees of 
freedom, goodness-of-fit index (GFI), adjusted- goodness-of-fit index (AGFI), root mean 
square error of approximation (RMSEA), Hoelter N, and the modification indices (see 
Appendix X). From these measures, a determination was made to respecify the model so 
that it would obtain a better fit with the data. 
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Model respecification involved reviewing the results of the modification indices 
to see where adjustments in the model might make a difference in overall fit and 
conceptually determining whether or not making these model adjustments would be 
theoretically meaningful.  For the models tested, three modification indices were far and 
above higher than all others. Those were between error terms e I (abdominal pain) and e3 
(diarrhea), e7 (joint pain) and e8 (muscle pain), and e 1 3  (difficulty concentrating) and 
e l 4  (memory problems). Since changes in these error terms conceptually made sense, 
they were added to the models to see if a better fit with the data could be obtained. The 
results of these model changes are detailed in Chapter Four. 
Summary 
Chapter Three describes the methods used in obtaining, formatting, and cleaning, 
the secondary data source (Comprehensive Clinical Evaluation Program data) used in this 
dissertation so that it could be made ready for structural equation modeling analysis by 
the AMOS modeling software. It also details the methods used in setting up, sending out, 
and recording the results of a stress survey so that primary data (stress scores of veterans) 
could be obtained. From both sources of data, structural equation models were developed 
to test the three hypotheses of this dissertation. The development of these models 
included discussions on model identification, variable measurement, the derivation of 
health outcome variables, and model respecification. 
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CHAPTER 4: RESULTS 
Introduction 
Chapter Four presents the empirical results of the analysis of that will be used to 
accept, reject, or modify the three hypotheses put forward regarding the relationship 
between physical health and psychological health in Gulf War veterans. I t  presents the 
structural equation models that graphically describe the three hypotheses regarding 
physical and psychological health and shows how well they fit with the data using 
numerous Goodness-of-Fit tests. From the results of these tests, decisions will be made 
as to whether a veterans psychological health has a causal effect upon their physical well 
being, whether or not the introduction of varying stress levels among veterans will 
change this relationship, and finally whether or not control variables such as a veterans 
age, gender, race, or marital status will further affect this relationship. 
The Goodness-of-Fit tests that will be used to determine the course of action on 
the hypotheses are the following: the chi-square value, chi-square/degrees of freedom, 
goodness-of-fit index (GFI), adjusted-goodness-of-fit index (AGFI), root mean square 
error of approximation (RMSEA), Hoelter N (.05), and the modification indices (see 
Appendix X). Decisions on accepting, rejection, or modifying the hypotheses under 
consideration will depend upon the overall results of each of these tests. All three 
hypotheses will be considered separately when determining course of action, however all 
will be viewed together when interpreting results. 
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Model respecification will be examined in each of the structural equation models 
that graphically describe the three hypotheses under consideration. Respecification will 
be based upon theoretical considerations as well as the output from the modification 
indices. To statistical ly determine if respecification improves model fit, the Chi-Squares 
from the original and correlated models will then be tested for independence. If the 
respecified model shows independence from the original model and has a better fitting 
Chi-Square, then that model will be used to describe the data. 
The structural equation model results will show how well the model in question 
fit with the data they supposedly describe. If, for example as shown in the model in 
Figure 9, psychological health has a causal effect on physical health, this relationship 
should be reflected in acceptable Goodness-of-Fit statistics. If a causal effect is  not 
reflected by the data, the Goodness-of-Fit statistics will show an unacceptable model. A 
causal effect between psychological health and physical health should be interpreted as a 
positive association between the two variables. This means that veterans who experience 
psychological health problems are more likely to experience physical health problems. 
The reverse is also true; veterans who have fewer psychological health problems are less 
likely to develop physical health problems. 
Results of Study Hypothesis 1 
The first hypothesis under consideration for this dissertation is the following: 
Ho = physical health = f (psychological health) versus HA = physical health :f. f 
(psychological health). The graphical representation of this hypothesis is shown in 
Figure 9. The arrow drawn from psychological health to physical health indicates a 
causal effect. The results of the model in Figure 9 are as follows: the Goodness-of-Fit 
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Index = 0.953 ;  the Adjusted Goodness-of-Fit Index = 0.937; the RMSEA = 0.06 1 ;  and 
the Hoelter N ( .05) = 328. All of these figures suggest a reasonably fitting model .  The 
Chi-Square = 4 1 79.685 and the Chi-Square/df =  46.963 were rather higher in this model, 
but since the since Chi-Square is dependent upon the sample size, a large Chi-Square and 
Chi-Square/df were not unexpected for this model. 
The three large modification indices shown: 8 1 2.80 for e l 3  (difficulty 
concentrating) and e l 4  (memory problems); 769.30 for e7 (joint pain) and e8 (muscle 
pain); and 6 1 0. 1 9 for e I (abdominal pain) and e3 (diarrhea) suggest that the model may 
be improved through respeci fication. Conceptually correlating the above error terms 
makes sense. Sufficient evidence exists in the literature to show that difficulty 
concentrating and having memory problems are related to one another; likewise joint pain 
and muscle pain often appear together; finally individuals who have abdominal pain often 
have accompanying diarrhea. 
Figure 1 0  shows a respecification of the model in Figure 9 with correlations 
between the error terms e l 3  (difficulty concentrating) and e l 4  (memory problems); e7 
(joint pain) and e8 (muscle pain); and e l  (abdominal pain) and e3 (diarrhea). The 
respecified Chi-Square value is compared to the original Chi-Square value in Table 1 3 .  
Taking the differences i n  Chi-Square results between the original and revised models and 
then dividing by the difference in degrees of freedom gives a Chi-Square value that can 
be used to test the independence of the models. The resultant value 1 0 1 3 .996 is much 
greater than the acceptable value for dependence using 
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Results of Structural Equation Modeling Analysis 
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Figure 9: A proposed structural equation model showing how physical health outcomes 
are affected by psychological health outcomes in a cohort of Gulf War veterans. The 
model does not have correlated measurement errors. 
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Figure 1 0: A proposed structural equation model showing how physical health outcomes 
are affected by psychological health outcomes in a cohort of Gulf War veterans. The 
model does have correlated measurement errors. 
an alpha level of .05 and 3 degrees of freedom. Thus the two models are considered 
independent of each other. Since the correlated model in Figure l O is a much better 
fitting model, it will be used as the model to describe the data. The Goodness-of-Fit 
results for the respecified model used in analyzing hypothesis 1 are shown in Table 1 4. 
Table 1 3 : A Comparison of the Chi-Square values between the uncorrelated model 
(Figure 9) and correlated model (Figure 1 0). 
Index Initial Model Revised Model 
Chi-Square 4 1 79.685 1 1 24. 1 36 
Degrees of Freedom (dt) 89 86 
Table 14 Goodness-of-Fit Results for Respecified Model (Figure 1 0). 
Index Revised Model 
Chi-Square 1 1 24. 1 36 
Degrees of Freedom (dt) 86 
Chi-Square/df 1 3 .07 1 
Goodness-of-Fit Index 0.978 
Adjusted Goodness-of-Fit Index 0.983 
RMSEA 0.03 1 
Hoelter N ( .05) 1 1 80 
The results of the model in Figure 10 above support the first hypothesis under 
1 1 0 
consideration, which states that physical health is a function of psychological health. The 
Goodness-of-Fit Index = 0.978 and the Adjusted Goodness-of-Fit Index = 0.983 are well 
above the .90 threshold for model fit; the RMSEA = 0.03 1 is below the .08 maximum 
allowable figure for model acceptance; and the Hoelter N ( .05) = 1 1 80 is well above the 
value of 200 needed for model fit. Since the next two models testing hypothesis 2 and 3 
build upon this core model which has three correlated error terms, the three correlated 
error terms in Figure 1 0  will be included in all subsequent model analysis. 
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Results of Study Hypothesis 2 
The second hypothesis that is under consideration for this dissertation is the 
following: Ho = physical health = f (psychological health, Gulf War Stress) .  
HA= physical health f. f (psychological health, Gulf War Stress). The graphical 
representation of this hypothesis is shown in Figure 1 1 . The arrow emanating from 
psychological health and going to physical health remains the same as in Figure 1 0. The 
major difference in this new model and thus new hypothesis is the addition of the 
variable Gulf War Stress to the equation. Gulf War Stress as quantified by veterans stress 
scores affects both physical and psychological health and thus has two different arrows 
emanating from it a going to the two respective latent variables. Table 1 5  gives the 
Goodness-of-Fit statistics for Figure 1 1 . 
Table 1 5 : Goodness-of-Fit Results (Figure 1 1). 
Index Revised Model 
Chi-Square 1 279.604 
Degrees of Freedom (df) 99 
Chi-Square/df 1 2.925 
Goodness-of-Fit Index 0.987 
Adjusted Goodness-of-Fit Index 0.982 
RMSEA 0.03 1 
Hoelter N ( .05) 1 1 76 
The results of the model in Figure 1 1  support the second hypothesis under 
consideration, which states that physical health is a function of psychological health and 
Gulf War Stress. The Goodness-of-Fit Index = 0.987 and the Adjusted-Goodness-of-Fit 
Index is 0.982 are well above the .90 threshold for model fit; the RMSEA = 0.03 1 is 
below the .08 maximum allowable figure for model acceptance; and the Hoelter N (.05) = 
1 1 76 is well above the value of 200 needed for model fit. 
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Figure I I :  A proposed structural equation model showing the effects of Gulf War stress 
on two latent variables, physical health and psychological health. The model contains 
correlated measurement errors. 
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Results of Study Hypothesis 3 
The third hypothesis that is under consideration for this dissertation is the 
following: Ho = physical health = f (psychological health, Gulf War Stress, age, gender, 
race, and marital status). HA= physical health -:f. f (psychological health, Gulf War Stress, 
age, gender, race, and marital status). The graphical representation of this hypothesis is 
shown in Figure 1 2 .  This model retains the relationships seen between variables in the 
previous models. The main difference between this model and its predecessors is that it 
adds the variables age, gender, race, and marital status to the equation to see if these 
factors have any influence on the way the model fits the data. The results of the model in 
Figure 1 2  are as follows: the Goodness-of-Fit Index = 0.983 ;  the Adjusted Goodness-of­
Fit Index = 0.978; the RMSEA = 0.030; and Hoelter N (.05) = 1 1 83 .  All of these figures 
suggest a reasonably fitting model. The Chi-Square for this model is 1 977 .974 and the 
Chi-Square/df is 1 2 .284. 
The modification indices taken from the output of the model in Figure 12 indicate 
that there is probable correlation among the newly added predictor variables. The 
modification indices for the predictor variables indicate four areas where correlation may 
improve model fit: 2 1 8 .649 between marital status and gender; 1 95 .080 between marital 
status and race; 1 1 4.889 between race and gender; and 1 1 4.368 between race and age. 
Conceptually, each of these four relationships makes sense. 
Figure 1 3  shows the shows a respecification of the model in Figure 1 2  with 
correlations between the predictor variables marital status and gender, marital status and 
race, race and gender, and race and age. The respecified Chi-Square value is compared to 
the original Chi-Square value in Table 1 6. Taking the difference in Chi-Square 
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Figure 1 2 :  A proposed structural equation model showing the effects of age, gender, race, 
marital status, and Gulf War stress on two latent variables physical health and 
psychological health. The model does have correlated measurement errors but not 
correlated predictor variables. 
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Figure 1 3 :  A proposed structural equation model showing the effects of age, gender, race, 
marital status, and Gulf War stress on two latent variables physical health and 
psychological health. The model has correlated measurement errors as well as correlated 
predictor variables. 
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results between the original and revised models and then dividing by the difference in 
degrees of freedom gives a Chi-Square value that can be used to test the independence of 
the models. The resultant value of 1 50.240 is much greater for the acceptable value for 
dependence using an alpha level of .05 and 4 degrees of freedom. Thus the two models 
are considered independent from each other. Since the correlating model in Figure 1 3  is 
a much better fit, it will be used to describe the data. The Goodness-of-Fit results for the 
respecified model used in hypothesis 3 are shown in Table 1 7. 
Table 1 6: A Comparison of the Chi-Square values between the uncorrelated predictor 
model (Figure 1 2) and correlated predictor model (Figure 1 3 ) .  
Index Initial Model Revised Model 
Chi-Square 1 977.974 1 377.0 1 5  
Degrees of Freedom (df) 1 6 1  1 57 
Table 1 7  Goodness-of-Fit Results for Respecified Model (Figure 1 3). 
Index Revised Model 
Chi-Square 1 377.0 1 5  
Degrees of Freedom (df) 1 57 
Chi-Square/df 8 .77 1 
Goodness-of-Fit Index 0.988 
Adjusted Goodness-of-Fit Index 0.985 
RMSEA 0.025 
Hoelter N ( .05) 1 660 
The results of the model in Figure 1 3  support the third hypothesis under 
consideration, which states that physical health is a function of psychological health, Gulf 
War Stress, age, gender, race, and marital status. The Goodness-of-Fit Index = 0.988 and 
the Adjusted Goodness-of-Fit Index are well above the .90 threshold for model fit; the 
RMSEA = 0.025 is well below the .08 maximum allowable figure for model acceptance; 
and the Hoelter N ( .05) = 1 660 is well above the value of 200 needed for model fit. 
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Summary 
The results section provides the answers to the three hypotheses proposed 
concerning the relationship between psychological health and physical health. In each 
case, the developed models graphically il lustrate that the hypotheses in question fit with 
the data. When necessary, the models were respecified to show the correlations that exist 
between the variables. This was done to better fit the models with the data. The results 
of this chapter indicate that the three hypotheses in question: 
Hypothesis 1 :  Ho = physical health = f (psychological health); 
Hypothesis 2:  Ho = physical health = f (psychological health, Gulf War Stress); and 
Hypothesis 3:  Ho = physical health = f (psychological health, Gulf War Stress, age, 
gender, race, and marital status) 
should all be accepted as fitting with the data. Table 1 8  is  a summary of the Goodness of 
Fit Statistics for hypotheses 1 , 2, and 3 respectively. The regression weights for 
hypothesis 3 are provided in Table 1 9. The meaning of these results to veterans will be 
discussed in the next chapter. 
Table 1 8  Summary of Goodness of Fit StatisticsfFigures 1 0, 1 1 , and 1 3). 
Index Hypothesis 1 Hypothesis 2 Hypothesis 3 
Figure 1 0  Figure 1 1  Figure 1 3  
Chi-Square 1 1 24. 1 36 1 2 79.604 l 377.0 1 5  
Degrees of Freedom (df) 86 99 1 57 
Chi-Square/df 1 3 .07 1 1 2 .925 8 .77 1 
Goodness-of-Fit Index 0.978 0.987 0.988 
Adjusted Goodness-of-Fit Index 0.983 0.982 0.985 
RMSEA 0.03 1 0.03 1 0.025 
Hoelter N (.05) 1 1 80 1 1 76 1 660 
RL (Squared Multiple Correlations) 0.82 0.82 0.670 
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Table 1 9  Re�ession Weis;hts for Fi�re 1 3  
Standardized 
Regression 
Coefficient Critical Ratio {*) 
Direct Effect of: 
Gulf War Stress on Ps�chological Health 0.0 1 0  22.842* 
Marital Status on Ps�chological Health -0.006 -0.346* 
Race on Ps�chological Health -0.004 -0.266* 
Gender on Ps�chological Health -0.004 -0. 1 36* 
Age on Ps�chological Health 0.00 1 1 .3 70* 
Ps�chological Health on Ph�sical Health 0.560 43 .855* 
Gulf War Stress on Ph�sical Health 0.003 1 3 .4 1 8* 
Marital Status on Ph�sical Health 0.028 2 .774* 
Race on Ph�sical Health 0.004 0.470* 
Gender on Ph�sical Health -0.002 -0. 1 04* 
Age on Ph�sical Health 0.000 0.5 1 0* 
Ps�chological Health on Del2ressed Mood 1 .000 
Ps�chological Health on Difficult� Concentrating 1 .3 2 1  7 1 .290* 
Ps�chological Health on Memory Problems 1 .249 63 .896* 
Ps�chological Health on Sleel2 Disturbances 1 .050 52.8 1 9 *  
Ph�sical Health on Abdominal Pain 1 .000 
Ph�sical Health on Bleeding Gums 0.688 33 .984* 
Ph�sical Health on Diarrhea 0.938 46. 1 1 5 *  
Ph�sical Health on Fatigue 1 .605 50.539* 
Ph�sical Health on Hair Loss 0.69 1 28 .76 1 * 
Ph�sical Health on Headache 1 .229 45.709* 
Ph�sical Health on Joint Pain 1 .3 1 4 43.6 1 5 *  
Ph�sical Health on Muscle Pain 1 .3 7 1  45.233*  
Ph�sical Health on Rash 0.749 28.297* 
Ph�sical Health on Shortness of Breath 1 .245 44.902* 
Ph�sical Health on Weight Control 1 .046 39.722* 
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CHAPTER 5 :  F INDINGS, DISCUSSIONS, AND CONCLUSIONS 
Introduction 
Chapter Five summarizes the findings of the statistical analysis used to test the 
three hypotheses concerning the relationship between physical and psychological health 
among Gulf War veterans. It presents the results of structural equation models that 
graphically illustrate the hypotheses under consideration, and states the rational behind 
the decisions as to accept, reject, or modify those hypotheses. A discussion ensues in this 
chapter on the meaning of these findings not only as they apply to the hypotheses in 
question, but also to the larger picture concerning overall veteran health during combat 
situations. 
This chapter next summarizes and discusses the implications of this research in 
l ight of the substantive contributions that it veterans gain from it. It l ikewise discusses 
the methodological considerations of the research including the use of structural equation 
modeling techniques to examine the latent variables stress, physical health, and 
psychological health. Practical considerations of the research to the overall health of 
veterans are examined, followed by policy considerations that may be drawn from this 
work. This chapter will finally present the limitations of this study and make 
recommendations for future research on this topic. 
Major Findings and Implications 
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The results of this research are used to make decisions on three hypotheses 
concerning the relationship between physical health and psychological health among 
veterans of the Gulf War. These results are important because they shed light on the 
question of whether or not psychological health problems do indeed have a causal effect 
the physical well being of veterans. If it can be shown that a causal relationship exists 
between the psychological health of veterans and their physical health, focus can be made 
in the area of veteran psychological health to combat both psychological as well as 
physical health problems that veterans are facing. 
The first step in determining if a causal relationship exists between a veterans '  
psychological health and their physical health was to  set up a hypothesis that would 
examine this relationship. This was done in hypothesis 1 which asked the question 
whether or not an individual 's  physical health was a function of their psychological 
health or not. It asked: 
Hypothesis 1 :  Ho = physical health = f (psychological health). 
HA= physical health ::f:. f (psychological health). 
From the results of the Goodness-of-Fit tests on the structural equation model in Figure 9, 
it is apparent that Ho = physical health = f (psychological health) fits with the data of Gulf 
War veterans and thus should be accepted. These results thus add support previous 
literature that suggests that an individuals' psychological heath has a causal effect on 
their physical well being. 
Once the first hypothesis has been supported by the results of the structural 
equation model analysis in Figure 9, the next step is to ask the question, "Does this causal 
relationship between psychological health and physical health hold up when Gulf War 
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Stress i s  entered into the equation?" Since veterans of the Gulf War experienced varying 
degrees of stress, it is important to see if stress could have an influence on this 
relationship. If Gulf War Stress played a random role in the model (meaning that 
veterans who experienced high stress had an equal chance of experiencing health 
problems as veterans experiencing low stress) the results of the Goodness-of-Fit statistics 
would indicate a poorer model fit, thus arguing that the model does not hold up well with 
the data it supposedly represents. If, on the other hand, Gulf War Stress played a more 
structured role (meaning that veterans who had experienced high stress also had a higher 
chance of experiencing health problems, and vice versa), then the results of the 
Goodness-of-Fit tests would argue that the model does indeed hold up well with the data. 
The second hypothesis was thus: 
Hypothesis 2 :  H o  = physical health = f (psychological health, Gulf War Stress). 
HA= physical health ::j:. f (psychological health, Gulf War Stress). 
From the results of the Goodness-of-Fit tests on the structural equation model in Figure 
1 1 , it is apparent that Ho = physical health = f (psychological health, Gulf War Stress) 
fits with the data of Gulf War veterans and thus should be accepted. These results thus 
both add support to the original hypothesis stating that psychological health has a causal 
effect on physical health among Gulf War veterans, and since Gulf War Stress was 
found to be more structured, lends support to the idea that stress during the Gulf War 
may have also had an impact on veterans health. 
The third question to be asked when looking at the structural equation model and 
its relationship with the Gulf War data is "How wel l does this model hold up when 
variables such as age, gender, race, and marital status enter into the equation?" Since 
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these personal identifying factors may have an affect on the causal relationship between 
psychological and physical health, it was important to incorporate them in model to see 
what affect they might have on that relationship. As with the variable Gulf War Stress, a 
randomness seen between these variables and health outcomes would indicate a poorer 
model fit whereas a more structured role between the variables and health outcomes 
would mean a better-modeled fit. If the data reflected that a veteran's  age, for example, 
was not a factor in influencing the health outcome variables, then a model representing 
that data would have a poorer overall fit if the variable age were included in the model .  
The same would apply to the variables gender, race, and marital status. 
The third hypothesis was thus: 
Hypothesis 3:  Ho = physical health = f (psychological health, Gulf War Stress, age, 
gender, race, and marital status). 
HA= physical health :f. f (psychological health, Gulf War Stress, age, 
gender, race, and marital status). 
From the results of the Goodness-of-Fit tests on the structural equation model in Figure 
1 3 , it is apparent that Ho = physical health = f (psychological health, Gulf War Stress, 
age, gender, race, and marital status) fits with the data of Gulf War veterans and should 
be accepted. These results thus support the causal relationship between psychological 
health and physical health as well as lend credibility to notion that the variables stress, 
age, gender, race, and marital status do have an effect on veterans' heath outcomes and 
are not just random variables. 
In each of the three models, which graphically represented the three hypotheses 
under consideration, an improved model fit occurred when the error terms with the 
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highest modification indices were correlated during model respecification. These error 
terms were e l 3  (difficulty concentrating) correlating with e l 4  (memory problems), e7 
(joint pain) correlating with e8 (muscle pain), and e I (abdominal pain) correlating with 
e3 (diarrhea). Correlated error terms show where there is high probabil ity that if a 
person picked one response, they would likely choose another that was correlated to the 
first response. Thus, for example, individuals who said that they frequently have 
difficulty concentrating are likely to have memory problems as well. The same goes for 
muscle pain and joint pain, and abdominal pain and diarrhea. 
Substantive Contributions 
The results of this study indicate that a veteran's psychological health status has a 
causal effect upon their physical health. This means that if a veteran has psychological 
health problems they may wind up having physical health problems as well. These 
results support those already found in the literature on this subject which show that an 
individual 's  psychological health influences their physical health. When the variables 
Gulf War Stress, age, gender, race, and marital status are added to the equation, the 
relationship remains true. The variables Gulf War Stress, age, gender, race, and marital 
status are also shown through structural equation modeling techniques to play a role in 
affecting the health outcomes in veterans .  Since they fit wel l with the model, an 
argument can be made that they are not random variables, but do play a role in affecting 
the vulnerabil ities of veterans to health problems. 
This study lends support to other studies that suggest that many physical 
problems have a psychological basis. It also lends support to the literature that states that 
there are vulnerable groups of veterans who may be more susceptible to having health 
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problems than others. This study would suggest to Gulf War veterans who have physical 
ailments that they may look to their psychological health status for an explanation of 
some of the problems they may have or might have been having. It recommends to 
current veterans who may be in a vulnerable group or are may be asked to experience 
highly stressful conditions may wish to have a psychological evaluation to see if they are 
at greater risk of becoming i l l .  This study is important to veterans because it statistically 
links their physical wel l being to their psychological well being. It also supports previous 
studies, which suggest that there are vulnerable populations of veterans that may be more 
susceptible to health problems than others. 
Methodological Contributions 
This study examines the effects of the latent variables psychological health and 
physical health on health outcomes of Gulf War veterans using structural equation 
modeling techniques. Without the modeling techniques used in this study, it would be 
difficult to determine how the latent variables psychological health and physical health 
affect the health outcomes of veterans. The models used in this study are able to 
graphically illustrate the hypotheses under question. They can statistically show trends in 
the data which will help researchers to focus in on the problems that veterans of the Gulf 
War have been and are facing. 
This study is also methodologically important in that it develops a scale similar to 
that the one produced by Holmes and Rahe to measure the effects of stress on health. 
The Gul f War Stress survey sent out to veterans and health experts shows how a 
potentially latent variable, stress can be quantified by a scale to develop measurable stress 
scores for veterans. These scores can be thus be added to an overall model looking at 
health outcomes to detennine what affect if any Gulf War stress has had on veteran 
health outcomes. 
This study is finally methodologically important because it uses structural 
equation modeling techniques to examine data from the Comprehensive Clinical 
Evaluation Program. No other study on Gulf War veterans has used this modeling 
technique on this very large and important database. By examining this large database 
using structural equation modeling techniques, trends in the health of Gulf War veteran 
health, which may have been previously overlooked, can be brought to l ight. 
Practical Util ities 
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The results of this study can aid veterans who have physical health 
problems by suggesting a psychological basis for their ailments. One of the major 
conclusions of this study is that psychological health has a positive association with 
physical health. This means that when an individual has psychological health problems, 
they also seem more likely to be at risk for physical health problems. Veterans who have 
unexplained physical ailments should thus be looked at for underlying psychological 
health problems. By treating or preventing psychological health problems, physical 
health problems may be cured or averted. 
The results of this study also suggest that stress affects both the psychological 
health as well as physical health of veterans. It shows that veterans who are highly 
stressed are more inclined to have health problems than those veterans who are not as 
much stressed. This study thus lends support to others, which suggest that stress is a 
causal factor in the health outcomes of veterans. By reducing the level of veteran stress, 
veteran health may improve. The potential stressors, which surveyed veterans and health 
experts, deemed the most stressful to Gulf War veterans should be good starting place 
when looking at a means to lower the stress level of troops in combat situations. 
Policy Contributions 
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The Departments of Defense and Veterans Affairs can aid veterans by increasing 
the level of fundinglresearch looking into how a veteran's physical health is influenced 
by their psychological health. If substantial evidence is uncovered suggesting that there 
is a definite l ink between an individuals psychological health and their physical well 
being, changes in how veterans are recruited or handled while in service may be in order. 
Since stress contributes to both psychological and physical health problems, policies that 
lower the stress levels of veterans, who should help to alleviate problems experienced by 
veterans. 
Finally, veterans should be made aware of the potential harm that poor 
psychological heath can have on their physical health. If a veteran is depressed, they 
should be made aware that there are medications available to offset that depression; if  
they have family or  substance abuse problems, they should be made aware that 
counseling is available; if they have anger issues, problems relaxing, or any of a host of 
other psychological heath problems, they should be made aware that treatment is 
available. By reducing the underlying causes to psychological health problems, both 
psychological and physical health problems may be averted. 
Limitations of the Study 
Although a great deal of effort was made to ensure that the study accurately 
reflected the experiences and health outcomes of Gulf War veterans, this study did have 
several l imitations that should now be brought to light. One of the major study 
limitations concerned the use of secondary data in the study. The Comprehensive 
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Clinical Evaluation Program although a large database with lots of useful information 
was not designed to quantify health outcomes as was done in this study. A factor 
analysis thus had to be performed among the outcome data so that it could effectively be 
used in the models. A second limitation to this study was the use of recall data. Veterans 
who answered question about the Gulf War did so several years after it had ended. They 
may have over time forgotten exposures/experiences that they encountered while serving 
in the Gulf. The use of recall data could thus have hampered this study. Finally, this 
study had to rely on self-report data. Veterans had to be taken on their word as to 
whether or not they were experiencing health problems as a result of service in the Gulf 
War. The motive to gain more health benefits may have affected the ways that some 
veterans responded to question about their health. 
Recommendations for Future Research 
Future studies on this topic may wish to survey veterans who are currently serving 
in Iraq and Afghanistan on how their exposures/experiences may have impacted their 
health outcomes. By surveying veterans who are just coming out of a war zone, you will 
eliminate the recall bias found in this study. Likewise, a new study on this topic could be 
designed to use primary data specifically meant to look at psychological heath and 
physical heath. A more current and better-designed study would improve our knowledge 
of how the stresses of combat affect both the physical and psychological health of 
veterans. 
Finally, the predictor variables used in this study could be looked at in greater 
detail in future studies. Race, instead of being either majority or minority could be 
broken down into more segmented groups. Likewise marital status, instead of being 
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married or not married, could be broken down into more detailed variables such as being 
married, single, separated, divorced, or widowed. 
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Appendix I :  Historical Background 
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In August 1 990, the United States began deploying troops to the Persian Gulf area 
in response to Iraq's  invasion of Kuwait. Between the initial phase, known as Operation 
Desert Shield, and the end of the armed conflict, known as Operation Desert Storm, 
approximately 697,000 U.S.  military personnel served in Saudi Arabia, Kuwait, and other 
countries in the Persian Gulf area (10M, 1 996). These Americans who fought in what 
became known as the Gulf War differed greatly in terms of demographics from any 
previous U.S .  military force. They were on average older, more ethnically diverse, 
contained more women, and had a larger percentage of troops coming from the National 
Guard and Reserves than any other force in U.S .  history (PACGWVI, 1 996). The vast 
majority of these troops who had never seen combat were now being asked to quickly 
assemble and take on the worlds fourth largest military force, in the Iraqi army, which 
had three years prior completed a long and bloody eight year war with neighboring Iran. 
They were in short, asked to be uprooted from their daily life activities, transplant 
themselves half way across the world to an unfami liar land, and prepare to fight a 
relatively unknown enemy for an unknown length of time. 
The deployment of American and Coalition fighting forces to southwest Asia in 
the fall of 1 990 came about as the result of Iraq's  aggression into Kuwait, its threat 
against Saudi Arabia, and its noncompliance to United Nations (U.N.) resolutions that it 
immediately withdraw its armed forces from Kuwait. Operation Desert Shield, the 
ordering by President George Bush of U.S. forces to the Persian Gulf began soon after 
the Iraqi incursion into Kuwait in August of 1 990. Its military mission was to prevent 
further Iraqi aggression into oil rich Saudi Arabia, show the Iraqis that the United States 
was committed to enforcing the mandated U.N. resolutions, and prepare for a possible 
military campaign to restore the sovereignty of Kuwait if the crisis could not be solved 
peacefully. 
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The Americans and their coalition partners upon arriving in the Persian Gulf 
found themselves up against a formidable enemy that seemed to be willing to use any 
means necessary to assert its authority upon the region. Under Saddam Hussein, Iraq had 
by 1 990 built itself up into a powerful military force with an army estimated to be over 
500,000 strong, an extensive air-defense network fashioned after the Soviet model, and a 
large number of aircraft, tanks, and SCUD (see Appendix XVI) missiles. It also had 
laser-guided bombs, radar-controlled sea skimming antiship missiles, and high 
performance jet aircraft purchased from Soviet, European, Chinese, and other sources 
(Blackwell, 1 99 1 ) . Most concerning to U.S .  and Coalition officials, however, was the 
large Iraqi stockpile of chemical and biological weapons (CW/BW) that Iraq was thought 
to possess and their seemingly indifference in using them (Blackwell, 1 99 1 ). Since 
Saddam Hussein had a history of using chemical weapons on both the Iranians in 1 982, 
and against its own Kurdish population in 1 988, all indications were that he would do so 
again against U .S .  and Coalition forces if so prompted. 
U .S .  military and Coalition personnel took the threat of CW/BW attack by Iraq 
very seriously. Troops arriving in the Gulf region were given a considerable amount of 
training in both the response to CW/BW alarms and in the use of their protective 
equipment (Clancy T. & Franks F . ,  1 997). In addition, to protect these troops from such 
threats, the Department of Defense obtained special permission from the Food and Drug 
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Administration (FDA) in Interim Rule 55 FR 528 1 4  (see Appendix XVII) to use drugs 
and vaccines, that were considered "investigational" by the FDA for military purposes. 
The two most common investigational drugs used by the DoD on U.S.  military personnel 
were the pretreatment drug Pyridostigmine Bromide (PB) and the vaccine Botulinum 
toxin (BT). Pyridostigmine bromide is a reversible cholinesterase inhibitor that is  given 
in pill form to prevent death in the event of exposure to nerve agents. Botulinum toxin is 
a vaccine that is  used against the pathogenic bacterium Clostridium botulinum, which 
when aerosolized, is potentially a very dangerous biological weapon. Troops were also 
vaccinated against the one of the oldest and most feared pathogenic bacteria, Bacillus 
anthracis commonly known as Anthrax. 
By early January 1 99 1  it became apparent that Saddam Hussein would not yield 
to UN demands that he immediately withdraw his troops from Kuwait and that a military 
option would be needed. With the passing of the UN established deadline on January 1 5 , 
1 99 1  to bring a peaceful conclusion to the crisis in the Gulf, President Bush, along with 
Coalition nations authorized the onset of Operation Desert Storm, the liberation of 
Kuwait through military means. At 3 a.m. January 1 7, 1 99 1  Iraqi time (7 p.m. EST 
January 1 6, 1 99 1 )  All ied forces launched Desert Storm with a massive and devastating 
bombing campaign against Iraq and her forces in Kuwait. The air campaign, which both 
damaged Iraq's  military infrastructure as well as lowered her morale, continued unabated 
until late February 1 99 1  when the Coalition forces were ready enter the ground phase of 
Desert Storm. On February 24, 1 99 1  at 4 a.m. Iraqi time (8 p.m. EST February 23, 1 99 1 )  
General Norman Schwarzkopf, the commander of Desert Storm forces, initiated the 
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ground campaign with a thrust into the heart of the Iraqi forces in central Kuwait. This 
was immediately followed by a flanking maneuver to the west around Iraqi forces by 
more mobile troops to cut off lines of supply and avenues of retreat. With no supplies 
and facing an overpowering force, thousands of Iraqi soldiers simply gave up rather than 
fight, as the Allies pushed through Iraq's defenses with relative ease. Learning that his 
army was in full retreat and the liberation of Kuwait on hand, Saddam Hussein in on last 
act of defiance ordered his troops to set fire to all Kuwaiti oil fields still in Iraqi hands. 
Despite this atrocious act, Al lied leaders were determined to end the war as soon as 
possible in order to spare further bloodshed. Once Kuwait was completely liberated and 
the Iraqi army no longer posed a threat to other countries in the region Coalition forces 
decided to bring the conflict to a conclusion. Thus on February 28, 1 99 1  after securing 
agreements through the U.N. that Iraq would remove its claim on Kuwait, destroy all 
weapons of mass destruction, and submit itself to weapons inspections, President George 
Bush suspended all further u.s.  military operations against the Iraqi army. 
The fighting, which took place from the middle of January until the cease-fire on 
February 28, 1 99 1 ,  included 40 days of air warfare and 5 days of ground combat. 
Although Iraq fired many SCUD missiles at U .S .  troops and Israel, none appeared to 
contain BW/CW that U.S .  and Coalition troops so feared. What 6 months prior had 
seemed to be a daunting task that would claim thousands ifnot tens of thousands of 
American lives soon proved to be a great success for such a large-scale military 
operation. The military objective of freeing Kuwait from its Iraqi aggressors was met 
with U.S. troops suffering minimal losses, 1 48 combat deaths, 1 45 deaths due to disease 
1 47 
or accidents, and 467 wounded service personnel, figures far lower than anticipated or 
occurring in previous large scale U.S .  military conflicts (Writer, 1 996). In all, the Gulf 
War was viewed by Americans as a great military success: Kuwait was free, the Iraqi 
anny was defeated, the U.S .  had stronger all iances with the nations that had made up the 
Coalition, and the world had seen the might of U.S .  military forces. 
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Appendix I I :  International Mil itary Coalition against Iraq 
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The international military Coalition put together in response to Iraq's failure to 
abide to U.N. resolutions demanding its withdrawal from Kuwait was the largest to be 
employed in combat since World War II. The Gulf War Coalition included ground, 
navel, and air forces from numerous countries. The primary contributors' of troops from 
outside the Gulf area were the United States (697,000), Britain (35 ,000), Egypt (35 ,000), 
France (25 ,000), Bangladesh (6,000), Pakistan (5,000), and Morocco ( 1 ,500). Substantial 
forces were also provided by countries in the regions surrounding Iraq and Kuwait, 
including Syria (20,000), Saudi Arabia (45 ,000), and the Gulf States - Bahrain, Qatar, 
Oman, and the United Arab Emirates ( 1 7,000). Other countries contributing military 
forces included Afghanistan, Argentina, Australia, Belgium, Canada, Czechoslovakia, 
Denmark, Germany, Greece, Hungary, Honduras, Italy, Kuwait, The Netherlands, New 
Zealand, Niger, Norway, Poland, Portugal, Senegal, South Korea, Spain, and Turkey. 
Source: United States General Accounting Office, Report on to the Chairman, 
Subcommittee on National Security, Veterans' Affairs, and International Relations, 
House Committee on Government Reform 
Coalition Warfare 
Gulf War Allies Differed in Chemical and Biological Threats Identified and in Use of 
Defensive Measures. 
April 200 1 
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Appendix I I I :  United Nations Security Counci l  Resolutions 
l S I  
A. United Nations Security Council Resolution 660 2 August 1 990 
The Security Council ,  alarmed by the invasion of Kuwait on 2 August 1 990 by 
the military forces of lraq, determining that there exists a breach of international peace 
and security as regards the Iraqi invasion of Kuwait, acting under Articles 39 and 40 of 
the Charter of the United Nations: 
I .  Condemns the Iraqi invasion of Kuwait; 
2. Demands that Iraq withdraw immediately and unconditionally all its forces to the 
positions in which they were located on 1 August 1 990; 
3 .  Calls upon Iraq and Kuwait to  begin immediately intensive negotiations for the 
resolution of their differences and supports all efforts in this regard, and 
especially those of the League of Arab States. 
4. Decides to meet again as necessary to consider further steps to ensure compliance 
with the present resolution. 
Adopted by 14  votes to none, with one abstention (Yemen) 
Of the 1 5  Security members five are permanent: China, France, Soviet Union, 
United Kingdom, and the United States. In 1 990, the remaining members, elected by the 
General Assembly to serve two-year terms, were: Canada, Colombia, Cuba, Ethiopia, 
Finland, Ivory Coast, Malaysia, Romania, Yemen, and Zaire. 
B .  United Nations Security Council Resolution 678 1 7  December 1 990 
Noting that, despite all efforts by the United Nations, Iraq refuses to 
comply with its obligation to implement resolution 660 ( 1 990) and in flagrant contempt 
of the Security Council, the United Nations: 
I .  Demands that Iraq comply fully with resolution 660 ( 1 990) and all subsequent 
relevant resolutions, and decides, while maintaining all its decisions, to allow Iraq 
one final opportunity, as a pause of goodwill ,  to do so; 
2. Authorizes Member States cooperating with the Government of Kuwait, unless 
Iraq on or before 1 5  January 1 99 1  fully implements, as set forth in paragraph I 
above, the foregoing resolutions, to use all necessary means to uphold and 
implement resolution 660 ( 1 990) and all subsequent relevant resolutions and to 
restore international peace and security in the area; 
3 .  Requests all States t o  provide appropriate support for the actions undertaken in 
pursuance of paragraph 2 of the present resolution; 
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4.  Requests the States concerned to keep the Security Council regularly informed on 
the progress of actions undertaken pursuant to  paragraphs 2 and 3 of the present 
resolution; 
Adopted by 1 2  votes to two (Cuba and Yemen), with one abstention (China) 
Source: http://www.ull.org/Oocs/scres/ 1 990/scres90.htm 
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Appendix IV: Timeline 
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o Numbers in timeline correspond to locations on timeline map. 
May 28-30, 1 990 - Iraqi President Saddam Hussein asserts oil overproduction by Kuwait 
and United Arab Emirates is "economic warfare" against Iraq. Iraq at the time is 
trying to recoup economic losses from an 8-year war with Iran ( 1 980- 1 988) .  
July 1 5- 1 7, 1 990 - Iraq accuses Kuwait of stealing oi l  from Rumaylah oil field on Iraq­
Kuwait border and warns of mil itary action. 
July 22, 1 990 - Iraq begins military buildup against Kuwait. 
August 2, 1 990 0 ttJ. - Iraq invades Kuwait and seizes Kuwaiti oil fields. Kuwait's emir 
flees. Iraq masses troops along the Saudi border. UN condemns Iraq's invasion 
and demands immediate withdrawal. 
August 6, 1 990 - UN imposes trade embargo on Iraq. 
August 7, 1 990 - Saudi Arabia requests U.S .  troops to defend against possible Iraqi 
attack. 
August 8, 1 990 - Saddam Hussein proclaims annexation of Kuwait. 
August 9, 1 990 0 #2- First U .S .  mil itary forces arrive in Saudi Arabia. UN declares 
Iraqi annexation of Kuwait void. 
August 1 0, 1 990 - Saddam Hussein declares a "j ihad" or holy war against the U.S .  and 
Israel. 
August 1 2, 1 990 - Naval blockade of Iraq begins. All shipments of Iraqi oil halted. 
August 28, 1 990 - Iraq declares Kuwait its 1 9th province, renames Kuwait City al­
Kadhima. 
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September 1 4- 1 5  - United Kingdom and France announce deployment of 1 0,000 troops 
to Gulf. 
December 1 7, 1 990 - UN sets deadline for Iraqi withdrawal on January 1 5, 1 99 1 .  
Saddam Hussein rejects all UN resolutions. 
January 3, 1 99 1  - Defense Department censors war reporting by press. 
January 9, 1 99 1  - Talks between US Secretary of State Baker and Iraqi Foreign Minister 
Tariq Aziz end in stalemate. 
January 1 2, 1 99 1  - Congress grants President Bush authority to wage war. 
January 1 7, 1 99 1  - Operation Desert Storm begins at 3 a.m. Baghdad time. 
January 1 9, 1 99 1  0 #3- First scud missiles strike Israel. 
January 22, 1 99 1  - Iraq begins blowing up Kuwaiti oil wells. 
January 25, 1 99 1  0 #4 - Iraq begins "environmental war" by pumping millions of 
gallons of crude oil into Gulf. 
January 30, 1 99 1  0 #5 - Iraqi and Coalition forces engage i n  first important ground 
battle in Khafji, Saudi Arabia. 
February I ,  1 99 1  - Secretary of Defense Richard Cheney warns US will retaliate if Iraq 
uses chemical or unconventional weapons. 
February 8, 1 99 1  - Total U.S .  troops in Gulf now over half mil lion. 
February 1 2- 1 3 , 1 99 1  - Air bombardment of Baghdad destroys three major bridges and 
kills 400 people in air-raid shelter. 
February 1 9, 1 99 1  - Soviet-Iraqi peace plan rejected by President Bush. Oil spill in Gulf 
now estimated at 1 . 5 million barrels. 
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February 22, 1 99 1  - President Bush issues 24-hour ultimatum: Iraq must withdraw from 
Kuwait to avoid start of ground war. 
February 24, 1 99 1  0 #6 - Allied ground campaign begins. Schwarzkopf's warlords 
carry out Gulf War's critical " left hook" maneuver as conceived by General 
Grant's 1 863 Civil War campaign at Vicksburg. 
February 25, 1 99 1  #7 - Iraqi Scud missile hits U .S .  barracks in Dhahran, Saudi 
0 -
Arabia, killing 28 U.S. soldiers. 
February 26, 1 99 1  0 # 8  - Hussein announces Iraq's withdrawal from Kuwait. Iraqi 
troops exodus from Kuwait City results in "Highway of Death. "  
February 27, 1 99 1  - Coalition forces enter Kuwait City. U.S.  1 s t  Armored Division fights 
battle of Medina Ridge against Iraqi Republican Guard in Iraq. President Bush 
declares Kuwait liberated. 
Source: http://www.pbs.org/wgbh/pages/frontline/teach/gulfguide/gwtimeline.html 
GULF WAR THEATER OF OPERA nONS 
Iraq 0 
Baghdad < 
Saudla Arabia 
Riyadh · 
Dhahran . 
o 
Iran 
Source: http://www.pbs.org/wgbh/pages/frontline/teach/gulfguideItimelinemap.html 
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Appendix V:  U.S .  Mi l itary Casualties from WWI through the Gulf War 
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War/ Branch of Number of Battle Deaths Other Deaths Wounds 
Conflict Service Serving 
World War I Total 4,734,99 1 1 1 6,5 1 6  63, 1 1 4  204,002 
1 9 1 7 - 1 9 1 8  
Army 4,057, 1 0 1  1 06,378 55,868 1 93,663 599,05 1 7,287 6,856 8 1 9  
Navy 78,839 2,85 1 390 9,520 
Marines 
World War II Total 
1 6, 1 1 2,566 405,399 1 1 3,842 671 ,846 
1 94 1  - 1 946 1 1 ,260,000 3 1 8,274 83,400 565,86 1 
Army 4, 1 83,466 62,6 1 4  25,664 37,778 
Navy 669, 1 00 24,5 1 1  4,778 68,207 
Marines 
5,720,000 36,5 1 6  2,830 1 03,284 
Korean War Total 
1 950 - 1 953 2,834,000 29,86 1 2, 1 33 77,596 
Army 1 , 1 77,000 647 1 55 1 ,576 
Navy 424,000 4,5 1 0  242 23,744 
Marines 1 ,285,000 1 ,498 300 368 
Air Force 
8,744,000 58, 1 98 1 0,788 1 53,303 
Total 
Vietnam 4,368,000 38,2 1 2  7,265 96,802 
Conflict Army 1 ,842,000 2,562 933 4, 1 78 
1 964- 1 973 Navy 794,000 1 4,840 1 ,749 5 1 ,392 
Marines 1 ,740,000 2,584 84 1 93 1 
Air Force 
696,562 148 1 5 1  467 
Total 
3 5 1 ,080 98 1 05 354 
Persian Gulf War 1 58 , 1 48 6 1 4  9 
1 990 - 1 99 1  Army 1 04,006 24 26 92 Navy 
Marines 82,528 20 6 1 2  
Air Force 800 0 0 0 
Coast Guard 
Sources: 1 )  Table 2-23, Principal Wars in which United States participated, U.S. military 
personnel serving and casualties. Military Casualty Information, Department of Defense. 
( 1 998), Internet site: httQ:l/web I .  whs.osd.millmmid/mO 1 /sms223r.htm. 2) Demographic 
and Military Characteristics of Participants in Persian Gulf War ( 1 994), Internet sites: 
httQ:llwww.gulflink.osd.mi lldsbmt/table I .gif, 
httQ:llweb I .osd.millmmid/casualty/table I O.htm 
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Appendix VI :  Purpose of Research on Gulf War Veterans 
1 6 1  
Gulf War veterans were exposed to a wide variety o f  environmental hazards and 
potential harmful substances during their service in Southwest Asia. The majority who 
answered their country's call to duty did their jobs and returned home resuming their 
normal activities with little noticeable difficulty. For others however, there were a wide 
range of health problems that seemed disproportionate to the brevity of actual combat and 
the relatively low casualty rate (10M, 1 996). Although it has been almost thirteen years 
since the Gulf War and many studies have been conducted trying to find the causes and 
or cures to these health problems, no single or definitive cause or global cure has 
emerged. Many theories over the years have been supported or disproven, by these 
continued research efforts, but overall ,  the causes of Gulf War I l lnesses remain undefined 
(FSRGWVI, 200 I ) . Nonetheless, progress has been made in understanding the health 
problems of veterans of the Gulf War, and efforts to attempt to remedy these problems 
will continue to remain a national priority. 
There are several reasons why the health concerns of servicemen and women who 
were deployed to the Gulf are sti l l  being studied this after the war has ended. First and 
foremost among them is our country's national obligation to our veterans. As President 
Lincoln stated in his second inaugural address: 
" With malice toward none, with charity for all, with firmness in the right as God 
gives us to see the right, let us strive on to finish the work we are in, to bind up the 
nation 's wounds, to care for him who shall have borne the battle and for his widow and 
orphan, to do all which may achieve and cherish ajust and lasting peace among 
ourselves and with all nations. " 
Abraham Lincoln 
March 4, 1865 
Today, a pair of metal plaques bearing the words: "To care for him who shall have borne 
the battle and for his widow and orphan" flank the entrances to the Washington, D.C. 
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headquarters of the Department of Veterans Affairs (VA) to underscore the government 's  
obligation to care for those injured during wartime and to provide for the fami lies of 
those who perished on the battlefield. Those servicemen and women who answered their 
county's  call to duty in the Gulf are no different than the long list of fighting men and 
women of the United States that have preceded them. Those who are having health 
problems as a result of service to their country, even though they may not be currently 
diagnosable, deserve the best our country can offer in terms of research into the causes 
and treatment of their i l lnesses. President Clinton summed up Americas obligation to her 
Gulf War veterans in a March 6, 1 995 speech to the Veterans of Foreign Wars (VFW): 
Caring for veterans is not a national option or a partisan program. It is a 
national tradition and a national duty . . .  There are thousands of veterans . . .  who served 
their country in the Gulf War and came home to find themselves ill . . .  Just as we relied on 
these men and women to fight for our country, they must now be able to rely on us to try 
to determine what happened to them in the Gulf and to help restore them to full health. 
We will leave no stone unturned. 
Bill Clinton 
March 6, 1 995 
The United States has an obligation to protect and care for our troops not only in 
the heat of battle, but also before and after the battle when the effects of war might not be 
as noticeable. Although the war ended almost thirteen years ago, there are stil l  veterans 
who are experiencing health problems as a result of serving in the Gulf War. These 
veterans who put their lives on hold and then on the line for this country deserve the best 
in terms of research and treatment that that this great nation can offer. 
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Appendix VI I :  Medical Evaluation Programs for Gulf War Veterans 
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VA Gulf War Registry 
With growing concerns that veterans were having health problems that emanated 
from their service during the Gulf War, the Department of Veterans Affairs (VA) in 1 992 
established a Gulf War Registry to both record potential harmful exposures encountered 
by veterans during deployment as well as track any il lnesses that they may be 
experiencing. The registry, which initially was set up to track veterans who exposed to 
smoke from the burning Kuwaiti oil fields, soon was expanded to cover any health­
related concerns veterans of the Gulf War might be having. Veterans who choose to 
participate in the registry are offered a free, complete physical examination with basic 
laboratory studies at V A medical centers around the country. They are asked about their 
medical history, their experiences in the Gulf War, including possible exposures to 
environmental hazards, and health problems if any they have had since returning from the 
Gulfregion. Once registered, participants receive priority heath care at VA facil ities and 
are notified of any Gulf War-related medical developments, benefit changes and related 
matters. To date, more than 75 ,000 Gulf veterans have received the Registry health 
examination (V A Fact Sheet, 2000). 
Comprehensive Clinical Evaluation Program (CCEP) 
In response to continuing concerns about health problems with regard to service 
in the Persian Gulf, the Department of Defense (DoD), in June of 1 994 instituted the 
Comprehensive Cl inical Evaluation Program (CCEP) to provide a thorough, systematic 
cl inical evaluation program for the diagnosis and treatment of Gulf War veterans. The 
main objective CCEP is to diagnose and treat active-duty military personnel who have 
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medical complaints that they believed could be related to their service in the Persian 
Gulf. (CCEP Guide, 1 995) In the CCEP, each individual receives a comprehensive 
medical evaluation that is based upon standardized cl inical protocols including a medical 
history, physical examinations, and laboratory tests (CCEP Phase I) .  Patients are 
referred to a second phase of the CCEP for further specialty consultations at a regional 
medical center when it is clinically indicated in the judgment of the primary care 
physician. (CCEP Phase II) .  CCEP Phase I I  consists of targeted symptom specific 
examinations along with mandated psychiatric evaluations that include the Structured 
Clinical Interview for DSM III-R and the Clinician Administered PTSD Scale. As of 
January 200 1 ,  over 50,000 veterans of the Gulf War have already registered for 
evaluation with the CCEP (Deploymentlink, 200 1 ) . 
Note: Members of the service who are stil l  on active duty or who are still in the Reserves 
or National Guard should request their medical evaluations through the CCEP. Veterans, 
who have already left the service, Reserves, or National Guard, request their medical 
evaluations through the VA Gulf Registry. 
Appendix VI I I :  Holmes and Rahe Social Readjustment Scale 
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Holmes and Rahe Social Readjustment Scale 
Rank Life event Mean Value 
I .  Death of spouse 1 00 
2 .  Divorce 73 
3 .  Marital separation 65 
4 .  Jail term 63 
5 .  Death of  a close family member 63 
6. Personal injury or il lness 53  
7 .  Marriage 50 
8 .  Fired at work 47 
9. Marital reconciliation 45 
1 0. Retirement 45 
I I . Change in health of family member 44 
1 2 . Pregnancy 40 
1 3 .  Sex difficulties 39 
1 4. Gain of new family member 39 
1 5 . Business readjustment 39 
1 6. Change in financial state 38  
1 7. Death of close friend 3 7  
1 8 . Change to different l ines of work 36  
1 9. Change in number of arguments with spouse 35  
20. Mortgage over $ 1 00,000 3 1  
2 1 .  Foreclosure of mortgage or loan 30 
22. Change in responsibilities at work 29 
23 .  Son or  daughter leaving home 29 
24. Trouble with in-laws 29 
25 .  Outstanding personal achievement 28 
26. Wife begins or stops work 26 
27. Begin or end of school 26 
28. Change in living conditions 25 
29. Revision of personal habits 24 
30. Trouble with boss 23 
3 1 .  Change in work hours or conditions 20 
32 .  Change in residence 20 
3 3 .  Change i n  schools 20 
34. Change in recreation 1 9  
35 .  Change in  church activities 1 9  
36. Change in social activities 1 8  
37 .  Mortgage or  loan less than $30,000 1 7  
38 .  Change in  sleeping habits 1 6  
39.  Change in the number of family get-togethers 1 5  
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Holmes and Rahe Social Readjustment Scale Continued: 
Rank Life event Mean Value 
40. Change in eating habits 1 5  
4 1 .  Vacation \ 3  
42. Christmas 1 2  
43 .  Minor Violations of the Law I I  
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Appendix IX:  Symbols for Diagrams of Structural Equation Models 
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Symbols for Diagrams of Structural Equation Models 
Physical Health 
D-{] 
Path Model i ng Notations 
BOXES are used to describe observed measures. Observed 
measures are sometimes called indicators. 
C IRCLES are used to describe theoretical variables. Other 
terms that are used are latent variables, unmeasured variables, 
and constructs. 
This ARROW, whether between two boxes or two circles 
represents a causal reoationship from a causal variable 
to an effect. 
This ARROW, which also can connect two boxes or two 
circles, represents a noncausal relationship between two 
variables. 
This ARROW, which does not originate from a box but rather 
from a circle with the letter e inside represents a residual to a 
measure or variable. 
This ARROW represents a covariance between two residuals. 
Source: Maruyama G.M. ,  1 997. 
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Appendix X :  Goodness-of-Fit Tests and Modification Indexes 
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The following goodness-of-fit tests will be applied to each model(s): 
1 )  Chi-square value - the chi-square statistic is one of the most common fit test 
programs. It tests the hypothesis that an unconstrained model fits the 
covariance/correlation matrix as well as the given model .  A chi-square of 0 
occurs only with a perfect fit. The more the implied sample covariances differ, 
the bigger the chi-square statistic, and the stronger the evidence against the null 
hypothesis (Arbuckle, 1 999). The chi-square value is also affected by sample 
size. The larger the sample size, the larger the chi-square value. Thus when 
interpreting the chi-square statistic, it is important to look at in context of sample 
size as well as in conjunction with other model fit statistics. 
2) Chi-square/degrees of freedom - chi-square/degrees of freedom is the minimum 
sample discrepancy divided by the degrees of freedom. Some researchers allow 
values as large a 5 as being adequate for model fit, but conservative use calls for 
rejecting models with relative chi-square/degrees of freedom greater than 2 or 3 .  
Like the chi-square, this index generally increases with sample size. 
3 )  Goodness-of-Fit Index (GFI) - the GFI  is a measure of the discrepancy between 
predicted and observed covariances. It varies from 0 (worst) to 1 (best) fit. By 
convention, the GFI should be equal or greater than .9 to be accepted by the 
model. 
4) Adjusted Goodness-of-Fit Index (AGFI) - the AGFI is a variant of the GFI, which 
uses mean squares instead of total sums of squares in the numerator and a 
denominator of I -GFI. The AGFI is a measure of goodness-of -fit while taking 
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into account the degrees of freedom available. It too, varies from 0 (worst) to 1 
(best) fit. AGFI should be at least .9 for a good model fit. 
5) Root Mean Square Error of Approximation (RMSEA) - The RMSEA is the 
square root of the mean squared amount by which the sample variances and 
covariances differ from the corresponding estimated variances and covariances, 
estimated on the assumption that the hypothesized model is correct. The smaller 
the RMSEA, the better the model fit. An RMSEA equal or less than 0.05 
represents a close fit. An RMSEA equal or less than 0.08 is an acceptable fit. 
6) Hoelter N - ifN is greater or equal to 200 at the alpha level of .05, it suggests that 
your model fits reasonably well .  Hoelter's critical N is the largest sample size for 
which one would accept the hypothesis that the model is correct. 
7) Modification Indices (MI) - the modification indices suggest paths to add to the 
hypothesized model to improve its fit. The modification indices represent the 
expected drop in overall chi-square value if the parameter under question were to 
be freely estimated in a subsequent run. Large modification indices indicate 
poorly fitting areas of the model. 
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Appendix XI :  Iraqi Chemical Weapons 
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CHEMICAL AGENTS 
The pre-Gulf War Iraqi arsenal contained chemical agents that were designed to 
kill, seriously injure, or incapacitate persons due to their physiological effects. Among 
the most worrisome to Coalition forces were the nerve agents' tabun, sarin, soman, 
cycJosarin and VX (methylphosphonothioic acid) and the vesicant (blistering) agents' 
sulfur mustard and nitrogen mustard (PAC Final Report, 1 996). These chemical agents, 
which are hard to recognize without detectors until clinical symptoms appear, are capable 
of being delivered by ballistic missiles, aerial bombs, short-range rockets, mines, or 
sprayed from aircraft, trucks, or tanks. According to the U.S .  General Accounting Office, 
Iraq had already del ivered mustard gas and tabun with arti l lery shells, aerial bombs, 
missiles, rockets, grenades, and bursting smoke munitions during the Iran-Iraq war. 
(GAO, Coalition Warfare, 200 1 )  
Nerve Agents 
History and Significance 
The first nerve agent (NA) discovered was tabun by Dr. Gerhard Schrader in 
Germany during the mid- 1 930s who at the time was in charge of a program to develop 
new types of insecticides (Paxman, 1 982). He and his colleagues found tabun to not only 
be an effective as an insecticide, but also noticed that it had properties that were very 
damaging on humans. In 1 935 ,  the Nazis had passed a decree that required all inventions 
of possible mi l itary signi ficance to be reported to the ministry of war. A sample of tabun 
was sent to the chemical warfare of the Army weapons office in May 1 937,  and Schrader 
summoned to Berlin to give a demonstration. As a result, in 1 939 a pilot plant for tabun 
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as a military weapon was set up and later in 1 942 a full plant was made. At the same 
time Nazi scientists discovered the related nerve agents sarin ( 1 938)  and so man ( 1 944). 
Nerve Agents fortunately were never used as a mil itary weapon by Germany 
during World War II (WWII), most likely due to fear of an in kind retaliation by the 
Allies. President Roosevelt had in fact announced a no-first-use policy but had promised 
instant retaliation for any Axis use of chemical agents. After the war, with the Soviets 
capturing both a ful l-scale tabun plant and a pilot sarin plant intact and the United States 
and Britain gaining knowledge from German chemists, both sides of the Cold War had 
Nerve Agent technology. Through separate research programs, an even more lethal 
nerve agent VX ("V" stands for venomous) was discovered simultaneously in the mid-
50s by both the Soviets and the British who shared their knowledge with the Americans. 
(USAMRICD, 1 995) 
Chemical Structure 
The Nerve Agents listed above are phosphoric acid esters, structurally related to 
the larger family of organophosphate compounds. They are highly toxic chemical agents 
that poison the nervous system and disrupt bodily functions that are vital to an 
individual ' s  survival. Their chemical structures are given below: 
Chemical Structure of Nerve Agents 
Agent X RJ 
Tabun CN N(CH) 2 
Sarin F CH) 
Soman F C H) 
Cyclosarin F CH) 
YX SCH2CH2N[CH(CH) 2h CH) 
Source: S I PRl ( 1 973) 
C2HS 
CH(CH) 2 
C H(CH) C(CH») 
Cyclohexyl 
C2Hs 
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Mechanism of Action 
The effects of nerve agents are mainly due a common mechanism that inhibits the 
enzyme acetylcholinesterase (AChE), which hydrolyses acetylcholine (ACh) wherever it 
is released. Acetylcholine is a neurotransmitter that activates specialized receptors at the 
nerve synaptic junction, promoting the discharge of the nerve on the other side of the 
synapse and stimulating the action of the nerve. Normally, as a nerve impulse arrives at a 
synapse, ACh is l iberated in packets from storage vesicles, crosses the synaptic cleft, and 
stimulates specialized receptors of the adjacent neuron, depolarizing the postsynaptic 
membrane. The enzyme AChE then, almost immediately, inactivates ACh so that 
transmission of the impulse ceases and the membrane can repolarize itself and be ready to 
respond to another stimulus. As a consequence of NA inhibition of AChE, ACh 
accumulates at synapses, giving rise to uncoordinated bursts of signals, initially 
stimulating function, and then paralyzing it. 
The nerve agents tabun and sarin are quite volatile, representing a considerable 
respiratory threat but with low persistence. Their volatility makes them less of a threat 
from dermal exposure. Soman and cyclosarin are somewhat less volatile and more 
persistent, and both pose significant dermal and respiratory threats. VX in not very 
volatile and is very persistent. It represents a serious dermal threat as well as dangerous 
one when delivered by aerosol. All are subject to hydrolysis and degradation in the 
environment lasting hours to a few days (Augerson, 2000). 
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Signs and Symptoms 
Signs and symptoms ofNA poisoning from the NATO Handbook on the Medical 
Aspects of NBC (Nuclear, Biological, and Chemical) Defensive Operations include the 
following: 
Mild Poisoning: ( 1 )  Unexplained runny nose, (2) Unexplained sudden headache, (3) 
Sudden drooling, (4) Pinpointed pupils (if exposure to NA vapour has occurred), 
(5)  Tightness of chest or difficulty breathing, (6) Localized sweating and 
muscular twitching, (7) Stomach cramps, (8) Nausea. 
Severe Poisoning: ( 1 )  Strange or confused behavior, (2) Wheezing, dyspnoea (severe 
difficulty in breathing), and coughing, (3) Severely pin-pointed pupils, (4) Red 
eyes with tearing, (5)  Vomiting, (6) Severe muscular twitching and general 
weakness, (7) Involuntary urination and defecation, (8) Convulsions, (9) 
Unconsciousness, ( 1 0) Respiratory failure, ( 1 1 )  Bradycardia. 
Source: NATO Handbook on the Medical Aspects of NBC Defensive Operations, 1 996 
Prevention and Treatment 
A combination of pretreatment and post exposure therapy may combat the lethal 
effects of Nerve Agent poisoning. Pretreatment therapy includes the administration of 
protective equipment and or drugs in advance of the poisoning that are designed to either 
increase the efficiency of treatment post-exposure or make post-exposure therapy 
unnecessary. During the Gulf War, troops were given and trained in the use of wearing 
all-enveloping protective clothing including masks, suits, gloves, and boots specifically 
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designed to protect an individual against a chemical or nerve attack. Many were also 
given a widely used pretreatment drug for NA exposure, the carbonate anticholinesterase 
pyridostigmine bromide (PB). Post exposure therapy includes the immediate masking of 
Nerve Agent casualties if the atmosphere is stil l  contaminated, prompt removal of any 
liquid NA from the skin, clothing, or eyes if present, and the administration of the 
antidote atropine if any signs or symptoms are noted (Virtual Navy Hospital, 1 995). 
Atropine is an essential drug in the treatment of nerve agent poisoning. It acts by 
blocking the effects of acetylcholine at receptors and produces relief from many of the 
symptoms previously listed. 
Vesicant (Blistering) Agents 
History and Significance 
Vesicants are so named because of the vesicles (blisters) they cause on the skin; 
however, these agents also damage the eyes and airways by direct contact and have other 
effects. Sulfur Mustard and Nitrogen mustard are the most feared vesicants historically, 
because of their chemical stability, their persistency in the field, the insidious character of 
their effects by attacking the skin as well as eyes and respiratory tract. (Pechura and Rail, 
1 993) Sulfur mustard was one of the most dreaded chemical weapons of World War I and 
was often used as a terror weapon meant to instill confusion and panic among the enemy 
prior to an offensive. Nitrogen mustard, which was developed in the 1 930s as a 
modification of sulfur mustard, was found to have greater systemic toxicity than sulfur 
mustard, and was found to be particularly potent on cells that are actively proliferating, 
including the lymphoid tissue, bone marrow, and certain cells l ining the gastrointestinal 
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tract (OSRD, 1 946). While both sulfur and nitrogen mustards had low lethality, their 
abil ity to cause incapacitating eye, respiratory, and skin injuries make them an effective 
military weapon. 
Chemical Structure 
The chemical structures of Nitrogen and Sulfur mustard are given below: 
Structure of Nitrogen Mustard Structure of Sulfur Mustard 
Mechanism of Action 
At the cellular level, sulfur and nitrogen mustards are able to exert their effects 
upon an individual due to their lipophilic nature, which allows them to readily penetrate 
the cell and eventually nuclear membranes, and their chloroethyl arms readily react with 
cellular DNA and RNA. Both mustards have a binding affinity for the nitrogen base 
guanine, which is a critical component of both DNA and RNA. The binding of mustard 
agent to guanine causes problems with cellular replication and protein development 
leading to mutations and/or the synthesis of non-functional proteins. Mustards eventual ly 
cause death at the cellular level through energy loss fol lowing DNA breakage, loss of cell 
membrane integrity, or perturbation of cytoskeletal organization (Smith et at. 1 995). 
Signs and Symptoms 
According to the Environmental Protection Agency (EPA), the symptoms of acute 
exposure to mustard gas may include dyspnea (difficult or labored breathing), cough, 
fever, headache, severe eye irritation, photophobia (sensitivity to light), lacrimation 
(tearing), and blindness. Irritation or ulceration of the respiratory tract may occur from 
inhalation; lesions may be fatal. Dizziness, malaise (body discomfort), anorexia, and 
lethargy can occur after acute exposure. Arrhythmias and CNS excitation with 
convulsions followed by CNS depression may occur. Nausea, vomiting, and diarrhea 
may be caused by ingestion or by systemic absorption. Hemorrhage and anemia may 
develop several days after exposure. Taken/rom the EPA, www.epa.gov. 
Prevention and Treatment 
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Besides putting on protective equipment, there i s  no practical treatment available for 
preventing the effects of mustard exposure. The aim of therapy should therefore be to ( I )  
relieve symptoms, (2) prevent infections, and (3) promote healing (NATO, 1 996). 
Decontaminating the patient from the mustard agent is a high priority of treatment. This 
includes removing contaminated clothing and washing the infected areas several times 
with water. Open blisters could cause secondary infections and thus must be treated with 
antibiotics. If respiratory problems are detected, air-purifying or supplied-air respiratory 
equipment should also be worn. 
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Appendix XII : Iraqi B iological Weapons 
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BIOLOGICAL AGENTS 
Prior to and during the Gulf War, U.S .  and Coalition officials were very fearful 
that Saddam Hussein would resort to using his biological and chemical warfare program 
in attempt to stave of any retaliatory strike against his forces in Kuwait. Since the mid­
eighties, he had spent close to $ 1 00 million on a biological warfare program that was 
concentrated on producing an aerosolized (airborne) form of the active spores of the 
naturally occurring bacteria anthrax (Bacillus anthracis) and on developing a botulinum 
toxin, formed by another bacterium Clostridium botulinum (Tucker, J .B.  1 993) .  Both 
biological warfare agents, once produced, could exert their effects very rapidly, almost 
instantaneously incapacitate any unprotected persons, and if untreated result in a high 
probability of dying an excruciating death within days. In announcing in a speech in 
Baghdad in  January of 1 99 1  that he had no intention of relinquishing Kuwait and was 
ready for the 'mother of all wars' Saddam Hussein implied that he would use any means 
necessary including biological weapons if war came about (000, 1 992). This was the 
first time since World War II that the United States had faced a military adversary with a 
highly probable biological warfare capability and the resolve to use it (Tucker, J .B. 
1 993). 
The two most likely biological agents thought to be used against U.S. and 
Coalition forces in the Gulf were aerosolized anthrax and botulinum toxin (Gulf War 
Review, 2000). Further information on each is given below. 
Bacillus anthracis 
History and Significance 
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Anthrax is a naturally occurring zoonotic disease caused by the rod shaped 
bacterium Bacillus anthracis which occurs primarily in of plant eating animals (goats, 
sheep, cattle, horses etc.) .  For centuries, it has caused disease in animals and, 
uncommonly serious il lness in humans throughout the world. Most human infections 
were caused by direct (cutaneous) contact with infected animals or contaminated animal 
products and had a low mortality rate if treated immediately with antibiotics. A rare 
aerosol form of anthrax, often called inhalation anthrax, was recognized a century ago 
among woolen mill workers who processed contaminated animal wool or hair usually in 
confined spaces. This aerosol form of anthrax was found to be so highly lethal that 
research soon began on using it as a potential biological weapon. It is now estimated that 
several countries, including Iraq are able to produce a weaponized form of anthrax 
(Zil inskas, 1 998). 
Threat 
Anthrax, in the minds of most military and counterterrorism planners, represents 
the single greatest biological warfare threat (Cieslak, 1 999). Not only is anthrax 
extremely lethal in its aerosolized form, but an attack can occur very quietly without any 
bombs going off or any observable "clouds" being present. With limited abilities to 
rapidly detect an aerosol ized anthrax attack, the first sign that an attack may be thousands 
of people rushing to the hospital after a few days of exposure. In 1 970, a World Health 
Organization (WHO) expert committee estimated that casualties fol lowing the theoretical 
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aircraft release of 50 kg of anthrax over a developed urban population of 5 mil l ion would 
be 250,000, 1 00,000 of whom would be expected to die without treatment (WHO, 1 970). 
A 1 993 report by the U .S .  Congressional Office of Technology Assessment estimated 
that between 1 30,000 and 3 mill ion deaths could follow the aerosolized release of 1 00kg 
of anthrax spores upwind of the Washington D.C. area - lethality matching or exceeding 
that of a hydrogen bomb (OT A, 1 993). An economic model developed by the Center for 
Disease Control (CDC) suggested that an aerosolized anthrax attack would cost $26.2 
bil lion per 1 00,000 persons exposed (Kaufmann, 1 997). 
Mechanism of Action 
The disease occurs with the inhalation of anthrax spores usually less than 5 
microns in size into the pulmonary alveolus of the lungs. Here they are engulfed by 
alveolar macrophages, which transport them to the regional tracheobronchial lymph 
nodes, where they germinate, multiply, and produce toxins (See Figure 1 4). These toxins 
cause massive hemorrhage and edema in the lymph nodes and mediastinum. Anthrax 
bacil l i ,  which arose from the germinated spores, can next spread to the blood, leading to 
septicemia, the seeding of other organs, and frequently hemorrhagic meningitis 
(Friedlander, 1 997). Death is the result of respiratory fai lure associated with pulmonary 
edema, overwhelming bacteremia, and often meningitis. 
1 86 
:-;:r:ii.,..----Anthrax spores 
Alveoli 
Lymph nodes 
fi'ADAM. 
Figure 1 4  reproduced with permission from Adam.com 
Figure 1 4 :  Anthrax Spores attaching to the lymph nodes of the lungs 
Signs and Symptoms 
The symptoms of inhalational anthrax begin after a I to 6 day incubation period 
fol lowing exposure. Initial symptoms are non-specific and include malaise, fever, 
myalgia and non-productive cough. These are often fol lowed after a period of 2-3 days 
by a sudden onset of severe respiratory distress associated with diaphoresis, cyanosis and 
increased chest pain. Chest X-ray examination usually shows a characteristic widening 
of the mediastinum and often pleural effusion (Inglesby, 1 999). Meningitis is  present as 
a complication in up to 50% of cases, and some patients may present with seizures 
(Friedlander, \ 999). Death usually follows in 24-36 hours following the onset of 
respiratory distress. 
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Prevention and Treatment 
The only currently approved vaccine for the prevention of anthrax is 
manufactured and distributed by the BioPort Corporation, in Lansing, Michigan (GAO, 
Anthrax Vaccine, 200 1 ). It is  a cell-free filtrate vaccine (meaning that it does not contain 
dead or l ive bacteria in its preparation) of a nonencapsulated attenuated strain of B 
anthracis. Although the safety and efficacy of the currently used anthrax vaccine have 
never been established either for cutaneous or inhalation exposure in humans (Nass, 
2002) trials using the vaccine on experimental monkeys have rendered them up to 88% 
immune to aerosol spore challenge (Ivins, 1 996). This standard anthrax vaccine which is 
currently approved by the Food and Drug Administration is routinely administered to 
persons at risk for exposure to anthrax spores (Dixon, 1 999). It is  DoD policy to 
vaccinate all forces unless medically (due to adverse reaction, pregnancy, etc.)  or 
administratively (retiring military personnel, military contractors etc. )  exempted 
(http://www .anthrax .mil[). S ince the existing anthrax vaccine supplies are currently 
limited, it in now only required that those military personnel assigned now or rotating to 
designated high threat areas be required to take the vaccine. 
A high index of clinical suspicion and rapid administration of effective 
antimicrobial therapy are essential for prompt diagnosis and effective treatment of 
anthrax. If an inhalational anthrax attack is suspected, treatment should immediately be 
started on persons who potentially were at risk of exposure. Given the difficulty in 
achieving rapid microbiologic diagnosis of anthrax, all persons with fever or systemic 
disease in an area where anthrax cases are occurring should be treated for anthrax until 
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the disease is excluded (Inglesby, 1 999). Limited clinical experience is available and no 
controlled trials in humans have been performed to validate current treatment 
recommendations, however, nonhuman primate studies and other animal in vitro data 
point to the use of ciprofloxacin or doxycycline as the appropriate antimicrobial 
prophylaxis to use until antimicrobial susceptibil i ty tests are known (CDC, 200 I ) . Once 
it is  determined whether or not anthrax is present and concerns regarding the antibiotic 
resistance in the particular strain are met, the most widely available, efficacious, and least 
toxic antibiotic should be administered to patients and persons requiring postexposure 
prophylaxis (Inglesby, 1 999). Because of the potential persistence of spores following a 
possible aerosol exposure, antibiotic therapy should be continued for at least 30 days if 
used alone, and although supporting data are less definitive, longer antibiotic therapy (up 
to 42--60 days) might be indicated (CDC, 2000). 
Clostridium botulinum 
History and Significance 
Botulism is a rare but serious paralytic i l lness caused by a nerve toxin that is 
produced by the bacterium Clostridium botulinum. The bacterium, which is a gram­
positive spore-forming anaerobe, can be found in soil samples and marine sediments 
throughout the world. Seven toxigenic types (designated by the letters A through G) of 
the organism exist, each producing an immunologically distinct form of botulinum toxin. 
Types A, B, E and F are the toxins most often responsible for disease in humans, while 
types C and D only cause disease in other animals (e.g., nonhuman mammals, birds, fish). 
Although type G has been isolated from soil in Argentina, no outbreaks involving it have 
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been recognized (FDA, 1 992). Botulism is generally seen in 3 clinical scenarios, as 
fol lows: ( 1 )  the ingestion of pre-formed toxins in food contaminated with C botulinum, 
(2) contamination of wounds by C botulinum, and (3) colonization of the intestine by C 
botulinum in infants younger than 1 year (CDC Facts about Botulism, 200 1 ) . A fourth, 
man-made form that results from aerosolized botulinum toxin is inhalational botulism. 
This man-made inhalational botulism is the one that has significance as a biological 
weapon. 
H istorically, the botulism toxin has been known to be effective as a biological 
weapon since the early days of World War I I .  The head of the Japanese biological 
warfare group (Unit 73 1 )  admitted to feeding cultures of C botulinum to prisoners with 
lethal effect during that country's occupation of Manchuria (Amon, 200 1 ) . Likewise, 
All ied intelligence information indicated that Germany was attempting to develop 
botulinum toxin as a cross-channel weapon to be used against invasion forces 
(Middlebrook, 1 997). From these concerns that Germany had weaponized botulinum 
toxin, more than a mill ion doses of botulinum vaccine were made for Allied troops 
preparing to invade Normandy on D-Day (Amon, 200 1 ) . Although botulinum toxin was 
never widely used as an offensive weapon during World War II, its potency and potential 
were recognized around the world. Soon many nations including the United States began 
biological weapons programs. With the recognition that the use of biological weapons 
potentially could have catastrophic effects on all of humanity, 1 44 nations have since 
1 972 have been signatories to the Biological and Toxin Weapons Convention (BTWC) 
which prohibits the development, production and stockpiling of biological and toxin 
weapons for offensive purposes. 
Threat 
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Botulinum toxin poses a major bioweapons threat because of its extreme potency 
and lethality; its ease of production, transport, and misuse; and the need for prolonged 
intensive care in affected persons (Arnon, 200 1 ) . It is the most poisonous substance 
known, with an estimated toxic dose (serotype A) of only 0.0 1 ug/kg if body weight (Gill , 
1 982) and is 1 5 ,000 times more toxic than the nerve agent VX and 1 00,000 times more 
toxic than sarin (Franz, 1 997). A single gram of crystall ine toxin, evenly dispersed and 
inhaled has the potential to kill more that one million people (Arnon, 200 1 ) . Although 
the, 1 972 BTWC prohibited the development, production and stockpiling of 
bacteriological (Biological) and toxin weapons, signatories Iraq and the Soviet Union had 
been known to be producing botulinum toxin (Arnon, 200 1 ) . With the economic 
difficulties in Russia after the demise of the Soviet Union, some thousands of scientists 
formerly employed by its bioweapons program have been recruited by nations attempting 
to develop biological weapons (Arnon, 200 1 ). 
Mechanism of Action 
The mechanism of action for botulism is similar for each of for each of the four 
types l isted. Once the toxin is absorbed and enters the bloodstream, it travels to the 
presynaptic nerve terminal at the neuromuscular junction and at the cholinergic 
autonomic sites. There it binds to a to a receptor or acceptor on the surface of the target 
neuron where it prepares for internalization by the neuron. A substantial body of 
1 9 1  
evidence indicates that the botulism toxin enters neurons by the general pathway used by 
several other bacterial toxins, a number of polypeptide hormones or growth factors, and 
even some viruses known as the receptor mediated endocytosis (RME) (Middlebrook, 
1 997). RME is the process by which substances (ligands) concentrated on the cell 
surface by virtue of binding receptors invaginate to become vesicles within the cell so as 
to be transported to one or more sites in the cell interior carr�ing along the contents. At 
various stages of vesicle trafficking, some of the cellular contents escape or are released 
into the cytoplasm. In the case of botulism, the toxins released from the vesicles cleaves 
at least one of three proteins that are involved in bringing the neurotransmitter 
acetylcholine to the nerve synapse (the location where nerve to nerve transmission of 
information occurs) (Hilbourne, 200 1 ) . Cleavage by the neurotoxin inhibits acetylcholine 
release from the synapse (Schiavo, 1 997). With the loss of communication, nerve 
paralysis results. 
Symptoms 
Clinical ly, botulism presents as a symmetric, descending flaccid paralysis that 
begins in the head and face and spreads downward. Initial findings may include drooping 
eyelids, blurred vision, double vision, dry mouth, slurred speech and difficulty 
swallowing, fol lowed by loss of muscle tone, generalized weakness, and loss of the gag 
reflex, which may require intubation to protect the airway. As paralysis extends beyond 
bulbar musculature, loss of head control, hypotonia, and generalized weakness become 
prominent. Deep tendon reflexes may be present initially but diminish or disappear in the 
ensuing days, and constipation may occur. In untreated persons, death results from 
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airway obstruction (pharyngeal and upper airway muscle paralysis) and inadequate tidal 
volume (diaphragmatic and accessory respiratory muscle paralysis) (Arnon, 200 1 ). 
Treatment 
The treatment of botulism is to give antitoxin, which is available from the health 
department, and to support aggressively, preferably in an leu. The licensed antitoxin 
contains antibodies against three of the seven types of botulinum toxin (A, B, and E), 
which cause most cases of human disease. The US Army holds an investigational 
antitoxin, which is active against all seven types. Because botulinum antitoxin is derived 
from horses, hypersensitivity reactions, including hives, serum sickness, and anaphylaxis 
occur in a significant minority of patients. Timely administration of neutralizing 
antibody will minimize subsequent nerve damage but will  not reverse the existing 
paralysis (Tacket, 1 984). If the respiratory system fails, mechanical ventilator support 
becomes necessary, often for many weeks. The recovery period reflects the time for the 
body to regenerate damaged nerve fibers (Hilbourne, 200 1 ) . 
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Appendix XI II :  Vaccines against Chemical and Biological Weapons 
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Botulinum Toxoid 
The threat of a botulism aerosol attack by the Iraqi army prompted the 
Department of Defense to investigate the using of a botulism toxoid as a means of 
protecting troops. At the time of the Gulf War, a botulinum toxoid existed that covered 
many of the serotypes of botulism harmful to humans. This toxoid, which was a 
modified bacterial toxin that is made nontoxic but has the capacity to stimulate the 
formation of antibodies, was distributed to several U.S .  combat units prior to and during 
the Gulf War. According to the Department of Veterans Affairs, approximately 1 37,850 
doses of botulinum toxoid were sent to the Gulf, and it is  estimated that 8,000 individuals 
vaccinated (Committee on Veterans Affairs, 1 998). Since the efficacy of this toxoid had 
never been proven due to the ethics involved in such testing, the toxoid was labeled as an 
Investigational New Drug (IND). Due to the military extingencies of the Gulf War, the 
FDA commissioner waived the informed consent requirements that go along with INDs 
so that troops could be protected. This thus meant that Gulf War military personnel who 
received the botulism toxoid were given an unapproved FDA pre-treatment vaccine 
without the ability to refuse taking it . 
A nthrax Vaccine 
Concerns that Iraq would use inhalational anthrax as a biological weapon against 
U .S .  forces in the Gulf prompted the military to administer Anthrax Vaccine Adsorbed 
(A V A) to estimated 1 50,000 service members during Operations Desert Storm and 
Desert Shield (Hilborne, 200 1 ) . The AVA vaccine given to these U.S .  military 
personnel was licensed in 1 970 and had previously been used mainly to protect at-risk 
1 95 
populations such as textile mill workers, veterinarians, laboratory scientists, and other 
workers with occupational risk, from acquiring anthrax. The recommended dosage 
schedule for these workers called for six injections over an 1 8-month period with booster 
shots occurring annually. Since 1 967 (when the vaccine was in its IND stage) to just 
prior to the Gulf War, more than 20,000 inoculations had routinely been administered to 
these at risk populations (PACGWVI, 1 996). The known overall effectiveness of the 
vaccine, prior to Operation Desert Shield was 92.5 percent (lower 95 percent confidence 
interval = 65 percent): 9 1 .4 percent in the high-risk group of workers and 1 00 percent in 
the low risk group of workers (Jollenbeck, 2002). It was not possible to evaluate the 
efficacy of the vaccine against inhalational anthrax separately because of the small 
number of cases (Jollenbeck, 2002). Thus, although the A V A vaccine was approved for 
general use at the time of the Gulf War and did not require consent for administration, its 
effectiveness for protecting an individual from an aerosolized attack had not been 
determined. This coupled with the unknown long-term effects of taking the A V A 
vaccine plus the possibil ity of becoming i l l  during wartime as result of taking the vaccine 
became a concern to a number of troops. 
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Appendix XIV: Pyridostigmine Bromide 
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Pyridostigmine bromide is a reversible cholinesterase inhibitor that was used 
during the Gulf War as a pretreatment for exposure to nerve agents. Its action is similar 
to that of nerve agents that bind to AChE and cause harm to the nervous system. The 
major difference between pyridostigmine bromide and nerve agents in terms of 
mechanism of action are that Pyridostigmine bromide binds reversibly to AChE whereas 
the binding of nerve agents is permanent. In theory, and demonstrated by animal models, 
pyridostigmine bromide administered as a pretreatment drug will compete with nerve 
agents in binding with AChE. Pyridostigmine bromide can thus prevent the permanent 
disabling of AChE by nerve agents by binding with it until the nerve agents have bound 
with something else or left the body. S ince it binds to AChE like nerve agents, 
administration of pyridostigmine bromide will give off symptoms of nerve agent attack 
but over time with the release of pyridostigmine bromide from AChE, a person's nervous 
system will return to normal. Pyridostigmine bromide also is a preferred drug against 
nerve agent attack because it has been shown to usually not cross into the central nervous 
system and thus have a harmful impact on brain function or mental performance 
(Golomb, 1 998). 
The FDA initially l icensed pyridostigmine bromide in 1 955 to treat persons with 
myasthenia gravis, an autoimmune disease characterized by increased weakness and 
fatigability of muscles (De Fraites, 1 996). Though Pyridostigmine bromide is approved 
by the FDA for use in treating patients with myasthenia gravis, it remains an 
investigational new drug (rND) for nerve agent pretreatment by the military (Rettig, 
1 999). Human studies demonstrating the efficacy of Pyridostigmine bromide against 
nerve agent lethality would clearly be unethical. Thus in order for it to be used as a 
pretreatment drug against chemical agents during the Gulf War, an FDA waiver 
regarding informed consent (Appendix XVII) was needed so that it could be used for 
military purposes. An estimated 250,000 to 300,000 U.S .  veterans of Operation Desert 
Shield/Operation Desert Storm took pyridostigmine bromide (PB) as a pretreatment 
adjunct to protect themselves from nerve agent attack (Golomb, 1 998). 
1 98 
Appendix  XV: Overview of Federally Sponsored Research on Gulf War 
Veterans '  I l lnesses 
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The Federal research effort with regard to Gulf War Veterans Il lnesses are 
sponsored by the Departments of Defense (DoD), Health and Human Services (HHS), 
and Veterans Affairs (VA) and include scientists from Federal, academic, and private 
institutions. From 1 994, when the federal government started funding research efforts 
that looked into the health concerns of Gulf War veterans, through 200 1 ,  these 
Departments have sponsored 2 1 1 distinct research proj ects on Gulf War veterans' 
i l lnesses with a cumulative expenditure of 1 96 . 1 million dollars (See Table 20). 
Table 20 Funding for research for Fiscal Years '94-'0 1 in $millions 
Dept. FY'94 FY'95 FY'96 FY'97 FY'98 FY'99 FY'OO FY' O I  FY'94-0 1 
DoD $ 6.5 $ 1 1 .0 $ 1 1 .9 $28.9 $ 1 3 .2  $23 .5  $24.8  $22.0 $ 1 4 1 . 8 
VA $ 1 .2 $ 2 .3  $ 3 .9 $ 2 .8  $ 4 .7  $ 9.0 $ 1 2.0 $ 8.4 $ 44.3 
HHS $ 0.0 $ 2 .5  $ 1 .6 $ 0.0 $ 1 .6 $ 1 .6 $ 1 .6 $ 1 .0 
Total $ 7 . 7  $ 1 5 .8  $ 1 7.4 $3 1 .7 $ 1 9.5  $34.2 $38 .4 $3 1 .4 
Source: Department of Veterans AffaIrS Annual Report to Congress on Federally 
Sponsored Research on Gulf War Veterans I l lnesses for 200 1 .  
While the majority of research projects on Gulf War veterans' i l lnesses are 
directly affiliated with the federal agencies sponsoring them, many projects are 
$ 1 0.0 
$ 1 96 . 1  
contracted out to medical schools, laboratories, scientific organizations, and universities 
in order to capture a wide array of scientific expertise for different areas of study. 
Sponsor federal agencies oversee the work of both in house and contracting agencies 
through a "peer review" process in which a panel of recognized medical experts 
periodically review the workplace faci lities, the background of the scientists, and the 
project methodology, to ensure that competent work is done. Every year, each project 
that is still ongoing is required to send a written update on project progress to their 
individual sponsoring federal agency. These sponsoring federal agencies in tum act 
together with the Research Working Group (RWG) of the Persian Gulf War Coordinating 
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Board, (a panel of medical researchers from government agencies that has expertise 
regarding health issues stemming from the Gulf War), to create an Annual Report to 
Congress updating it on all the research progress that is being made and identifying any 
gaps in the research that may exist. 
The portfolio of federally sponsored research projects is  broad, spanning from 
small-scale pilot studies that may look at the health outcomes of hundreds of veterans to 
large-scale epidemiology studies that look at tens of thousands of veterans. Topics that 
are researched are determined by the Research Working Group and are divided into four 
distinct types of research: clinical research, epidemiological research, mechanistic 
research, and developmental research. Figure 4 shows the diversity of research 
approaches that have been funded by Department of Defense, Health Human Services, 
and Veterans Administration since 1 994. The greatest numbers of research projects thus 
far have been in the area of clinical research, which uses the application of an 
intervention such as case-control study to define risk factors. This has been fol lowed by 
epidemiological research which looks at population based studies that focus on health 
outcomes such as mortality, symptoms, hospitalization, etc . ,  using such devises as postal 
surveys, interviews, and medical reviews. Thirdly research has focused in on 
mechanistic research which looks at the underlying mechanisms of disease using in vitro 
and in vivo modeling techniques. Finally, there have been a small number of research 
projects that focus specifically on developing new prevention and treatment measures. 
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Figure 1 5 :  Cumulative number of federal ly funded research projects by research type 
( 1 994-2002). 
Source: Department of Veterans Affairs Annual Report to Congress on Federally 
Sponsored Research on Gulf War Veterans Il lnesses for 2002 . 
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Of the original 2 1 1 research projects regarding Gulf War veterans'  i l lnesses, 1 24 
have already been completed by the year 200 1 . Table 2 1  shows the number of new 
research projects that have been started and the number of research projects that have 
been completed for the years 1 994 through 200 1 .  
T bl 2 1  N b f d a e urn er o new an completed projects by year 
Fiscal Year New Completed 
1 992- 1 994 62 3 
1 995 2 1  8 
1 996 1 6  4 
1 997 36  1 0  
1 998 1 7  1 5  
1 999 30 1 6  
2000 1 4  42 
200 1 1 5  26 
Total 2 1 1 1 24 
* For programs/centers with multiple projects, each project is counted as an individual 
project for accounting purposes. 
Source: Department of Veterans Affairs Annual Report to Congress on Federal ly 
Sponsored Research on Gulf War Veterans I llnesses for 2000. 
Since the September attacks, military and veterans issues have gained a new 
priority in Congress. Before asking troops to be sent all over the world to fight the war 
on terrorism, Congressional officials want to make sure that they have incorporated all 
the lessons of past deployments so as not to repeat any mistakes in the future. One area 
of concern that has that has not been completely resolved is that the i l lnesses surrounding 
veterans of the Gulf War. In order to try to resolve or gain as much knowledge as 
possible on this issue, Congress has, as of October 2002, authorized a nearly doubling of 
the V A budget to fund studies into finding the causes and cures of these i l lnesses (V A 
press release, 2002). The agency will now plan to make available up to $20 mil l ion for 
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research into Gulf War il lnesses during fiscal year 2004, an amount that is considerably 
larger than previous years. 
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Appendix XVI : Iraqi Scud Missile Threat 
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Iraq began launching short-range ballistic missiles (known as Scuds, See Figure 
1 2) at Israel and Coalition forces soon after the Coalition's Gulf War air campaign began 
on January 1 7, 1 99 1 .  Many Gulf War veterans observed or became aware of incoming 
or overflying Scud missi les and or Patriot missiles fired in defense. American and other 
Coalition forces in the Kuwait Theater of operations were well aware that Iraq had the 
capabi lity to use chemical and biological weapons, and that a means of delivering them 
was through use of Scud missiles. This threat represented a significant cause for concern 
for anyone within their range. 
Iraq's Scud attacks involved 88 missiles; of which 46 reached Coalition countries 
in the Kuwait Theater of operations and 42 reached or closely approached Israel. A few 
more probably fai led early in flight and struck within Iraq's borders. Iraq told United 
Nations inspectors after the war that they launched 93 ballistic missiles, 50 against the 
Coalition in the Kuwait theater of operations and 43 against Israel. Scuds, while 
inaccurate, nonetheless damaged area targets and caused 28 of the 1 48 United States 
battle deaths during the Gulf War. Scuds often broke up on reentry, dispersing propellant 
that sometimes caused burning sensations of the skin and throat, nausea, headaches, 
breathing difficulties and other symptoms in some United States service members. Also, 
Scud attacks and precautionary alerts disrupted l ives and operations by forcing passive 
defense measures and generating stress. 
Source: Information Paper: Iraq's  Scud Ballistic M issiles. Released July 25, 2000. 
Department of Defense; web: 
http://www. i ragwatch.org/government/US/Pentagonidodscud .htm 
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Figure 1 6: Iraqi Scud missile range during the Gulf War. 
Appendix XVI I :  FDA Interim Rule 55 FR 528 1 4  
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In the shadow of the impeding Gulf War Department of Defense officials became 
increasingly concerned about how to protect U.S.  military forces against Iraqi CWfBW 
agents. Protective vaccines against Botulinum Toxin and nerve agents had been 
developed at the time of the Gulf War but had not been approved by the FDA for the 
purpose which the DoD had intended their use. They were considered Investigational 
New Drugs (IN D), a term the FDA placed on drugs that had completed pre-clinical 
testing but had not yet completed their clinical trials on human subjects. Pyridostigmine 
Bromide (PB) and Botulinum Toxoid (BT) were two of the most promising 
pharmaceuticals available for defending against CW/BW agents. At the time of the Gulf 
War, the FDA had classified both as INDs. S ince INDs are subject to stringent FDA 
regulations that require strict guidelines of voluntary informed consent for human 
subjects the Department of Defense in order to comply with FDA regulations would be 
required to obtain informed consent for use of Pyridostigmine bromide and Botulinum 
toxoid from every service member deployed to the Gulf (Rettig, 1 999). This posed a 
serious problem for Department of Defense because if they complied with FDA 
regulations and permitted troops to refuse the vaccines intended for their own protection, 
refusing troops may inadvertently put other troops at risk in the event of a CW/BW 
attack. Those troops refusing vaccine protection would either have to leave the combat 
field or stay and fight without protection in the event of a CW/BW attack. In either 
event, they would decrease the likelihood of a successful mission and increase the danger 
to all service personnel. 
In response to the Iraqi CW IBW threat, Department of Defense concluded that it 
needed to be prepared to use Pyridostigmine bromide and Botulinum toxoid for troop 
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protection. I t  felt  that i t  should seek FDA approval for using these investigational 
products for treatment and pretreatment purposes and that allowing informed consent to 
service members in the Gulf would not be feasible (Rettig, 1 999). It therefore requested 
on October 30, 1 990 that the FDA establish authority to waive the requirement of 
informed consent in the use of investigational drugs during certain military extingencies 
such as the conflict in the Gulf. The FDA responded by issuing Interim Rule 55 FR 
528 1 4  on December 2 1 ,  1 990 that permitted Department of Defense to waive informed 
consent requirements under specific military operations. The ruling gave the 
commissioner of the FDA the authority to waive informed consent requirements for 
Department of Defense personnel who were involved in combat or the immediate threat 
of combat. It required that Department of Defense include a written j ustification 
supporting the conclusions of the physician(s) responsible for medical care of the military 
personnel involved and a duly constituted institutional review board approval of the 
investigational drugs to be administered without informed consent. Under these rules, 
Department of Defense requested and was granted informed consent waivers for the two 
investigational drugs Pyridostigmine Bromide and Botulinum toxoid on January 8, 1 99 1 .  
The fol lowing i s  the text of the Interim Rule of December 2 1 ,  1 990: 
Section 50.23 [2 1 CFR Part 50], "Exception from general requirements," is 
amended by adding new paragraph (d) to read as follows: d)( 1 )  The commissioner may 
also determine that obtaining informed consent is  not feasible when the Assistant 
Secretary of Defense (Health Affairs) requests such a determination in connection with 
the use of an investigational drugs (including an antibiotic or biological product) in a 
specific protocol under an investigational new drug application ( IND) sponsored by the 
Department of Defense (DOD). DOD's request for a determination that obtaining 
informed consent from military personnel is not feasible must be l imited to a specific 
mil itary operation involving combat or the immediate threat of combat. The request must 
also include a written justification supporting the conclusions of the physician(s) 
responsible for the medical care of the military personnel involved and the investigator(s) 
identified in the IND that a military combat exigency exists because of special military 
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combat (actual or threatened) circumstances in which, in order to faci litate the 
accomplishment of the military mission, preservation of the health of the individual and 
the safety of other personnel require that a particular treatment be provided to a specified 
group of mil itary personnel, without regard to what might be any individual's personal 
preference for no treatment or for some alternative treatment. The written request must 
also include a statement that a duly constituted institutional review board has reviewed 
and approved the use of the investigational drug without informed consent. The 
Commissioner may find that informed consent is not feasible only when withholding 
treatment would be contrary to the best interests of military personnel and there is no 
available satisfactory alternative therapy. (2) In reaching a determination under paragraph 
(d)( 1 )  of this section that obtaining informed consent is not feasible and withholding 
treatment would be contrary to the best interests of military personnel, the Commissioner 
will review the request submitted under paragraph (d)( I )  of this section and take into 
account all pertinent factors, including, but not l imited to: (i) The extent and strength of 
the evidence of the safety and effectiveness of the investigational drug for the intended 
use; ( i i)  The context in which the drug will  be administered, e.g., whether it is intended 
for use in a battlefield or hospital setting or whether it will be self-administered or will be 
administered by a health professional; ( i i i)  The nature of the disease or condition for 
which the preventive or therapeutic treatment is intended; and (iv) The nature of the 
information to be provided to the recipients of the drug concerning the potential benefits 
and risks of taking or not taking the drug. (3) The Commissioner may request a 
recommendation from appropriate experts before reaching a determination on a request 
submitted under paragraph (d)( l )  of this section. (4) A determination by the 
Commissioner that obtaining informed consent is not feasible and withholding treatment 
would be contrary to the best interests of military personnel will expire at the end of 1 
year, unless renewed at DOD's request, or when DOD informs the Commissioner that the 
specific military operation creating the need for the use of the investigational drug has 
ended, whichever is earlier. The Commissioner may also revoke this determination based 
on changed circumstances. 
James S. Benson 
Deputy Commissioner of Food and Drugs 
Louis W. Sullivan 
Secretary of Health and Human Services 
Friday, December 2 1 ,  1 990 
(Source, 55 Federal Register 528 1 4, " Informed Consent for Human Drugs and Biologics; 
Determination That Informed Consent is  Not Feasible," December 2 1 ,  1 990.) 
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Appendix XVI I I :  UN Security Counci l  Resolution Establishing Terms for 
Cease Fire 
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United Nations Security Council Resolution 687 3 April 1 99 1  
The United Nations (UN) Security Council passed Resolution 687 on April 3 ,  
1 99 1  to  dictate the terms of the Gulf War cease-fire. Resolution 687 required Iraq to 
declare and destroy its stockpile of weapons of mass destruction and their ballistic missile 
delivery systems as well as establish a UN Special Commission (UNSCOM) to monitor 
and verify the elimination of Iraq's weapons. UNSCOM was given the responsibility of 
ensuring the destruction of Iraq's chemical and biological weapons, confirming the 
destruction of ballistic missiles with a range greater than 1 50 km, verifying the control 
and removal of nuclear materials, and conducting long-term monitoring of Iraqi 
compliance. The precise terms are laid out in paragraphs 7 to 1 4  of the resolution below: 
7 .  Invites Iraq to  reaffirm unconditionally its obligations under the Geneva Protocol 
for the Prohibition of the Use in War of Asphyxiating Poisonous or Other Gases, 
and of Bacteriological Methods of Warfare, signed at Geneva on 1 7  June 1 925, 
and to ratify the Convention on the Prohibition of the Development, Production 
and Stockpiling of Bacteriological (Biological) and Toxin Weapons and on Their 
Destruction, of 1 0  April 1 972; 
8. Decides that shall unconditionally accept the destruction, removal, or rendering 
harmless, under international supervision, of: 
a. All  chemical and biological weapons and all stocks of agents and all related 
subsystems and components and all research, development, support and 
manufacturing faci l ities; 
b .  All  ballistic missiles with a range greater than 1 50 kilometers and related major 
parts, and repair and production facilities; 
9 .  Decides, for the implementation of paragraph 8 above, the following: 
a. Iraq shall submit to the Secretary-General, within fifteen days of the adoption of 
the present resolution, a declaration of the locations, amounts and types of all 
items specified in paragraph 8 and agree to urgent, on-site inspection as specified 
below; 
b. The Secretary-General ,  in consultation with the appropriate Governments and, 
where appropriate, with the Director-General of the World Health Organization, 
within forty-five days of the passage of the present resolution, shall develop, and 
submit to the Council for approval, a plan calling for the completion of the 
fol lowing acts within forty-five days of such approval : 
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I .  The forming of a Special Commission, which shall carry out immediate on-site 
inspection of Iraq's biological, chemical and missile capabilities, based on Iraq's 
declarations and the designation of any additional locations by the Special 
Commission itself; 
I I .  The yielding by Iraq of possession to the Special Commission for destruction, 
removal or rendering harmless, taking into account the requirements of public 
safety, of all items specified under paragraph 8 (a) above, including items at the 
additional locations designated by the Special Commission under paragraph 9 (b) 
( i)  above and the destruction by Iraq, under the supervision of the Special 
Commission, of all its missile capabilities, including launchers, as specified under 
paragraph 8 (b) above; 
I I I .  The provision by the Special Commission of the assistance and cooperation to the 
Director-General of the International Atomic Energy Agency required in 
paragraphs 1 2  and 1 3  below; 
1 0. Decides that Iraq shall unconditionally undertake not to use, develop, construct or 
acquire any of the items specified in paragraphs 8 and 9 above and requests the 
Secretary-General, in consultation with the Special Commission, to develop a 
plan forth future ongoing monitoring and verification of Iraq's compliance with 
this paragraph; to be submitted to the Security Council for approval within one 
hundred and twenty days of the passage of this resolution; 
1 1 . Invites Iraq to reaffirm unconditionally its obligations under the Treaty on the 
Non-Proliferation of Nuclear Weapons of 1 July 1 968; 
1 2 . Decides that Iraq shall unconditionally agree not to acquire or develop nuclear 
weapons or nuclear-weapons-usable material or any subsystems or components or 
any research, development, support or manufacturing facil ities related to the 
above; to submit to the Secretary-General and the Director-General of the 
International Atomic Energy Agency within fifteen days of the adoption of the 
present resolution a declaration of the locations, amounts, and types of all items 
specified above; to place all of its nuclear-weapons-usable materials under the 
exclusive control, for custody and removal, of the International Atomic Energy 
Agency, with the assistance and cooperation of the Special Commission as 
provided for in the plan of the Secretary-General discussed in paragraph 9 (b) 
above; to accept, in accordance with the arrangements provided for in paragraph 
1 3  below, urgent on-site inspection and the destruction, removal or rendering 
harmless as appropriate of all items specified above; and to accept the plan 
discussed in paragraph 1 3  below for the future ongoing monitoring and 
verification of its compliance with these undertakings; 
1 3 .  Requests the Director-General of the International Atomic Energy Agency, 
through the Secretary-General, with the assistance and cooperation of the Special 
Commission as provided for in the plan of the Secretary-General in paragraph 9 
(b) above, to carry out immediate on-site inspection of Iraq's nuclear capabilities 
based on Iraq's declarations and the designation of any additional locations by the 
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Special Commission; to develop a plan for submission to the Security Council 
within forty-five days calling for the destruction, removal, or rendering harmless 
as appropriate of all items listed in paragraph 1 2  above; to carry out the plan 
within forty-five days following approval by the Security Counci l ;  and to develop 
a plan, taking into account the rights and obligations of Iraq under the Treaty on 
the Non-Proliferation of Nuclear Weapons of I July 1 968, for the future ongoing 
monitoring and verification of Iraq's compliance with paragraph 1 2  above, 
including an inventory of all nuclear material in Iraq subject to the Agency's 
verification and inspections of the International Atomic Energy Agency to 
confirm that the Agency's safeguards cover all relevant nuclear activities in Iraq, 
to be submitted to the Security Council for approval within one hundred and 
twenty days of the passage of the present resolution; 
1 4 .  Takes note that the actions t o  be taken by Iraq in paragraphs 8 ,  9, 1 0, 1 1 , 1 2  and 
1 3  of the present resolution represent steps towards the goal of establishing in the 
M iddle East a zone free from weapons of mass destruction and all missiles for 
their delivery and the objective of a global ban on chemical weapons. 
Source: http://www.un.org/Docs/scresI l 99 1 /scres9 1 .htm 
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Appendix XIX:  Gulf War Veteran Stress Survey Cover Letter 
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Gulf War Veteran Stress Survey 
Dear Veteran : This is a request for your help. I am completing my dissertation on Gulf 
War i l lnesses and would very much appreciate your answers to this survey. Please click 
on the following link to respond: 
http://www.phd.sahp.vcu.edulDissertationiFrankKennv/ 
Usemame: GulfWar 
Password: myveteran 
This survey is not affiliated with the government or any veteran's organization in any 
way. It is being done as part of my Ph.D. research at Virginia Commonwealth University. 
The results will help to correlate stressful wartime exposures with subsequent health 
outcomes among Gulf War veterans. It will provide useful information with regard to 
how deployment stress impacts the health of our military personnel. 
All  responses to this survey will be kept confidential and sent to a secure location at 
Virginia Commonwealth University prior to analysis. 
For questions or comments, please email me at fikenny@hsc.vcu.edu 
<mai lto :fikenny(a),hsc.vcu .edu> . A quick response would be greatly appreciated. 
Thank you. 
Frank Kenny (Ph.D. candidate, Virginia Commonwealth University) 
Appendix XX: Gulf War Veteran Survey 
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Are you a Gulf War Veteran? 
I r-Yes No 
If you are a Gulf War Veteran, which branch of the military did you serve with? I u.s. Arffij ::1 
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Please rank each o f  the following exposures experienced by you i n  the Gulf War from 0 
(least stressful) to 1 0 (most stressful). 
If you were NOT exposed to a particular event, please rank the appropriate stress level 
you think may apply from 0 (least stressful) to 1 0 (most stressful). 
Please click on an exposure item for a detailed definition. 
Passive Cigarette Smoke : 
(least stressful) 
I 0 I 1 I 2 r 3 r 4 r 5 r  
(most stressful) 
6 I 7 I 8 I 9 I 1 0  
Oil Fire Smoke: 
(least stressful) 
I 0 I 1 I 2 I 3 I 4 I 5 1  
Tent Heater Smoke : 
(least stressful) 
r 
O
r 1 r 2 r 3 I 4 I 5 1  
CARC Paint: 
(least stressful) 
I 0 1 1 I 2 I 3 I 4 I 5 1  
Other Paints: 
( least stressful) 
I 0 1 1 I 2 I 3 I 4 I 5 1  
Solvents: 
( least stressfu l )  
I 0 1 1 I 2 I 3 I 4 I 5 1  
(most stressful) 
6 I 7 I 8 I 9 I 1 0  
(most stressful) 
6 I 7 c' 8 I 9 I 1 0  
(most stressful) 
6 I 7 I 3 I 9 I 1 0  
(most stressful) 
6 I 7 I 8 I 9 I 1 0  
(most stressful)  
6 I 7 I 8 I 9 I 1 0 
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Diesel Fuel :  
( least stressful ) (most stressful ) ( 
O ( 1 ( 2 ( 
3 ( 4 ( s ( 6 ( 7
( 
8 
( 9 ( 
1 0  
Other Petrochemicals: 
( least stressful) (most stressful) ( 
O ( 1 ( 2 ( 3 ( 4
( 
s ( 6 ( 7
( 
8
( 9 ( 1 0  
Depleted Uranium: 
( least stressful) (most stressful) 
( O ( 1 ( 2 ( 
3 ( 4 ( s ( 6 ( 7
( 
8
( 9 ( 
1 0  
Nerve Gas: 
(least stressful) (most stressful) ( 
O ( 1 ( 2 ( 
3 ( 4 ( s ( 6 ( 7
( 
8
( 9 ( 1 0  
Mustard Gas: 
(least stressful) (most stressful) 
( 
O ( 1 ( 2 ( 3 ( 4
( 
s ( 6 ( 7
( 
8
( 9 ( 1 0  
M icrowaves (Strong Radar): 
(least stressful) (most stressful) 
( 
O ( 1 ( 2 ( 
3 I 4 ( S l 6 ( 7
( 
8 1 9 1  1 0  
P B  (Pyridostigmine Bromide) Pills: 
( least stressful) (most stressful) 
( 
O ( 1 I 2 ( 
3 ( 4 1  S ( 6 I 7
( 
8
( 9 ( 1 0  
Insect Repellents: 
(least stressful)  (most stressful) 
( O ( 1 ( 2
1 3 ( 4
( 
S l 6 ( 7
( 
8
( 9 ( 1 0  
Botulism Immunization : 
( least stressful ) ( most stressful ) 
( 
O ( I
I 2 
I 3 ( 4 ( S I 6 ( 7 1  8 1 9
( 
1 0  
Anthrax Immunization : 
( least stressful ) (most stressful ) 
I 
O ( I
I 2 ( 3 ( 4 1  S l 6 ( 7 1  8 1 9
( 
1 0  
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Malaria Prevention: 
( least stressful) (most stressful) 
I 0 1 1 I 2 I 3 I 4 1  5 1 6 1 7 1  8 I 9 1  1 0  
Food Contamination: 
(least stressful) (most stressful) 
I 0 1 1 I 2 1 3 I 4 1  5 1 6 1 7 1  8 1 9 1  1 0  
Water Contamination: 
(least stressful) (most stressful ) 
I 0 1 I I 2 I 3 I 4 1  5 1 6 1 7 1  8 1 9 1  1 0  
Combat EXQosure: 
(least stressful) (most stressful)  
I 0 1 1 I 2 1 3 I 4 1  5 1 6 1 7 1  8 1 9 1  1 0  
Wounded i n  Action: 
(least stressful) (most stressful) 
I 0 1 1 I 2 1 3 I 4 1  5 1 6 1 7 1  8 1 9 1  1 0  
Witnessing o f  Casualties: 
(least stressful) (most stressful) 
I 0 1 1 I 2 1 3 
(
-
4 1  5 I 6 1 7 1  8 1 9 1  1 0  
Scud Attacks: 
(least stressful) (most stressful) 
I 0 1 1 I 2 I 3 I 4 1  5 1 6 1 7 1  8 I 9 1  1 0  
Chemical Alarms : 
(least stressful) (most stressful) 
I 0 1 1 I 2 I 3 I 4 1  5 1 6 1 7 1  8 1 9 1  1 0  
Thank you for your participation i n  this survey. This survey i s  being performed to fulfill 
requirements for my Ph.D. in Health Administration at Virginia Commonwealth 
University. 
Questions or comments? E-Mai l :  Frank 1. Kenny 
.§ubrrit Form I Beset Form I 
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Gulf War Veteran Stress Survey Links 
1 )  Passive C igarette Smoke 
During the Gulf War, l iving conditions for many troops were often quickly 
assembled and crowded. With smokers and nonsmokers sharing close quarters that were 
often poorly ventilated, the chances of exposure to passive or second hand tobacco smoke 
were greatly increased for a number of troops that were not normally used to this type of 
exposure. These crowded l iving conditions coupled with that fact that smokers tend to 
increase the amount they smoke as a means of reducing wartime stress and as a means of 
combating boredom increased dramatically the potential for exposure. S ince second hand 
smoke at minimum is an annoyance and at worst may be l inked to several types of 
cancer, exposure can often lead to an increase in the overall stress level that an individual 
experIences. 
2) Oil F ire Smoke 
At the end of the Gulf War, more than 600 Kuwaiti oil wells and several pools of 
spilled oil  were left burning after being ignited by retreating Iraqi troops. Huge, dramatic 
plumes of billowing smoke from these fires rose high into the atmosphere. These oil well 
fires produced dense clouds of soot, liquid, aerosols, and gases that were both harmful to 
the environment as well as individuals coming into contact with them. U .S .  service 
personnel in the Gulf who were close to these plumes of smoke could have been exposed 
to hazardous substances contained within them. 
The burning Kuwaiti crude oil produced a wide range of harmful combustion 
products including a high concentration of potentially noxious gases and coated carbon 
particles. Some of the known harmful combustion products included carbon monoxide 
(CO), sulfur dioxide (S02), oxides of nitrogen (NOx), volatile organic compounds 
(VOCs), ozone (03),  various polycyclic aromatic hydrocarbons (PAHs), and acid 
aerosols. In addition, hydrogen sulfide (H2S), a major component of natural gas, was 
present at various concentrations at some of the affected oil fields. 
The known immediate health effects from inhaling large amounts of smoke and 
particulates are primarily respiratory in nature. They include coughing, wheezing, 
increased airway resistance, and the development of respiratory infections. Toxic gases 
that can be found in oil-well fire smoke-such as H2S and S02-can cause eye and nose 
irritation, decreased pulmonary function, and increased airway reactivity. Benzene and 
PAHs, which are also contained in oil-well fire smoke, are known to be human 
carcinogens. 
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(Source: Presidential Advisory Committee on Gulf War Veterans' Il lnesses, 1 997) 
3) Tent Heater Smoke 
During the Gulf War tents were quickly set up to temporarily house a large 
number of mil itary personnel in preparation for the upcoming battle to liberate Kuwait. 
These tents although serving their purpose of housing troops were often poorly 
ventilated. When fuels were used inside these tents for heaters, cooking stoves, and/or 
portable generators, the fumes and exhausts produced by these fuels exposed many 
service members to the vapors benzene, toluene, xylene, ethyl benzene, as well as the 
combustion products carbon monoxide, sulfur dioxide, nitrogen dioxide, lead and other 
pollutants. 
Among the most serious concerns for troops would be lead toxicity due to the 
burning of leaded fuels and carbon monoxide poisoning. Excessive exposure to lead has 
been associated with subjective signs of neurotoxicity such as forgetfulness, lethargy, and 
weakness and has been shown to cause brain and kidney damage. Carbon monoxide 
likewise is a very serious problem for exposed troops because of its absence of smell, 
taste or color. Formed by incomplete fuel oil combustion, carbon dioxide levels can 
build up in a poorly ventilated room causing an individual to experience drowsiness, 
nausea, and even asphyxiation. During the war, four hospitalizations in U .S .  Army field 
hospitals occurred because of asphyxiation from carbon monoxide poisoning. 
(Source: Presidential Advisory Committee on Gulf War Veterans' I l lnesses, 1 997) 
4) Chemical Agent-Resistant Coating (CARC) Paint 
Several thousand vehicles and pieces of equipment deployed to the Gulf region 
had to be quickly repainted from the tree-colored woodland camouflage paint scheme to 
desert camouflage prior to the start of the Gulf War. The desert paint was a urethane­
based chemical CARC, which makes up the largest category of paint applied to the U .S .  
mil itary vehicles and equipment. CARC is resistant to  a variety of  chemicals and 
solvents and has a unique quality for preventing chemical warfare agents, such as blister 
and nerve agents, from penetrating into the coating. 
Inhaling high concentrations of some of the compounds and solvents in CARC 
can cause some short-term symptoms like coughing, shortness of breath and watery eyes. 
Long-term exposure could lead to respiratory problems, including asthma. Paint fumes 
are the factor that presents the most potential risk to users. 
CARC paint emits very little in the way of harmful fumes when applied with a 
brush or roller, but when it is aerosolized during spray-painting applications, the risk of 
inhaling high concentrations of harmful components rises significantly. CARC paint 
contains no carcinogenic compounds and presents no health risks when dry unless the 
painted surface is sanded or welded. 
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(Source: Office of the Special Assistant for Gulf War I l lnesses, Environmental Exposure 
Final Report CARC, 2000, www .gulflink.osd.mil) 
5) Other Paints 
Due to the urgent massing of combat power in tactical assembly areas CARC 
paints used to camouflage and protect vital military equipment were initially in short 
supply. To protect mil itary equipment until more CARC paint arrived, locally procured 
paints of varying quality were used during the Gulf War to camouflage military 
equipment. Individuals who were responsible for painting military equipment often 
worked as much as 1 6  hour days and oftentimes had serious deficiencies in the type and 
quantity of personal protective equipment available. Many of these soldiers also had not 
received sufficient training and information regarding the potential respiratory hazards of 
breathing in paint fumes. 
6) Solvents 
Early desert maneuvers during Operation Desert Shield in Saudi Arabia 
uncovered a problem for American troops. The sand and microscopic sand dust changed 
the tolerances in their M- 1 6A rifles and caused malfunctions. Likewise the harsh desert 
environment adversely affected other military equipment essential for the liberation of 
Kuwait. With a potential ground war looming, it was imperative that coalition forces 
keep their weapons and sensitive military equipment ready for combat. This required that 
coalition troops constantly use degreasing solvents to clean their equipment to ensure that 
they would function correctly. Health hazards associated with solvent exposure include 
toxicity to the nervous system, reproductive damage, liver and kidney damage, 
respiratory impairment, cancer, and dermatitis. 
226 
7) Diesel Fuel 
U.S .  forces used diesel fuel to power mil itary vehicles, as a means of waste 
incineration, and for fueling stoves, heaters, and generators during the Gulf War. Diesel 
fuel was also widely used as a means of suppressing the regions fine sand and dust that 
often caused problems for military operations. It was often sprayed on roadways, 
runways, and even inside tents to suppress the blowing sand. As a consequence of its 
use, many Gulf War troops were exposed to either the vapors of the diesel fuel used or its 
combustion products. 
According to the Occupational Safety and Health Administration (OSHA), 
prolonged breathing of diesel fuel vapors can damage kidneys and/or lower blood clotting 
ability. Prolonged exposure to diesel exhaust can lead individuals to experience adverse 
health effects ranging from headaches and nausea to cancer and respiratory disease. 
(Source: U .S .  Department of Labor, Occupational Safety and Health Administration) 
8) Other Petrochemicals 
U.S .  service members in certain jobs were occupationally exposed to petroleum 
fuel vapors and combustion products, such as toluene, xylene, benzene, ethyl benzene, 
carbon monoxide, sulfur dioxide, nitrogen dioxide, particulates, lead, and other pol lutants 
during the Gulf War. Troops involved with fueling vehicles or aircraft or in charge of 
burning waste and trash were often most at risk. The vapors of these petroleum fuels as 
well as their combustion products produced a variety of potentially serious medical 
conditions. Benzene, for example, which makes up about one percent of U.S .  gasoline 
and up to five percent of European formulations is a known human carcinogen that is 
associated with certain types of leukemia. Likewise, the inhalation of petroleum 
combustion products has been associated with fatigue, headache, nausea, blurred vision, 
dizziness, convulsions, paralysis, and loss of consciousness depending on the dose. U .S .  
service members could have been exposed to petroleum fuels by inhalation, ingesting 
contaminated water or dust, and skin contact. 
The fuel used most widely during the war for both vehicles and equipment was Jet 
A- I ,  an internationally used kerosene-based aviation fuel provided at no cost by the Saudi 
Arabian government. Of the 1 .8 bill ion gallons of fuel used during Operations Desert 
Shield/Desert Storm, roughly 75 percent was jet fuel (mostly Jet A- I ), 24 percent was 
diesel fuel, and I percent was gasoline. The gasoline used during Operations Desert 
Shield/Desert Storm was commercial leaded gasoline refined to Saudi Arabia's national 
standard. 
(Source: Presidential Advisory Committee on Gulf War Veterans' I l lnesses Final Report, 
1 997) 
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9) Depleted Uranium 
Depleted uranium (DU) is derived from the heavy metal uranium, which occurs 
naturally as mineral deposits that are mined and processed for use in nuclear power plants 
or nuclear weapons. DU is the natural uranium left over after more of the highly 
radioactive uranium isotopes used in these power plants and weapons are extracted. DU 
contains about half of the radioactivity of natural uranium. It is considered a very low­
level radioactive material . However, as with other heavy metals, such as lead, uranium 
can be toxic to the kidneys and other organs including the lungs. 
Depleted uranium was first used in the development of major weapon systems 
because of its high density and superior mechanical properties, and because it is relatively 
abundant and cost effective. Al lied forces used DU in tank armor and in penetrators of 
various antitank munitions during the Gulf War where they fired a total of 320 tons 
(290,300 kilograms) of DU projectiles at Iraqi mil itary forces. 
Although Iraq did not possess DU rounds, friendly-fire incidents exposed some 
U.S .  soldiers to DU following impact of DU rounds to their own or others' vehicles or to 
damaged vehicles they inspected, recovered, or repaired. When a DU penetrator hits an 
armored target, it disintegrates due to the resulting kinetic energy transfer that results in 
extreme heat and formation of uranium oxide particles. The uranium oxide particles that 
form are usually small, and due to their high density they settled quickly onto vehicles, 
bunkers and onto the surrounding sand where they could be easily inhaled. Soldiers with 
the highest exposures were in, on, or near vehicles when they were struck. 
(Sources: Department of Yeterans Affairs Gulf War web page www.va.gov.gulfwar and 
Office of the Special Assistant for Gulf War I l lnesses, Depleted Uranium Information 
page.) 
1 0) Nerve Gas 
The pre-Gulf War Iraqi arsenal contained nerve agents that were designed to kill, 
seriously injure, or incapacitate persons due to their physiological effects. Among the 
most worrisome to Coalition forces were the nerve agents' tabun, sarin, soman, 
cyclosarin, and YX (methylphosphonothioic acid). These agents, which are hard to 
recognize without detectors until clinical symptoms appear, posed a real and imminent 
threat to coalition forces in the Gulf region. They act by inhibiting the vital enzyme 
acetylcholinesterase (AChE), which is responsible for breaking down the 
neurotransmitter acetylcholine (Ach) at the nerve synaptic junctions. The resultant state 
is physiological-pathological overstimulation by excessive ACh resulting in neurologic 
and respiratory problems that if left untreated could result in death. 
At the time of the Gulf War, coalition forces fully had expected Saddam Hussein 
to use his known supply of nerve agents. He had had a history of doing so both against 
the Iranians during the Iran-Iraq war and against his own people the Kurds and was 
thought likely to do so against coalition forces. During the Gulf War, coalition forces 
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were very worried about Saddam delivering these weapons of mass destruction through 
ballistic missiles, aerial bombs, short-range rockets, mines, or even having them sprayed 
from aircraft, trucks, or tanks. 
(Source: RAND, A Review of the Scientific Literature as It Pertains to Gulf War 
Illnesses, Volume 5 Chemical and Biological Warfare Agents). 
1 1  ) Mustard Gas 
Mustard Gas had been a worry of armed forces since its destructive use in World 
War I. It was such a terrible weapon that neither side was willing to use it in World War 
II for fear that the other side would retaliate in kind. When coalition forces deployed in 
the Gulf in 1 990, there was concern that Iraq might use mustard agents in their defense of 
Kuwait. They had already used aircraft and artillery to deliver mustard in their war with 
Iran and it was widely thought that mustard gas would be a chief weapon in the Iraqi 
arsenal against coalition forces. Iraq at the time of the Gulf war had the capacity of 
delivering mustard gas via mortar rounds, artillery, free rockets, aerial bombs, aerosol 
and liquid spray tanks. 
Mustard gas can be absorbed into the body either by breathing its vapors or by 
skin contact. Exposure then can cause severe irritation and tissue damage including 
blistering to the eyes, skin, respiratory, and digestive tracts. At the cellular level mustard 
gas has a binding affinity for the nitrogenous base guanine, which is a critical component 
of both DNA and RNA. The binding of mustard gas to guanine causes problems with 
cellular replication and protein development leading to mutations and/or the synthesis of 
non-functional proteins. Mustards eventually cause death at the cellular level through 
energy loss following DNA breakage, loss of cell membrane integrity, or the perturbation 
of cycloskeletal organization. 
(Source: Gulf War Review, October 2000) 
1 2) Microwaves (Strong RADAR) 
Microwaves are a form of non-ionizing radiation extremely common in most of 
the world. The radio frequencies of interest in the Persian Gulf extend from about 
300GHz to 30 MHz. The upper portion of this range includes the wavelengths used for 
radar, radio, television, microwave ovens, and diathermy. During the Gulf War, 
microwaves were used to communicate among units, eavesdrop on Iraqi communications, 
and to jam enemy radar installations. 
The biological effects of microwaves on troops were primarily those of molecular 
agitation, that is, heat production. The heating effect is obvious, but other, less detectible 
biological effects have been described and debated for years. Human studies, as well as 
animal experiments, support an increase in cataracts after exposure to high intensity 
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microwaves and changes in hearing have been described in experimental animals. These 
have been described as non-thermal effects but this idea has been challenged. 
(Source: Department of Veterans Affairs Gulf War web page www .va.gov/gulfwar) 
1 3 ) PB (Pyridostigmine Bromide) Pills 
Pyridostigmine bromide (PB) is a reversible cholinesterase inhibitor that was used 
during the Gulf War as a pretreatment for exposure to the nerve agent soman. Its action 
is simi lar to that of nerve agents that bind to the vital enzyme acetylcholinesterase 
(AChE) and cause harm to the nervous system. The major difference between 
Pyridostigmine bromide and nerve agents in terms of mechanism of action is that 
Pyridostigmine bromide binds reversibly to AChE whereas the binding of nerve agents is 
permanent. In theory, and demonstrated by animal models, Pyridostigmine bromide 
administered as a pretreatment drug will compete with nerve agents in binding with 
AChE. Pyridostigmine bromide can thus prevent the permanent disabling of AChE by 
nerve agents by binding with it until the nerve agents have bound with something else or 
left the body. Since it binds to AChE like nerve agents, administration of Pyridostigmine 
bromide will  give off symptoms of nerve agent attack but over time with the release of 
Pyridostigmine bromide from AChE, a person's  nervous system will return to normal. PB 
also is a preferred drug against nerve agent attack because it has been shown to usually 
not cross into the central nervous system and thus have a harmful impact on brain 
function or mental performance. 
During the Gulf War Pyridostigmine bromide was given to U.S .  troops in pill 
form so that it could be self-administered upon a unit commander' s  order. Most U.S .  
troops were give bl ister packs containing Pyridostigmine bromide pills during the Gulf 
War and DoD estimates that approximately 250,000 personnel took at least some of the 
PB pills . The controversy surrounding PB lies in the fact that although it had been 
authorized by the FDA to treat Myasthenia Gravis (an autoimmune disorder) since 1 955,  
it was sti l l  considered an investigational new drug (lND) by the Food and Drug 
Administration (FDA) for other uses. Under FDA rules, INDs require the informed 
consent of the persons who take the drugs. In December 1 990, just a few months prior to 
the Gulf War, the FDA granted Department of Defense a waiver from the informed 
consent requirement due to the immediate threat of combat. Many troops at this time 
were concerned about being forced to a drug that under other circumstances would not 
have been approved by the FDA for its use. They were worried both about the long-term 
health implications as well as the possible adverse reactions of taking the drug. 
(Source: Institute of Medicine, Gulf War and Health Volume 1 ,  Depleted Uranium, 
Pyridostigmine Bromide, Sarin, Vaccines) 
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1 4) Insect RepelIents 
During the Gulf War, preventive medicine personnel anticipated the need to 
control the regions ubiquitous insect and rodent populations. They were especially 
concerned with sand flies and mosquitoes which carry several infectious diseases, 
including leishmaniasis, sand fly fever, and malaria. To combat these potential infectious 
disease threats, U .S .  health officials used numerous insect repellant products, including 
sprays, powders, baits, pest strips, and flypaper. 
Although these insect repel lent products were EPA approved and not considered 
harmful when used according to instructions, potential product misuse and service 
members who spent long times in areas where insect repellents were used may have had 
exposures higher than recommended amounts. 
Potential troops at risk for over exposure to insect repellents included repellent 
applicators that may have lacked sufficient training or protective equipment and troops 
who were exposed to insect repellents used improperly. Most repellents were intended 
for outdoor use only, but many repellents were used indoors in areas where military 
personnel worked, ate, and slept. This thus exposed troops to higher amounts of insect 
repellent than the EPA recommended as safe.  
(Source: Deployment Health Support, Information Paper Pesticides, 
http://deploymentlink.osd.mil) 
1 5) Botulism Immunization 
One of the most feared biological weapons that Iraq was thought and later proved 
to have had in its arsenal during the Gulf War was the botulinum toxin produced by the 
anaerobic bacterium Clostridium botulinum. The botulinum toxin, which according to 
the CDC is the most potent lethal substance known to man (lethal dose I ng/kg), is the 
cause to potentially fatal muscle paralytic disease botulism. For U.S. forces in the Gulf, 
this toxin posed a major bioweapons threat due to its extreme potency and lethality, its 
ease of production, and the threats of Iraq to use any means necessary to defend Kuwait. 
Although the 1 972 Biological and Toxin Weapons Convention, to which Iraq was a 
signatory, prohibited offensive research and production of biological weapons, U.S .  
intelligence believed Saddam Hussein to be in possession of significant quantities of this 
highly lethal toxin in a weaponized form ready to be used on U.S .  forces. 
Concerns regarding Iraq's capabi lities of using the deadly botulinum toxin as an 
offensive weapon led to the decision that all available vaccines against it should be used 
to protect U.S .  service members. At the time of the Gulf War, a botulinum toxoid existed 
that covered many of the serotypes of botulism harmful to humans. This toxoid, a 
modified bacterial toxin made nontoxic but continuing to have the capacity to stimulate 
the formation of antibodies, was distributed to several U .S .  combat units prior to and 
during the Gulf War. According to the Department of Defense, it is estimated that 8,000 
U.S. service men and women were vaccinated with botulinum toxoid during the war. 
Since the efficacy of this toxoid had never been proven due to the ethics involved in such 
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testing, the Food and Drug Administration (FDA) labeled the toxoid as  an  Investigational 
New Drug ( IND). Due to the military extingencies of the Gulf War, the FDA 
commissioner waived the informed consent requirements that go along with INDs so that 
troops could be protected. This thus meant that Gulf War mil itary personnel who 
received the botulism toxoid were given an unapproved FDA pre-treatment vaccine 
without the ability to refuse taking it. 
(Sources: Gulf War and Health, Volume I ,  Depleted Uranium, Pyridostigmine Bromide, 
Sarin, Vaccines; Center for Disease Control www.bt.cdc .gov. Botulism Toxin as a 
Biological Weapon, JAMA. 200 I ;  285 :  1 059- 1 070). 
1 6) Anthrax Immunization 
Anthrax is a naturally occurring zoonotic disease caused by the rod shaped 
bacterium Bacillus anthracis that occurs primarily in plant eating animals (goats, sheep, 
cattle, horses etc . ) .  For centuries, it has caused disease in animals and, uncommonly 
serious il lness in humans throughout the world. In the past century, a rare aerosol form 
of anthrax, often called inhalation anthrax, was recognized to be such a highly lethal form 
of the disease that research was soon undertaken to tum it into a biological weapon. In 
1 972, recognizing the danger of the spread of weapons of mass destruction, including the 
biological warfare agent inhalational anthrax, 1 44 countries including Iraq signed a 
biological warfare treaty which outlawed the possession of all biological weapons. 
Concerns prior to the Gulf War regarding Iraq ' s  offensive biological warfare 
capabilities, led to decisions that available vaccines should be utilized as preventive 
measures against biological warfare agents. Military planners and health officials were 
worried that Iraq had secretly possessed supplies of we aponi zed inhalational anthrax in 
violation of the 1 972 treaty. They therefore ordered U.S. forces to take the Food and 
Drug Administration (FDA) approved vaccine for anthrax as a preventative measure. 
The Department of Defense (DoD) estimated that 3 1 0,680 doses of the anthrax vaccine 
licensed by the FDA were distributed to the Gulf War theatre and that 1 50,000 U.S .  
troops received at  least on vaccination. Many troops were concerned about taking the 
anthrax vaccine during the Gulf War since the there was a possibility of an adverse 
reaction and since the long term affects of the anthrax vaccine were unknown. 
(Source: Gulf War and Health, Volume I ,  Depleted Uranium, Pyridostigmine Bromide, 
Sarin, Vaccines, Institute of Medicine, 2000) 
1 7) Malaria Prevention 
Malaria is l ife threatening parasitic disease that is transmitted from person to 
person from the bite of an infective female Anopheles mosquito, which requires blood to 
nurture her eggs. While biting a target individual, an infected Anopheles mosquito will 
inject protozoan parasites of the genus Plasmodium into that individual 's bloodstream. 
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These parasites will intern invade that individuals red blood cells (RBCs) where they will 
multiply and cause the RBCs to change shape, stick together, or even rupture. The 
RBCs, which are responsible for carrying oxygen to vital organs, will less be able to 
perform their task and the infected individual will suffer as a consequence. Some of the 
major symptoms of malaria are chills, high fever, and anemia. If left untreated, infected 
RBCs can block blood vessels supplying the brain (cerebral malaria), or damage other 
vital organs and cause death in the infected individual. 
Malaria affects primari ly the populations of tropical and subtropical regions 
however it has been known to exist in both Kuwait and Iraq. Although it is unlikely to be 
found in a desert environment, it may be present focally in river valleys, salt marshes, and 
in irrigated areas. Outbreaks have been known to occur whenever major displacements 
of people occur, such as during military conflicts, social upheavals, or natural disasters. 
To combat the malaria threat during the Gulf War, many U.S .  forces were given 
antimalarial drugs for preventative purposes. Among the common antimalarial drugs 
used were chloroquine (Aralen), mefloquine (Lariam), primaquine, pyrimethamine 
(Daraprim), and quinine, which came in tablet, capsule, and injectable forms. 
Recommended dosage depended on the type of antimalarial drug, its strength, the form in 
which it is being used (such as tablet or injection) and if drug resistant strains of malaria 
are known to be in the area. Dosages were given on a set schedule for maximum 
protective effect. 
Possible worries to U.S .  forces when taking malarial medications were the side 
effects often experienced when using them. Antimalarial drugs often cause 
l ightheadedness, dizziness, blurred vision and other vision changes. They have also been 
impl icated in causing panic attacks, hallucinations, anxiety, depression, paranoia, and 
other mental and mood changes, sometimes lasting for months after the last dose. Troops 
in the region wanted to be at their best when facing the enemy. Taking antimalarial 
medications and possibly experiencing side effects was a cause for concern to them. 
(Sources: RAND, A Review of the Scientific Literature As It Pertains to Gulf War 
Illnesses, Volume I ,  Infectious Diseases, 200 1 ,  and 
http://www.principalhealthnews.com/topic/malariadrugs) 
1 8) Food Contamination 
Experience with previous wars in the Middle East led military and civilian experts 
to predict that a number of U.S .  forces would come down with food borne diseases 
endemic to the Persian Gulf region. Among the most worrisome were Escherichia coli, 
Shigella, Salmonella, Campylobacter, Hepatitis A, and Brucellosis. Each of these 
diseases may be transmitted through the ingestion of undercooked infected food or 
contaminated food that is the result of poor sanitation. Most of these diseases concerned 
health officials because they not only disable the individual inflicted, but also they may 
lead to outbreaks that could spread the il lness to other individuals. 
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Although most U.S. troops were given prepackaged food and advised not to eat 
locally produced food, it was difficult to keep all troops just eating the assigned rations. 
Many troops consumed locally grown food or cooked for themselves and for others. 
Since sanitation was often primitive in the desert camps with strains on latrines and 
communal washing faci lities, there was always a high potential that a food borne 
outbreak would occur. An outbreak during time of war a concern to both troops as well 
as those in command. 
(Source: RAND, A Review of the Scientific Literature As it Pertains to Gulf War 
Il lnesses, Volume I ,  Infectious Diseases, 200 I ) . 
1 9) Water Contamination 
Military planners and health officials were concerned that troops exposed to poor 
sanitation conditions and unknown local water supplies during their deployment to the 
gulf might end up acquiring water borne il lnesses such as cholera, typhoid, and giardia. 
These i l lnesses along with others like them could have seriously impacted the readiness 
of affected units and in tum caused logistical problems for all troops in the region. 
Health officials felt that crowded makeshift living quarters with primitive sanitation 
facilities, would become the breeding grounds for water borne il lnesses. This coupled 
with the fact that many troops were using unknown local water supplies for bathing, 
cleaning, and cooling off purposes, made them very concerned with regards to troops 
becoming afflicted with borne il lnesses. 
During the first two months of troop deployment (August and September, 1 990) 
troops deployed to the gul f were in particular exposed to contracting water borne 
il lnesses. Most troops had just arrived and sanitation facilities were just being set up and 
thus basic at best. With air temperatures as high as 1 1 5 of and temperatures of the sand 
reaching 1 50 of troops had to drink large quantities of water to prevent dehydration. 
Many troops took their chances with unknown local drinking supplies to cool off and 
prevent dehydration at the risk of acquiring water borne illnesses. The water situation 
became better in the winter months after the outside temperatures fell, sanitation 
improved, and more bottled water became available, however many troops were sti ll 
concerned about their health. 
With the lighting of the Kuwaiti oil fields by Iraqi soldiers prior to their departure 
of Kuwait a new problem emerged for U.S .  troops in terms of water consumption. Local 
water supplies were now contaminated with the fallout of the oil fires. Persons drinking 
any water besides the supplied bottled water were at risk on ingesting unknown quantities 
of fuel contaminants. With troops on the move chasing the Iraqi army out of Kuwait, it 
was difficult to keep supplies in line. Thus many troops may out of necessity have been 
forced to consume potentially contaminated water. 
(Source: RAND, A Review of the Scientific Literature As It Pertains to Gulf War 
Il lnesses, Volume I ,  Infectious Diseases, 200 1 ) . 
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20) Combat Exposure 
Going into the combat phase of the Gulf War, troops were concerned about 
confronting a formidable enemy that was "battle hardened" by an extended conflict with 
Iran. The Iraqi army, which had just overrun Kuwait, was at the time the fourth largest 
in the world and equipped with some of the most sophisticated weaponry of the Soviet 
military arsenal. Many troops had heard of high u.S .  casualty estimates predicted by 
world news organizations and of Sad dam Hussein 's  threat that the battle for Kuwait 
would be the "mother of all battles". They had known about the chemical and biological 
weapons threat and were now hearing debates raging in the media with regards to the 
usefulness or effectiveness of gear they had to protect themselves from that threat. They 
had a lot to worry about and were concerned that once actual combat began, the 
predictions of a high casualty war may indeed come true. 
Once the air war had started troops had to worry about Iraqi SCUD missiles that 
could hit their positions at any time with little or no warning. Facing an enemy leader 
that had shown no mercy in using weapons of mass destruction to brutalize his own 
people many thought that if Saddam was going to use these types of weapons, he would 
certainly do so once the war began. Saddam had the capacity to load any number of 
nerve or chemical warheads onto his missiles and send them off against U.S. forces. 
Many troops believed that the more desperate Saddam became, the more likely he would 
resort to using weapons of mass destruction. 
The actual ground war produced its own source of stress for U.S.  forces in the 
Gulf region. No one knew how long the war would last, how determined the enemy 
would be, or what ends Saddam would go to in order to hold on to Kuwait. Troops had 
to fear being subject to ground and arti llery attacks, possibly being captured and tortured, 
and to losing their friends to enemy or friendly fire. They also had to put up with the 
stress of possibly having to shoot or be shot at by enemy troops. On top of this was the 
real possibil ity that they would wind up injured or die in combat. 
(Source: RAND, Psychological and Psychosocial Consequences of Combat and 
Deployment with Special Emphasis on the Gulf War, 200 1 ) . 
2 1 )  Wounded in Action 
An injury or wound suffered in battle can be can be a traumatic experience to the 
individual involved. Seriously injured or wounded persons must endure the pain of their 
injury, worry about living or dying, and stress about the possibility of suffering a 
permanent loss or long term disability from their injury. Oftentimes several people are 
wounded at once, so there is the added worry about the safety of friends who were 
nearby. There is additional stress involved being removed from the battlefield and 
receiving adequate medical attention. A wounded or injured person is oftentimes in a 
vulnerable position and thus has to worry about being wounded again or even captured. 
Once in a secure location, a wounded person has to worry about the possibility that the 
wound could become infected and lead to other problems such as a fever or other illness. 
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They are concerned not only about the length of time for recovery, but also if a full 
recovery can be achieved. Being far from home, away from the support loved ones, can 
be particularly is difficult on the wounded person. A wounded individual must finally 
worry about how the injury may impact their future life. Some disabling injuries could 
impact future military service or may have an effect on ones ability to return to civilian 
work. 
22) Witnessing of Casualties 
Nothing can fully prepare a soldier for what he or she may see on the battlefield 
after an encounter with the enemy. In this age of highly technical warfare where missiles 
can be fired for mi les and the enemy can barely be seen prior to an attack, the casualties 
of war are often only truly recognized in the aftermath of battle. It is always an 
unpleasant sight to witness up close the carnage and destructiveness of war including its 
human casualties. Whether they were friend or foe, the images of casualties on a recently 
fought battlefield will be hard to ever forget. 
In the aftermath of the highly successful air and ground offensives, many 
personnel - including noncombatants - were exposed to evidence of widespread 
devastation, including the deaths of tens of thousands of Iraqis. The cold reality of war 
suddenly was thrust into the faces of those who witnessed these casualties. Charred and 
dismembered bodies were seen throughout Kuwait and on the roadways heading back to 
Iraq. Many of these enemy troops had little chance against the overwhelming firepower 
of the coalition forces. Although there were few, coalition and civilian casualties were 
also witnessed by U.S .  forces during the Gulf War. The visualization of these as well as 
Iraqi casualties had a profound impact on many of the troops who served. 
(Source: RAND, A Review of the Scientific Literature As It Pertains to Gulf War 
I l lnesses, Volume 4, Stress, 1 999). 
23) SCUD Attacks 
One of the most feared weapons in the Iraqi arsenal during the Gulf War were 
Soviet made short range ballistic missi les known as Scuds. Pre-war intelligence judged 
that Iraq might have modified these conventional ballistic missiles by arming them with 
chemical or biological warheads thus making them far more dangerous to Coalition 
troops. At the time of the Gulf War it was estimated that Iraq had 1 50 of these modified 
Scud missi les ready for use. According to the Defense Intelligence Agency CD. LA.), the 
most likely agents in Iraq's  warheads were the nerve agent VX, and the blister agent 
mustard. 
Many U.S.  troops observed or became aware of incoming or overflying Scud 
missi les, Patriot missi les fired in defense, and Scud missile or debris impacts. They knew 
that Iraq had the capability to use chemical and biological weapons, and of Saddam 
Hussein's past with regards to weapons of mass destruction. With each Scud attack or 
perceived Scud attack U.S. troops were forced to take defensive measures such as 
heading for cover and going to full chemical protection mode. Such precautionary 
measures disrupted lives and generated stress among U.S.  forces. 
(Source: Information Paper, Iraq ' s  Scud Ball istic Missi les, 
http://www.gulflink.osd.mi llscud info iiO 
24) Chemical Alanns 
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Since Saddam Hussein had a history of using chemical weapons against Iran and 
in suppressing his own people there was widespread concern among U.S.  forces prior to 
the Gulf War that he would attempt to use similar weapons in his defense of Kuwait. In 
light of this threat U .S .  forces were supplied and trained in the use of numerous types of 
chemical detectors that would sound alarms when and if chemical agents were detected. 
These detectors were used to alert troops that a chemical attack may be underway so that 
defensive measures such as taking cover, putting on protective gear, and taking 
prophylactic agents aimed at mitigating the consequences of exposure to chemical 
weapons could be taken. 
Although troops in the gulf region underwent extensive training and mock drills 
to prepare themselves for possible chemical attacks, apprehension and uncertainty about 
possible attacks, the effectiveness of defensive suits, and the possible side effects of 
prophylactic agents weighed heavily on the minds of many soldiers. Constant training 
for a chemical attack and the numerous alarms indicating possible chemical detections 
increased the salience of this potential threat. For many troops being forced to wear both 
a protective mask and suit at a moments notice was a cause for both physical as well as 
mental strain .  
(Source: RAND, A Review of the Scientific Literature As It Pertains to Gulf War 
I l lnesses, Volume 4, Stress, 1 999). 
Appendix XXI I :  Gulf War Stress Survey Results 
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Veteran Veteran Veteran Veteran 
1 st e-mail 2nd e-mail mai l/inter Total 
Exposure/Experience tl Mean tl Mean tl Mean tl Mean 
Passive Cigarette Smoke 1 1 8 2.73 60 3 .25 32 2. 1 9  2 1 0  2 .8 
2 Oil Fire Smoke 1 1 8 6. 1 1  60 6.85 32 5.28 2 1 0  6.2 
3 Tent Heater Smoke 1 1 8 2.94 60 2.82 32 1 .9 1  2 1 0  2 .75 
4 CARC Paint 1 1 8 2 .46 60 2.68 32 2.03 2 1 0 2.46 
5 Other Paints 1 1 8 2.29 60 2.78 32 1 .97 2 1 0  2 .38 
6 Solvents 1 1 8 3 .29 60 4.03 32 3 .09 2 1 0  3 .47 
7 Diesel Fuel 1 1 8 4.69 60 5.32 32 4.56 2 1 0  4.85 
8 Other Petrochemicals 1 1 8 4.3 1 60 4. 1 2  3 2  3 .94 2 1 0  4.2 
9 Depleted Uranium 1 1 8 3 .67 60 3 .62 32 4.41 2 1 0  3 .77 
1 0  Nerve Gas 1 1 8 5 . 1 4  60 4.55 32 4.97 2 1 0  4.94 
I I  Mustard Gas 1 1 8 4. 1 9  60 3 .58 32 4.59 2 1 0  4.08 
1 2  Microwaves 1 1 8 3 .64 60 4.23 32 3 .53 2 1 0  3 . 8  
1 3  PB Pills 1 1 8 6.34 60 6.03 32 7.03 2 1 0  6.36 
1 4  Insect Repellents 1 1 8 4.47 60 4.45 32 3 .47 2 1 0  4.3 1 
1 5  Botul ism Immunization 1 1 8 4.89 60 4.82 32 6 2 1 0  5 .04 
1 6  Anthrax Immunization 1 1 8 6.25 60 5.97 32 6.09 2 1 0  6. 1 5  
1 7  Malaria Prevention 1 1 8 4.26 60 4. 1 32 4.34 2 1 0  4.23 
1 8  Food Contamination 1 1 8 3 .87  60 3 .4 32 3 .06 2 1 0  3 .6 1  
19  Water Contamination 1 1 8 4. 1 4  60 3 .78 32 3 .63 2 1 0  3 .96 
20 Combat Exposure 1 1 8 6.67 60 5 .95 32 7.06 2 1 0  6.52 
2 1  Wounded in Action 1 1 8 3 .25 60 2.67 32 5 .03 2 1 0  3 .35  
22 Witnessing of Casualties 1 1 8 5 . 1 4  60 5 . 1 3  32 6.09 2 1 0  5.29 
23 SCUD Attacks 1 1 8 6.3 60 6. 1 32 7.03 2 1 0  6.35 
24 Chemical Alarms 1 1 8 7 .07 60 7.42 32 7.09 2 1 0  7. 1 7  
Veteran 1 51 emai l - a group e-mail sent out to 1 600 veterans on October 28, 2003 and 
November 6, 2003 containing a Gulf War Stress Survey. 
Veteran 2nd emai l - a group e-mail sent out to 800 different veterans on November 1 7, 
2003 and November 24, 2003 containing a Gulf War Stress Survey. 
Veteran mai llinter - Gulf War Stress Survey results that were obtained either by mailing 
the survey to veterans of personally interviewing them. 
Veteran Total - the total results of the Gulf War Stress Survey sent out to veterans. 
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Veteran Health Expert Combined 
Total e-mail Total 
Exposure/Experience tl Mean tl Mean Mean 
1 Passive Cigarette Smoke 2 1 0  2 .8  22  2.27 2 .54 
2 Oil Fire Smoke 2 1 0  6.2 22 5.95 6.08 
3 Tent Heater Smoke 2 1 0  2.75 22 2.23 2 .49 
4 CARC Paint 2 1 0  2 .46 22 1 .86 2 . 1 6  
5 Other Paints 2 1 0  2 .38 22 3 .09 2 .74 
6 Solvents 2 1 0  3 .47 22 3 . 1 8  3 .33  
7 Diesel Fuel 2 1 0  4.85 22 3 .55  4.2 
8 Other Petrochemicals 2 1 0  4.2 22 3 .95 4.08 
9 Depleted Uranium 2 1 0  3 .77 22 6. 1 4  4.96 
1 0  Nerve Gas 2 1 0  4.94 22 5 .45 5 .2  
1 1  Mustard Gas 2 1 0  4.08 22 5.23 4.66 
1 2  M icrowaves 2 1 0  3 .8  22 2 .86 3.33 
1 3  PB Pills 2 1 0  6.36 22 6.68 6.52 
1 4  Insect Repellents 2 1 0  4.3 1 22 3 . 1 8  3 .75 
1 5  Botulism Immunization 2 1 0  5 .04 22 4.32 4.68 
1 6  Anthrax Immunization 2 1 0  6. 1 5  22 6.23 6. 1 9  
1 7  Malaria Prevention 2 1 0  4.23 22 4.9 1 4 .57 
1 8  Food Contamination 2 1 0  3 .6 1 22 3. 1 4  3 .38  
1 9  Water Contamination 2 1 0  3 .96 22 3 .55 3 .76 
20 Combat Exposure 2 1 0  6.52 22 6.95 6.74 
2 1  Wounded in Action 2 1 0  3 .35  22 5.95 4.65 
22 Witnessing of Casualties 2 1 0  5.29 22 5 .77 5.53 
23 SCUD Attacks 2 1 0  6.35 22 6 .9 1  6.63 
24 Chemical Alarms 2 1 0  7. 1 7  22 7.59 7.38 
Veteran Total - the total results of the Gulf War Stress Survey sent out to veterans .  
Health Expert e-mail - the results of the Gulf War Stress Survey sent out to health 
experts. 
Combined Total - the average of the mean results for the Gulf War Stress Survey for 
both veterans and health experts. 
Appendix XXII I :  Comprehensive Clinical Evaluation Program 
Exposure/Experience Questionnaire 
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Comprehensive Cl inical 
Evaluation Program (CCEP) 
Before you beg in ,  the administrator wil l  take 
you through a tutorial that includes several 
instruction screens to demonstrate how the 
CCEP questionnaire works. Please read 
each screen carefully and follow the 
instructions. If you have any problems or 
questions, ask the administrator to assist 
you. 
BEGIN CCEP QUESTIONNAIRE 
0 1 69 - I n troduction 
Welcome to the CCEP Patient 
Questionnaire. 
Please read each screen completely 
and careful ly before making your 
selections. Provide a response for 
each screen .  Do not skip screens. 
If you do not understand a question -
ask the administrator. 
0 1 7 1  - Demographics 
Sponsor relationship 
o I am the sponsor {145] 
o I am married to the sponsor {513] 
o I am a child of the sponsor {514] 
0 1 72 
Gulf War duty status 
o I served in an Active unit during the 
Gulf War {Q155] 
If Yes, Branch to Q 1 55 
o I served in a National Guard unit 
during the Gulf War {Q1 73] 
If Yes, Branch to Q 1 73 
o I served in a Reserve unit during the 
Gulf War {Q1 74] 
If Yes, Branch to Q 1 74 
o All others {Q1 75] 
If Yes, Branch to Q 1 75 
24 1 
0 1 55 
Gulf War service (select ONLY one) 
o I served in the active Army during the 
Gulf War {502] 
o I served in the active Air Force during 
the Gulf War {503] 
o I served in the active Marine Corps 
during the Gulf War {504] 
o I served in the active Navy during the 
Gulf War {505] 
o I served in the active Coast Guard 
during the Gulf War {506] 
o I served in another active branch 
during the Gulf War {520] 
o I was not in the service during the 
Gulf War {507] 
Branch to Q 1 76 
0 1 73 
Gulf War service (select ONLY one) 
o I served in the Army National Guard 
during the Gulf War {1 71] 
o I served in the Air National Guard 
during the Gulf War {1 70] 
o I served in another branch of the Nat 
Guard during Gulf War {524] 
o I was not in the service during the 
Gulf War {507] 
Branch to Q 1 76 
0 1 74 
Gulf War service (select ONLY one) 
D I served in the Army Reserves during 
the Gulf War {525] 
D I served in the Air Force Reserves 
during the Gulf War {526] 
D I served in the Marine Corps 
Reserves during the Gulf War {527] 
D I served in the Navy Reserves during 
the Gulf War {528] 
D I served in the Coast Guard Reserves 
during the Gulf War {529] 
D I served in another branch of the 
Reserves during Gulf War {530] 
D I was not in the service during the 
Gulf War {507] 
Branch to Q 1 76 
0 1 75 
Gulf War service (select ONLY one) 
D I was a civi l ian employee during the 
Gulf War {531] 
D I was the spouse of a soldier who 
served duri ng the Gulf War {532] 
D I was the spouse of a civilian who 
served the Gulf War {533] 
D I was the child of a soldier who served 
during the Gulf War {534] 
D I was the child of a civilian who 
served the Gulf War {535] 
D I was associated with the Gulf War in 
some other way {536] 
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0 1 76 
Service history (select ALL that apply) 
D I have served in armed conflicts i n  
Vietnam {282] 
D I have served in armed conflicts in 
Grenada {284] 
D I have served in armed conflicts i n  
Panama {285] 
o I have served in armed conflicts in 
Somalia {286] 
o I have served in armed conflicts in 
Haiti {287] 
D I have served in armed conflicts in 
Bosnia {288] 
o I have served in other armed conflicts 
not l isted above {283] 
088 - General Health 
D 
0 
D 
D 
D 
089 
In general ,  would you say your health 
is 
Excellent {289] 
Very good {290] 
Good {291] 
Fair {292] 
Poor {293] 
Compared to 1 year ago, 
D my general health is Much better now 
{294] 
D my general health is Somewhat better 
now {295] 
o my general health is About the same 
now {296] 
o my general health is Somewhat worse 
now {297] 
D my general health is Much worse now 
{298] 
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Q93 Q 1 00 - Duty Status 
Days lost from work in last 90 days Duty Status 
0 o days lost from work [308J 0 I am currently on active duty status 
0 1 -6 days lost from work {309J {094J 
0 7-1 5 days lost from work {31OJ If Yes, Branch to 094 
0 1 6-30 days lost from work {3 1 1J 0 I am not currently on active duty 
0 31 -60 days lost from work {31 2J status {085J 
0 6 1 -90 days lost from work {313J If Yes, Branch to 085 
Q 1  Q94 
Cigarette use Physical fitness testing 
0 YES, I smoke cigarettes now {02J 0 YES, I have passed my physical 
If Yes, Branch to 02 fitness test within last year {344J 
0 YES, I used to smoke cigarettes, but I 0 NO, I did not pass my latest physical 
have quit {03J fitness test {345J 
If Yes, Branch to 03 0 I have NOT TAKEN a physical fitness 
0 NO, I have never smoked cigarettes test within last year {21J 
{147J Q95 
If No, Branch to 0 1 00 
Medical boards 
Q2 0 YES, I am currently undergoing a 
Current smoker medical board {346J 
0 YES, I smoke LESS THAN 1 PACK of 0 NO, I am not currently undergoing a 
cigarettes PER DAY {IJ medical board {347J 
0 YES, I smoke 1 -2 PACKS of 
cigarettes PER DAY {2J 
Q96 
0 YES, I smoke MORE THAN 2 PACKS Duty l imitations 
of cigarettes PER DAY {3J 0 YES, I am currently on a profile or 
Branch to 0 1 00 
l ight duty {348J 
0 NO, I am not currently on a profile or 
Q3 l ight duty {349J 
Former smoker 
0 YES, I USED to smoke LESS THAN 1 
PACK of cigarettes PER DAY {4J 
0 YES, I USED to smoke 1 -2 PACKS of 
cigarettes PER DAY {5J 
0 YES, I USED to smoke MORE THAN 
2 PACKS of cigarettes PER DAY {6J 
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097 0 1 3 1  
Active duty status (within next year) Abdominal pain - currency 
0 YES, I am facing possible termination 0 I am currently experiencing abdominal 
from active duty {350] pain {465] 
0 NO, I am not facing possible 0 I have experienced abdominal pain in 
termination from active duty {351] the past but not now {466] 
0 NOT SURE if I 'm facing possible 
termination from active duty {20] 041 
Abdominal pain - onset 
085 - Medical 0 onset more than 3 months PRIOR to 
Complaints/Symptoms Gulf War Service {I l l] 
YES, I have experienced one or more 0 onset within 3 months PRIOR to Gulf 
of these symptoms: abdominal pain, War Service {l IB] 
bleeding gums, depressed mood, 0 onset during Gulf War Service {1 19] 
d iarrhea, d ifficulty concentrating, 0 onset with in 3 months AFTER Gulf 
fatigue, hair loss, headaches, jOint 
War Service {120] 
pain , memory problem, muscle pain, 0 onset more than 3 months AFTER rash,  shortness of breath, sleep 
Gulf War Service {121] d isturbance, weight change, or 
OTHER symptoms. 
042 0 Click here if you HA VE experienced 
ANY symptoms {Q54] Abdominal pain - duration 
If Yes, Branch to 054 0 less than one month {122] 
0 Cl ick here if you HAVE NOT 0 one to six months {123] 
experienced ANY of these symptoms 0 six months to one year {124] 
{300] 0 one to three years {1251 
If Have Not, Branch to 090 0 greater than three years {126] 
054 043 
Abdominal pain Abdominal pain - frequency 
0 YES, I have experienced abdominal 0 rarely {130] 
pain {Q131] 0 some of the time {354] 
0 NO, I have not experienced any 0 most of the time {355] 
abdominal pain {321] 0 al l  of the time {356] 
If No, Branch to 055 
Q44 
Abdominal pain - impairment 
o This has min imal effect on me 
performing my daily activities [127] 
o This l imits me from performing my 
dai ly activities [128] 
o This prevents me from performing my 
dai ly activities [129] 
Q55 
Bleeding gums 
o YES, I have experienced bleeding 
gums [0132] 
o NO, I have not experienced any 
bleeding gums [322] 
If No, Branch to 056 
Q 1 32 
Bleeding gums - currency 
o I am currently experiencing bleeding 
gums [352] 
o I have experienced bleeding gums in 
the past but not now [353] 
Q45 
Bleeding gums - onset 
o onset more than 3 months PRIOR to 
Gulf War Service [82] 
o onset with in 3 months PRIOR to Gulf 
War Service [83] 
o onset during Gulf War Service [84] 
o onset with in 3 months AFTER Gulf 
War Service [85] 
o onset more than 3 months AFTER 
Q46 
Bleeding gums - duration 
0 less than one month [87] 
0 one to six months [88] 
0 six months to one year [89] 
0 one to three years [90] 
0 greater than three years [91] 
Q47 
Bleeding gums - frequency 
0 rarely [1 15] 
0 some of the time [1 16] 
0 most of the time [357] 
0 all of the time [358] 
Q48 
Bleeding gums - impairment 
o This has minimal effect on me 
performing my daily activities [92] 
o This l imits me from performing my 
daily activities [93] 
245 
o This prevents me from performing my 
daily activities [114] 
Q56 
Depressed mood 
o YES, I have experienced a depressed 
mood [0133] 
o NO, I have not experienced any 
depressed moods [323] 
If No, Branch to 057 
Q 1 33 
Gulf War Service [86] 
Depressed mood _ currency 
o I am currently experiencing a 
depressed mood [467] 
o I have experienced a depressed 
mood in the past but not now [468] 
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049 057 
Depressed mood - onset Diarrhea 
0 onset more than 3 months PRIOR to 0 YES, I have experienced diarrhea 
Gulf War Service {94] {Q134] 
0 onset within 3 months PRIOR to Gulf 0 NO, I have not experienced any 
War Service {95] diarrhea {324] 
0 onset duri ng Gulf War Service {96] If No, Branch to 058 
0 onset within 3 months AFTER Gulf 
War Service {97] 0 1 34 
0 onset more than 3 months AFTER Diarrhea - currency 
Gulf War Service {98] 0 I am currently experiencing d iarrhea 
{469] 
050 0 I have experienced diarrhea in the 
Depressed mood - duration past but not now {470] 
0 less than one month {99] 
0 one to six months {100] 053 
0 six months to one year {101] Diarrhea - onset 
0 one to three years {102] 0 onset more than 3 months PRIOR to 
0 greater than three years {103] Gulf War Service {107] 
0 onset within 3 months PRIOR to Gulf 
051 War Service {108] 
Depressed mood - frequency 0 onset during Gulf War Service {109] 
0 rarely {359] 0 onset with in 3 months AFTER Gulf 
0 some of the time {360] War Service {1 10] 
0 most of the time {361] 0 onset more than 3 months AFTER 
Gulf War Service {1 1 1] 0 al l  of the time {362] 
067 
Diarrhea - duration 052 
0 less than one month {1 12] 
Depressed mood - impairment 
0 one to six months {1 13] 
0 This has minimal effect on me 0 six months to one year {1 73] 
performing my dai ly activities {104] 
0 one to three years {1 74] 0 This l imits me from performing my 
daily activities {105] 0 greater than three years {1 75] 
0 This prevents me from performing my 
dai ly activities {106] 
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Q68 
Diarrhea - frequency Q70 
0 rarely {1 76J Difficulty concentrating - onset 
0 some of the time {177J 0 onset more than 3 months PRIOR to 
0 most of the time {1 78J Gulf War Service {180J 
0 all of the time {1 79J 0 onset within 3 months PRIOR to Gulf 
War Service {18 1J 
Q69 0 onset during Gulf War Service {182J 
Diarrhea - impairment 0 onset within 3 months AFTER Gulf 
0 This has minimal effect on me War Service {183J 
performing my daily activities {363J 0 onset more than 3 months AFTER 
0 This l imits me from performing my Gulf War Service {184J 
daily activities {364J 
Q71 0 This prevents me from performing my 
daily activities {365J Difficulty concentrating - duration 
0 less than one month {185J 
Q58 0 one to six months {186J 
Difficulty concentrating 0 six months to one year {187J 
0 YES, I have experienced difficulty 0 one to three years {188J 
concentrating {Q135J 0 greater than three years {189J 
0 NO, I have not experienced any 
d ifficulty concentrating {325J Q72 
If No, Branch to 037 Difficulty concentrating - frequency 
0 rarely {190J 
Q 1 35 0 some of the time {191J 
Difficu lty concentrating - currency 0 most of the time {192J 
0 I am currently experiencing difficulty 0 al l  of the time {193J 
concentrating {471J 
0 I have exper'd difficulty concentrating Q73 
in past but not now {472J Difficulty concentrating - impairment 
0 This has minimal effect on me 
performing my dai ly activities {366J 
0 This l imits me from performing my 
daily activities {367J 
0 This prevents me from performing my 
daily activities {368J 
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037 033 
Fatigue Fatigue - frequency 
0 YES, I have experienced fatigue [09] 0 rarely [303] 
0 NO, I have not experienced any 0 some of the time [304] 
fatigue [244] 0 most of the time [305] 
If No, Branch to 060 0 al l  of the time [306] 
09 036 
Fatigue - currency Fatigue - impairment 
0 I am currently experiencing fatigue [65] 0 This has min imal effect on me 
0 I have experienced fatigue in the past performing my dai ly activities [132] 
but not now [275] 0 This l imits me from performing my 
daily activities [134] 
038 0 This prevents me from performing my 
Fatigue - onset daily activities [136] 
0 onset more than 3 months PRIOR to 
Gulf War Service [302] 060 
0 onset within 3 months PRIOR to Gulf Hair loss 
War Service [248] 0 YES, I have experienced hair loss 
0 onset during Gulf War Service [249] [0136] 
0 onset within 3 months AFTER Gulf 0 NO, I have not experienced any hair 
War Service [247] loss [327] 
0 onset more than 3 months AFTER If No, Branch to 061 
Gulf War Service [246] 
0 1 36 
039 Hair loss - currency 
Fatigue - duration 0 I am currently experiencing hair loss 
0 less than one month [245] [473] 
0 one to six months [250] 0 I have experienced hair loss in the 
0 six months to one year [251] past but not now [474] 
0 one to three years [252] 
0 greater than three years [253] 
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074 061 
Hair loss - onset Headaches 
0 onset more than 3 months PRIOR to 0 YES, I have experienced headaches 
Gulf War Service (208J (0137J 
0 onset within 3 months PRIOR to Gulf 0 NO, I have not experienced any 
War Service (209J headaches (328J 
0 onset during Gulf War Service (210J If No, Branch to 062 
0 onset within 3 months AFTER Gulf 
War Service (21 1J 0 1 37 
0 onset more than 3 months AFTER Headaches - currency 
Gulf War Service (212J 0 I am currently experiencing 
headaches (475J 
075 0 I have experienced headaches in the 
Hair loss - duration past but not now (476J 
0 less than one month (213J 
0 one to six months (214J 078 
0 six months to one year (215J Headaches - onset 
0 one to three years (21 6J 0 onset more than 3 months PRIOR to 
0 greater than three years (21 7J Gulf War Service (222J 
0 onset within 3 months PRIOR to Gulf 
076 War Service (223J 
Hair loss - frequency 0 onset during Gulf War Service (224J 
0 rarely (21 8J 0 onset within 3 months AFTER Gulf 
0 some of the time (219J War Service (225J 
0 onset more than 3 months AFTER 0 most of the time (220J 
Gulf War Service (226J 
0 al l  of the time (221J 
079 077 
Headaches - duration 
Hair loss - impairment 
0 less than one month (227J 
0 This has min imal effect on me 
0 one to six months (228J 
performing my dai ly activities (369J 
0 six months to one year (229J 
0 This l imits me from performing my 
0 daily activities (370J one to three years (230J 
0 This prevents me from performing my 0 greater than three years (231J 
daily activities (371J 
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0 1 0 1 0 1 03 
Headaches - frequency Joint pain - onset 
0 rarely [232) 0 onset more than 3 months PRIOR to 
0 some of the time [233) Gulf War Service [236) 
0 most of the time [234) 0 onset within 3 months PRIOR to Gulf 
0 al l  of the time [235) War Service [237) 
0 onset during Gulf War Service [238) 
0 1 02 0 onset within 3 months AFTER Gulf 
Headaches - impairment War Service [239) 
0 This has minimal effect on me 0 onset more than 3 months AFTER 
performing my daily activities [372) Gulf War Service (240] 
0 This l imits me from performing my 
daily activities [373) 0 1 04 
0 This prevents me from performing my Joint pain - duration 
daily activities [374) 0 less than one month [241) 
0 one to six months [242) 
062 0 six months to one year [243) 
Joint pain 0 one to three years [137) 
0 YES, I have experienced joint pain 0 greater than three years [138) 
(Q138] 
0 NO, I have not experienced any joint 0 1 05 
pain [329) Joint pain - frequency 
If No, Branch to 063 0 rarely [139) 
0 some of the time (140] 
0 1 38 0 most of the time [141) 
Joint pain - currency 0 all of the time [142) 
0 I am currently experiencing joint pain 
[477) 0 1 06 
0 I have experienced joint pain in the Joint pain - impairment 
past but not now [478) 0 This has min imal effect on me 
performing my daily activities [143) 
0 This limits me from performing my 
daily activities [378) 
0 This prevents me from performing my 
daily activities [379) 
Q63 
Memory problem 
o YES, I have experienced a memory 
problem {Q139] 
o NO, I have not experienced any 
memory problems {330] 
If No, Branch to 01 45 
Q 1 39 
Memory problem - currency 
o I am currently experiencing a memory 
problem {479] 
o I have experienced a memory 
problem in the past but not now {480] 
Q 1 07 
Memory problem - onset 
o onset more than 3 months PRIOR to 
Gulf War Service {380] 
o onset within 3 months PRIOR to Gulf 
War Service {381] 
o onset during Gulf War Service {382] 
o onset within 3 months AFTER Gulf 
War Service {383] 
o onset more than 3 months AFTER 
Gulf War Service {384] 
Q 1 08 
Memory problem - duration 
o less than one month {38S] 
o one to six months {386] 
o six months to one year {387] 
o one to three years {388] 
o greater than three years {389] 
Q 1 09 
Memory problem - frequency 
o rarely {390] 
o some of the time {391] 
o most of the time {392] 
o al l  of the time {393] 
Q 1 1 0  
Memory problem - impairment 
o This has minimal effect on me 
performing my daily activities {394] 
o This l imits me from performing my 
daily activities {39S] 
2 5 1  
o This prevents me from performing my 
daily activities {396] 
Q 1 45 
Muscle pain 
o YES, I have experienced muscle pain 
{Q140] 
o NO, I have not experienced muscle 
pain {491] 
If No, Branch to 064 
Q 1 40 
Muscle pain - currency 
o I am currently experiencing muscle 
pain {481] 
o I have experienced muscle pain in the 
past but not now {482] 
0 1 1 1  
Muscle pain - onset 
o onset more than 3 months PRIOR to 
Gulf War Service [397] 
o onset within 3 months PRIOR to Gulf 
War Service [39B] 
o onset duri ng Gulf War Service [399J 
o onset within 3 months AFTER Gulf 
War Service [400] 
o onset more than 3 months AFTER 
Gulf War Service [401] 
0 1 1 2  
Muscle pain - duration 
0 less than one month [402] 
0 one to six months [403] 
0 six months to one year [404] 
0 one to three years [405] 
0 greater than three years [406] 
0 1 1 3  
Muscle pain - frequency 
0 rarely [407] 
0 some of the time [40B] 
0 most of the time [409] 
0 all of the time [4 10] 
0 1 1 4  
Muscle pain - impairment 
o This has minimal effect on me 
performing my dai ly activities [4 1 1] 
o This l imits me from performing my 
daily activities [4 12] 
o This prevents me from performing my 
daily activities [4 13] 
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064 
Rash 
o YES, I have experienced a rash [Q 141] 
o NO, I have not experienced any rash 
[331] 
If No, Branch to 059 
0 1 4 1  
Rash - currency 
o I am currently experiencing a rash 
[4B3] 
o I have experienced a rash in the past 
but not now [4B4] 
0 1 1 5  
Rash - onset 
o onset more than 3 months PRIOR to 
Gulf War Service [414] 
o onset within 3 months PRIOR to Gulf 
War Service [4 15] 
o onset during Gulf War Service [4 16] 
o onset within 3 months AFTER Gulf 
War Service [4 1 7] 
o onset more than 3 months AFTER 
Gulf War Service [4 1B] 
0 1 1 6  
Rash - duration 
o less than one month [4 19] 
o one to six months [420] 
o six months to one year [421] 
o one to three years [422] 
o greater than three years [423] 
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0 1 1 7  0 1 1 9  
Rash - frequency Shortness of breath - onset 
0 rarely {424] 0 onset more than 3 months PRIOR to 
0 some of the time {425] Gulf War Service {194] 
0 most of the time {426] 0 onset within 3 months PRIOR to Gulf 
0 al l  of the time {427] War Service {195] 
0 onset during Gulf War Service {196] 
0 1 1 8  0 onset within 3 months AFTER Gulf 
Rash - impairment War Service {197] 
0 This has minimal effect on me 0 onset more than 3 months AFTER 
performing my daily activities (428] Gulf War Service {198] 
0 This l imits me from performing my 
daily activities {429] 0 1 20 
0 This prevents me from performing my Shortness of breath - duration 
dai ly activities {430] 0 less than one month {199] 
0 one to six months {200] 
059 0 six months to one year {201] 
Shortness of breath 0 one to three years {202] 
0 YES, I have experienced shortness of 0 greater than three years {203] 
breath {Q142] 
0 NO, I have not experienced any 0 1 2 1  
shortness of breath (326] Shortness of breath - frequency 
If No, Branch to 065 0 rarely {204] 
0 some of the time {205] 
0 1 42 0 most of the time {206] 
Shortness of breath - currency 0 all of the time {207] 
0 I am currently experiencing shortness 
of breath (485] 
0 I have experienced shortness of 0 1 22 
breath in past but not now {486] Shortness of breath - impairment 
0 This has minimal effect on me 
performing my daily activities (377] 
0 This l imits me from performing my 
daily activities (375] 
0 This prevents me from performing my 
dai ly activities {376] 
065 
Sleep disturbance 
o YES, I have experienced sleep 
disturbance [0143J 
o NO, I have not experienced any sleep 
disturbance [332J 
If No, Branch to 066 
0 1 43 
Sleep disturbance - currency 
o I am currently experiencing sleep 
disturbance [487J 
o I have experienced sleep d isturbance 
in the past but not now [488J 
0 1 64 
Snore loudly 
o I never snore loudly or have someone 
tel l  me I do [135J 
o I sometimes snore loudly or have 
someone tell me I do [152J 
o I often snore loudly or have someone 
tell me I do [159J 
o I always snore loudly or have 
someone tell me I do [161J 
0 1 65 
Stop breathing whi le sleeping 
o I never stop breathing or have 
someone tell me I do [163J 
o I sometimes stop breathing or have 
someone tell me I do [165J 
o I often stop breathing or have 
someone tell me I do [167J 
o I always stop breathing or have 
someone tell me I do [169J 
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0 1 23 
Sleep disturbance - onset 
o onset more than 3 months PRIOR to 
Gulf War Service [431J 
o onset within 3 months PRIOR to Gulf 
War Service [432J 
o onset during Gulf War Service [433J 
o onset within 3 months AFTER Gulf 
War Service [434J 
o onset more than 3 months AFTER 
Gulf War Service [435J 
0 1 24 
Sleep disturbance - duration 
o less than one month [436J 
o one to six months [437J 
o six months to one year [438J 
o one to three years [439J 
o greater than three years [440J 
0 1 25 
Sleep disturbance - frequency 
o rarely [441J 
o some of the time [442J 
o most of the time [443J 
o al l  of the time [444J 
0 1 26 
Sleep disturbance - impairment 
o This has minimal effect on me 
performing my dai ly activities [445J 
o This l imits me from performing my 
daily activities [446J 
o This prevents me from performing my 
daily activities [447J 
066 
Weight change of more than 10 Ibs 
o YES, I have experienced a weight 
change of more than 10 Ibs (0144J 
o NO, I have not experienced a wI. 
change of more than 1 0  Ibs (333J 
If No, Branch to 090 
0 1 44 
Weight change - currency 
o I am currently experiencing a weight 
GAIN (489J 
o I have experienced a weight GAIN in 
the past but not now (490J 
o I am currently experiencing a weight 
LOSS (51 5J 
o I have experienced a weight LOSS in 
the past but not now (516J 
0 1 63 
Weight change - cause 
o I am trying or have tried to gain or 
lose weight on purpose [51 7J 
o my weight changes are or have been 
due to a pregnancy [518J 
o my weight changes are unexplained 
[519J 
0 1 27 
Weight change - onset 
o onset more than 3 months PRIOR to 
Gulf War Service [448J 
o onset within 3 months PRIOR to Gulf 
War Service [449J 
o onset during Gulf War Service [450J 
o onset within 3 months AFTER Gulf 
War Service [451J 
o onset more than 3 months AFTER 
Gulf War Service [452J 
0 1 28 
Weight change - duration 
o less than one month (453J 
o one to six months [454J 
o six months to one year [455J 
o one to three years (456J 
o greater than three years [457J 
0 1 29 
Weight change - frequency 
o rarely [458J 
o some of the time [459J 
o most of the time (460J 
o al l  of the time [461J 
0 1 30 
Weight change - impairment 
o This has minimal effect on me 
performing my daily activities [462J 
o This l imits me from performing my 
daily activities [463J 
255 
o This prevents me from performing my 
dai ly activities [464J 
090 
Other symptoms 
o YES, I have OTHER symptoms to 
discuss with a provider [299J 
o NO, I do NOT have OTHER 
symptoms to discuss with a provider 
[301J 
025 - Reproductive H istory 
Conception ( 1 988-1 994) 
o YES, children were conceived 
between 1 988-1 994 [OI IJ 
o NO, chi ldren were not conceived 
between 1 988-1 994 (158J 
If No, Branch to 032 
256 
0 1 1 0 1 3  
Conception (select ALL that apply) M iscarriage (select ALL that apply) 
0 1 chi ld conceived in 3 years BEFORE 0 1 miscarriage in 3 years BEFORE 
Gulf service {33] Gulf service {42] 
0 2 chi ldren conceived in 3 years 0 2 miscarriages in 3 years BEFORE 
BEFORE Gulf service {34] Gulf service {44] 
0 3 or more chi ldren conceived in 3 0 3 or more miscarriages in 3 years 
years BEFORE Gulf service {35] BEFORE Gulf service {45] 
0 1 child conceived in 3 years AFTER 0 1 miscarriage in 3 years AFTER Gulf 
Gulf service {37] service {46] 
0 2 chi ldren conceived in 3 years 0 2 miscarriages in 3 years AFTER Gulf 
AFTER Gulf service {38] service {47] 
0 3 or more children conceived in 3 0 3 or more miscarriages in 3 years 
years AFTER Gulf service {39] AFTER Gulf service (48] 
032 027 
Infertility ( 1 988-1 994) Stillbirth ( 1 988-1 994) 
0 YES, infertility problems occurred 0 YES, stillbirths occurred between 
between 1 988-1 994 {O30] 1 988- 1 994 {OI5] 
0 NO, infertility problems did not occur 0 NO, sti l lb irths did not occur between 
between 1 988-1 994 {168] 1 988-1 994 {162] 
If No, Branch to Q26 If No, Branch to Q28 
030 0 1 5  
Infertility (select ALL that apply) Sti l lbirth (select ALL that apply) 
0 YES, i nfertil ity problems in the 3 years 0 1 sti l lbirth in 3 years BEFORE Gulf 
BEFORE Gulf service {41] service {49] 
0 YES, infertility problems in the 3 years 0 2 sti l lbirths in 3 years BEFORE Gulf 
AFTER Gulf service {43] service {50] 
0 3 or more sti l lbirths in 3 years 
026 BEFORE Gulf service (51] 
Miscarriage ( 1 988-1 994) 0 1 sti l lbirth in 3 years AFTER Gulf 
0 YES, miscarriages occurred between service {52] 
1 988-1 994 {OI3] 0 2 stillbirths in 3 years AFTER Gulf 
0 NO, miscarriages did not occur service {53] 
between 1 988-1 994 {160] 0 3 or more sti l lb irths in 3 years AFTER 
If No, Branch to Q27 Gulf service {54] 
257 
028 0 1 9  
Infant death ( 1 988-1 994) Birth defects (select ALL that apply) 
0 YES, infant deaths occurred between 0 1 birth with defects in 3 years 
1 988-1 994 {O1 7] BEFORE Gulf service {59] 
0 NO, infant deaths did not occur 0 2 births with defects in 3 years 
between 1 988-1 994 {164] BEFORE Gulf service {6O] 
If No, Branch to 029 0 3 or more births with defects in 3 
years BEFORE Gulf service {61] 
0 1 7  0 1 birth with defects in 3 years AFTER 
Infant death (select ALL that apply) Gulf service {62] 
0 1 infant death in 3 years BEFORE 0 2 births with defects in 3 years 
Gulf service {55] AFTER Gulf service {63] 
0 2 infant deaths in 3 years BEFORE 0 3 or more births with defects in 3 
Gulf service {56] years AFTER Gulf service {64] 
0 3 or more infant deaths in 3 years 
BEFORE Gulf service {1 72] 086 - Gulf War Service 
0 1 infant death in 3 years AFTER Gulf Service during Gulf War 
service {57] 0 YES, I served in the Gulf War {O31] 
0 2 infant deaths in 3 years AFTER Gulf 0 NO, I did not serve in the Gulf War 
service {58] {O40] 
0 3 or more infant deaths in 3 years If No, Branch to 040 
AFTER Gulf service (144] 
031 - Wartime 
029 Exposures/Experiences 
Birth defects ( 1 988-1 994) Passive cigarette smoke 
0 YES, birth defects occurred between 0 YES, I was exposed to passive 
1 988-1 994 {O19] cigarette smoke £7] 
0 NO, birth defects d id not occur 0 NO, I was not exposed to passive 
between 1 988-1 994 {166] cigarette smoke {148] 
If No, Branch to 086 0 I DON'T KNOW if I was exposed to 
passive cigarette smoke {31 7] 
258 
098 021 
Oil fire smoke Solvents 
0 YES, I was exposed to smoke from oil 0 YES, I was exposed to solvents [12J 
fires [8J 0 NO, I was not exposed to solvents 
0 NO, I was not exposed to smoke from [255J 
oi l  fires [31 5J 0 I DON'T KNOW if I was exposed to 
0 I DON'T KNOW if I was exposed to solvents [258J 
smoke from oil fires [31 8J 
034 
099 Diesel fuel 
Tent heater smoke 0 YES, I was exposed to diesel fuel [13J 
0 YES, I was exposed to smoke from a 0 NO, I was not exposed to d iesel fuel 
tent heater [9J [157J 
0 NO, I was not exposed to smoke from 0 I DON'T KNOW if I was exposed to 
a tent heater [316J diesel fuel [261J 
0 I DON'T KNOW if I was exposed to 
smoke from a tent heater [319J 020 
Other petrochemicals 
04 0 YES, I was exposed to other 
CARC paint petrochemical substances [14J 
0 YES, I was exposed to CARC paint 0 NO, I was not exposed to other 
being appl ied to vehicles [10J petrochemical substances [259J 
0 NO, I was not exposed to CARC 0 I DON'T KNOW if I was exposed to 
painting [146J other petrochemicals [262J 
0 I DON'T KNOW if I was exposed to 
CARC painting [256J 0 1 8  
Depleted uranium 
022 0 YES, I was exposed to depleted 
Other paints uranium [15J 
0 YES, I was exposed to painting (other 0 NO, I was not exposed to depleted 
than CARC paint) [I IJ uranium [260J 
0 NO, I was not exposed to other 0 I DON'T KNOW if I was exposed to 
painting [254J depleted uranium [263J 
0 I DON'T KNOW if I was exposed to 
other painting [257J 
259 
035 0 1 2  
NeNe gas Insect repellents and flea collars 
0 YES, I was exposed to neNe gas or 0 YES, I used insect repellents or flea 
other neNe agents [16J col lars [1BJ 
0 NO, I was not exposed to neNe gas 0 NO, I d id not use i nsect repellents or 
or other neNe agents [149J flea collars [269J 
0 I DON'T KNOW if I was exposed to 0 I DON'T KNOW if I used insect 
neNe gas or neNe agents [266J repellents or flea collars [271J 
0 1 6  023 
Mustard gas Botulism immunization 
0 YES, I was exposed to mustard gas 0 YES, I was immunized against 
or other blistering agents [17J botulism [0147J 
0 NO, I was not exposed to mustard 0 NO, I was not immunized against 
gas or blistering agents [264J botulism [156J 
0 I DON'T KNOW if I was exposed to If No, Branch to 0 1 0  
mustard gas o r  other agents [267J 0 I DON'T KNOW if I was immunized 
against botul ism [273J 
0 1 4  If Don't Know, Branch to 0 1 0  
M icrowaves (strong radar) 
0 YES, I was exposed to microwaves 0 1 47 
[22J Botul ism route of administration 
0 NO, I was not exposed to microwaves 0 I received 1 shot [497J 
[265J 0 I received 2 shots [49BJ 
0 I DON'T KNOW if I was exposed to 0 I received more than 2 shots [499J 
microwaves [26BJ 0 I took pi l ls [501J 
0 I do not recal l  how I was immunized 
05 [500J 
PB (pyridostigmine) pi l ls 
0 YES, I took PB (pyridostigmine 0 1 0  
bromide) pi l ls [19J Anthrax immunization 
0 NO, I did not take PB (pyridostigmine 0 YES, I was immunized against 
bromide) pi l ls [155J anthrax [0146J 
0 I DON'T KNOW if I took PB 0 NO, I was not immunized against 
(pyridostigmine bromide) pills [270J anthrax [272J 
If No, Branch to 091 
0 I DON'T KNOW if I was immunized 
against anthrax [274J 
If Don't Know, Branch to 091 
260 
Q 1 46 Q7 
Anthrax route of administration Food 
0 I received 1 shot [492] 0 YES, I ate food contaminated 
0 I received 2 shots [493] w/smoke, oi l ,  or chemicals [25] 
0 I received more than 2 shots [494] 0 NO, I did not eat contaminated food 
0 I took pi l ls [495] [276] 
0 I do not recal l  how I was immunized 0 I DON'T KNOW if I ate contaminated 
[496] food [278] 
Q91 Q24 
Malaria prevention Water 
0 YES, I was protected against malaria 0 YES, I bathed in/drank water other 
[Q159] than provided by services [24] 
0 NO, I was not protected against 0 NO, I did not bathe in/drink water 
malaria [133] other than that provided [150] 
If No, Branch to 06 0 I DON'T KNOW if I bathed in/drank 
0 I DON'T KNOW if I was protected water other than provided [280] 
against malaria [307] 
If Don't Know, Branch to 06 Q81 
Water 
Q 1 59 0 YES, I bathed in/drank water 
Malaria route of administration contaminated w/smoke, oi l ,  chemical 
0 I took 1 p i l l  [508] [153] 
0 I took 2 pi l ls [509] 0 NO, I did not bathe in/drink 
0 I took more than 2 pi l ls [510] 
contaminated water [279] 
0 I DON'T KNOW if I bathed in/drank 
0 I received shots [51 1] contaminated water [281] 
0 I do not recall how I was protected 
[512] Q8 
Q6 Combat 
Food 
0 YES, I was involved in actual combat 
0 YES, I ate food other than that 
[28] 
provided by services [23] 0 NO, I was not involved in actual 
0 NO, I did not eat food other than that 
combat [154] 
provided [151] 0 
I DON'T KNOW if I was involved in 
0 I DON'T KNOW if I ate food other 
actual combat [320] 
than that provided [277] 
080 
Wounded in action 
0 YES, I was wounded in action {29] 
0 NO,  I was not wounded in action {334] 
0 I DON'T KNOW if I was wounded in 
action {335] 
082 
Casualties witnessed 
0 YES, I witnessed casualties {3D] 
0 NO, I did not witness casualties {336] 
0 I DON'T KNOW if I witnessed 
casualties {337] 
083 
SCUD attacks 
0 YES, I witnessed SCUD attacks {31] 
0 NO, I d id not witness SCUD attacks 
{33B] 
0 I DON'T KNOW if I witnessed SCUD 
attacks {339] 
084 
Chemical alarms 
0 YES, I witnessed chemical alarms {32] 
0 NO, I did not witness chemical alarms 
{34D] 
0 I DON'T KNOW if I witnessed 
chemical alarms {34 1] 
092 
Other exposures or experiences 
o YES, I have OTHER 
exposures/experiences to discuss 
{342] 
o NO, I do NOT have OTHER 
exposures/experiences to discuss 
{343] 
040 
2 6 1  
END OF QUESTIONNAIRE 
The questionnaire is now complete. 
Thank you for your attention. Please 
notify the administrator that you have 
finished. 
Appendix XXIV: Comprehensive Clinical Evaluation Program 
Exposure/Experiences Descriptive Statistics 
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Table 22:  Descriptive Variable Statistics 
Age 
Stress Scores 
Marital Status 
MARITAL 
Age 
N = 1 2,205 
Min = 1 8  
Max = 69 
Mean = 36.25 
Standard Deviation = 7.26 
1 51 Quartile = 3 1 .00 
2nd Quartile = 35 .00 
3rd Quartile = 4 1 .00 
Stress Scores 
N = 1 2,205 
Min = .00 
Max = 1 09.55 
Mean = 47.26 
Standard Deviation = 1 8 .08 
1 51 Quartile = 34.89 
2nd Quartile = 47.3 1 
3rd Quartile = 59.69 
Marital Status 
N = 1 2,205 
# Married = 8,972 
# Not Married = 3,233 
Max (married) = 1 
Min (not married) = 0 
Mean = .74 
263 
264 
Gender 
'2000 Gender 
"'000 N = 1 2,205 
# Males = 1 1 ,047 
# Females = 1 , 1 58 
Max (males) = I 
Min (females) = 0 
� Mean = . 9 1  
! 
0.00 
PERS_SEX 
Race Race* 7000 
6000 N = 1 2,205 
# Majority = 6,328 (5 1 .8 %) 
sooo # Minority = 5,877 (48.2 %) 
'000 Max (majority) = I 
3000 Min (minority) = 0 
2000 Mean = .52 
g � 1000 
! 
RACE 
Race Breakdown 
*Race Breakdown: 
White = 6,328 (5 1 .8 %) 
Black = 3,692 (30.2 %) 
Unknown/Other = 1 ,297 ( 1 0.6  %) 
Hispanic = 628 (5 . 1 %) 
Asian/Pacific Islander = 1 86 ( 1 .5 %) 
� Native American = 74 ( .6 %) 
! 
RACE_CD 
Table 23 :  Descriptive Statistics on Exposure data 
Passive Cigarette Smoke 
PASSIVE 
Oil Fire Smoke 
OILJIRE 
Tent Heater Smoke 
I) Passive Cigarette Smoke 
N = 1 2,205 
# Exposed = 9, 1 48 (75 %) 
# Not Exposed = 3,057 (25 %) 
Max (exposed) = 1 
Min (not exposed) = 0 
Mean = .75 
2) Oil Fire Smoke 
N = 1 2,205 
# Exposed = 8 , 1 20 (66.5 %) 
# Not Exposed = 4,085 (33 .5 %) 
Max (exposed) = I 
Min (not exposed) = 0 
Mean = .67 
3) Tent Heater Smoke 
N = 1 2,205 
# Exposed = 7,409 (60.7 %) 
# Not Exposed = 4,796 (39.3 %) 
Max (exposed) = 1 
Min (not exposed) = 0 
Mean = .6 1 
265 
CARC Paint 
Other Paints 
Solvents 
SOLVENTS 
4) CARC Paint 
N = 1 2,205 
# Exposed = 4,5 1 7  (63 %) 
# Not Exposed = 7,688 (37 %) 
Max (exposed) = 1 
Min (not exposed) = 0 
Mean = .37 
5) Other Paints 
N = 1 2,205 
# Exposed = 3,487 (28.6 %) 
# Not Exposed = 8,7 1 8  (7 1 .4 %) 
Max (exposed) = 1 
Min (not exposed) = 0 
Mean = .29 
6) Solvents 
N = 1 2,205 
# Exposed = 6,40 1 (52.4 %) 
# Not Exposed = 5,804 (47.6 %) 
Max (exposed) = I 
Min (not exposed) = 0 
Mean = .52 
266 
Diesel Fuel 
DIESELJ 
Other Petrochemicals 
Depleted Uranium 
DEPLETED 
7) Diesel Fuel 
N = 1 2,205 
# Exposed = 1 0,362 (84.9 %) 
# Not Exposed = 1 ,843 ( 1 5 . 1  %) 
Max (exposed) = 1 
Min (not exposed) = 0 
Mean = .85 
8) Other Petrochemicals 
N = 1 2,205 
# Exposed = 5869 (48. 1 %) 
# Not Exposed = 6336 (5 1 .9%) 
Max (exposed) = 1 
Min (not exposed) = 0 
Mean = .48 
9) Depleted Uranium 
N = 1 2,205 
# Exposed = 1 ,909 ( 1 5 .6 %) 
# Not Exposed = 1 0,296 (84.4 %) 
Max (exposed) = 1 
Min (not exposed) = 0 
Mean = . 1 6  
267 
Nerve Gas 
0.00 .50 
Mustard Gas 
14000 
12000 
10a00 
8000 
6000 
<000 
i 
! 
2000 
0.00 .50 1.00 
MUSTARD 
Microwaves (Strong Radar) 
MICROWAV 
1 0) Nerve Gas 
N = 1 2,205 
# Exposed = 806 (6.6 %) 
# Not Exposed = 1 1 ,399 (93.4 %) 
Max (exposed) = 1 
Min (not exposed) = 0 
Mean = .07 
1 1 ) Mustard Gas 
N = 1 2,205 
# Exposed = 206 ( 1 .7%) 
# Not Exposed = 1 1 ,999 (98 .3)  
Max (exposed) = 1 
Min (not exposed) = 0 
Mean = .02 
1 2  Microwaves (Strong Radar) 
N = 1 2,205 
# Exposed = 2,489 (20.4 %) 
# Not Exposed = 9,7 1 6  (79.6 %) 
Max (exposed) = 1 
Min (not exposed) = 0 
Mean = .20 
268 
Pyridostgmine Bromide 
Insect Repellents 
Botulism Immunization 
BOTULISM 
1 3) PB Pills 
N = 1 2,205 
# Exposed = 9, 1 33 (74.8 %) 
# Not Exposed = 3,072 (25.2 %) 
Max (exposed) = 1 
Min (not exposed) = ° 
Mean = .75 
1 4) Insect Repellents 
N = 1 2,205 
# Exposed = 8,363 (68.5 %) 
# Not Exposed = 3,842 (3 1 .5 %) 
Max (exposed) = 1 
Min (not exposed) = ° 
Mean = .69 
1 5) Botulism Immunization 
N = 1 2 ,205 
# Exposed = 3, 1 1 4 (25 .5 %) 
# Not Exposed = 9,09 1 (74.5 %) 
Max (exposed) = 1 
Min (not exposed) = ° 
Mean = .26 
269 
Anthrax Immunization 
ANTHRAX 
Malaria Immunization 
MALARIA 
Food Contamination 
1 6) Anthrax Immunization 
N = 1 2,205 
# Exposed = 5,594 (45.8 %) 
# Not Exposed = 6,6 1 1 (54.2 %) 
Max (exposed) = I 
Min (not exposed) = 0 
Mean = .46 
1 7) Malaria Prevention 
N = 1 2,205 
# Exposed = 5,882 (48.2 %) 
# Not Exposed = 6,323 (5 1 .8 %) 
Max (exposed) = I 
Min (not exposed) = 0 
Mean = .48 
1 8) Food Contamination 
N = 1 2,205 
# Exposed = 1 ,547 ( 1 2 .7  %) 
# Not Exposed = 1 0,658 (87.3 %) 
Max (exposed) = I 
Min (not exposed) = 0 
Mean = . 1 3  
270 
Water Contamination "000 ,--------_____ ----, 
"'000 
8000 
6000 
'000 
Combat Exposure 
COMBAT_I 
Wounded in Action 
000 50 1 .00 
WOUNDED 
1 9) Water Contamination 
N = 1 2 ,205 
# Exposed = 1 ,358 ( 1 1 . 1  %) 
# Not Exposed = 1 0,847 ( 88 .9%) 
Max (exposed) = I 
Min (not exposed) = 0 
Mean = . 1 1  
20) Combat Exposure 
N = 1 2 ,205 
# Exposed = 5 ,5 1 3  (45 .2 %) 
# Not Exposed = 6,692 (54.8 %) 
Max (exposed) = I 
Min (not exposed) = 0 
Mean = .45 
2 1 )  Wounded i n  Action 
N = 1 2,205 
# Exposed = 1 5 8  ( 1 .3 %) 
# Not Exposed = 1 2 ,047 (98 .7%) 
Max (exposed) = I 
Min (not exposed) = 0 
Mean = . 0 1  
2 7 1  
Witnessing of Casualties 
CASUALTI 
Scud Attacks 
Chemical Alarms 
'_ .---------------------� 
8000 
6000 
.000 
2000 
22) Witnessing of Casualties 
N = 1 2 ,205 
# Exposed = 6892 (56.5%) 
# Not Exposed = 53 1 3  (43 .5 %) 
Max (exposed) = 1 
Min (not exposed) = 0 
Mean = .56 
23) Scud Attacks 
N = 1 2,205 
# Exposed = 6,208 (50.9 %) 
# Not Exposed = 5,997 (49. 1 %) 
Max (exposed) = 1 
Min (not exposed) = 0 
Mean = . 5 1 
24) Chemical Alarms 
N = 1 2,205 
# Exposed = 8, 1 69 (66.9 %) 
# Not Exposed = 4,036 (33 . 1  %) 
Max (exposed) = I 
Min (not exposed) = 0 
Mean = .67 
272 
Table 24 : Descriptive Statistics on Health Outcome Data 
Abdominal Pain 
-r--------------------, 
6000 
'000 
'.0 
Bleeding Gums 
1_�-
-----------------__. 
6000 
'000 
2000 
0.0 1 .0 2.0 JO . 0  
Depressed Mood 
1) Abdominal Pain 
N = 1 2 ,205 
Min 0: 6,809 (55 .8  %) 
\ :  920 (7.5 %) 
2: 3 ,407 (27.9 %) 
3: 876 (7.2 %) 
Max 4 :  1 93 ( \ .6 %) 
Mean: .9 1 
Standard Deviation: 1 . 1 2  
2) Bleeding Gums 
N = 1 2,205 
Min 0: 8,297 (68.0 %) 
1 :  929 (7 .6 %) 
2: 2, 1 45 ( 1 7.6  %) 
3: 644 (5 .3  %) 
Max 4 :  1 90 ( \ .6 %) 
Mean: .65 
Standard Deviation: 1 .04 
3) Depressed Mood 
N = 1 2,205 
Min 0: 5 , 1 88 (42.5  %) 
\ :  1 , 1 47 (9.4 %) 
2: 4, 1 4 1  (33 .9 %) 
3: 1 ,450 ( 1 \ .9 %) 
Max 4: 279 (2 .3 %) 
Mean: 1 .22 
Standard Deviation: 1 . 1 8  
273 
Diarrhea 
DIARRHEA 
Difficulty Concentrating 
Fatigue 
FATIGUE 
4) Diarrhea 
N = 1 2,205 
Min 0: 5,322 (43 .6 %) 
1 :  1 ,635 ( \ 3.4 %) 
2: 3 ,895 (3 1 .9 %) 
3: 1 , 1 3 5 (9.3 %) 
Max 4: 2 1 8  ( 1 .8 %) 
Mean: 1 . 1 2  
Standard Deviation: 1 . 1 3 
5) Difficulty Concentrating 
N = 1 2,205 
Min 0: 4,688 (38 .4 %) 
I :  502 (4. 1 %) 
2 :  4, 1 60 (34. 1 %) 
3 :  2,274 ( \ 8 .6  %) 
Max 4 :  501 (4.8 %) 
Mean: 1 .47 
Standard Deviation: 1 .29 
6) Fatigue 
N = 1 2,205 
Min 0: 2,9 1 7  (23.9 %) 
I :  522 (4.3 %) 
2: 3 ,854 (3 1 .6 %) 
3: 3 ,607 (29.6 %) 
Max 4 :  1 ,305 ( 1 0.7 %) 
Mean : 1 .99 
Standard Deviation: 1 .3 1  
274 
Hair Loss 
3.0 <.0 
Headache 
HEADACHE 
Joint Pain 
<000 
3000 
2000 
� 1000 
I 
00 10 20 30 < 0  
JOINT_PA 
7) Hair Loss 
N = 1 2,205 
Min 0: 8,235 (67.5 %) 
I :  72 1 (5.9 %) 
2 :  1 ,588 ( 1 3 .0 %) 
3: 827 (6.8 %) 
Max 4 :  834 (6 .8  %) 
Mean : . 8  
Standard Deviation: 1 .28 
8) Headache 
N = 1 2,205 
Min 0: 3 ,723 (30.5 %) 
I :  1 , 1 09 (9. 1 %) 
2: 4,802 (39.3 %) 
3: 1 ,997 ( 1 6.4 %) 
Max 4 :  574 (4.7 %) 
Mean: 1 . 56 
Standard Deviation: 1 .2 1  
9) Joint Pain 
N = 1 2,205 
Min 0: 2,6 1 5  (2 1 .4 %) 
I :  47 1 (3 .9 %) 
2 :  3 ,235 (26.5 %) 
3: 3 ,438 (28.2 %) 
Max 4 :  2,446 (20.0 %) 
Mean: 2 .22 
Standard Deviation: 1 .39 
2 7 5  
Memory Problems 
/;' � 
! 
MEM_PROB 
Muscle Pain 
/;' � 
! 
... 1.. 2 .• 3 .• . .  
MUS_PAIN 
Rash 
RASH 
1 0} Memory Problems 
N = 1 2 ,205 
Min 0: 4,42 1 (36.2 %) 
1 :  64 1 (5 .3 %) 
2 :  3,8 1 2  (3 1 .2 %) 
3: 2 , 1 67 ( 1 7.8  %) 
Max 4: 1 , 1 64 (9.5 %) 
Mean : 1 .59 
Standard Deviation: 1 .3 8  
II} Muscle Pain 
N = 1 2,205 
Min 0: 5 ,468 (44.8 %) 
1 :  694 (5 .7  %) 
2: 3 ,248 (26.6 %) 
3 :  1 ,903 ( 1 5 .6  %) 
Max 4 :  892 (7 .3  %) 
Mean: 1 .35  
Standard Deviation: 1 .37  
1 2} Rash 
N = 1 2,205 
Min 0: 6,038 (49.5 %) 
I :  1 ,392 ( 1 1 .4 %) 
2: 2,277 ( 1 8 .7 %) 
3 :  1 , 1 3 8  (9.3 %) 
Max 4:  1 ,360 ( 1 1 . 1  %) 
Mean : 1 .2 1  
Standard Deviation: 1 .42 
276 
277 
Shortness of Breath 
1 3  Shortness of Breath 
N = 1 2,205 
Min 0: 6,4 1 9  (52.6 %) 
1 :  937 (7.7 %) 
2 :  3 ,028 (24.8 %) 
3 :  1 ,258 ( 1 0. 3  %) 
[ Max4: 563 (4.6 %) 
! Mean: 1 .07 0 Standard Deviation : 1 .26 
SHORT_BR 
Sleep Disturbances 
5000 1 4) Sleep Disturbances 
N = 1 2,205 
'000 Min 0: 4,5 1 7  (37.0 %) 
3000 1 :  464 (3 .8 %) 
2: 2,67 1  (2 1 .9 %) 
2000 3 :  2,802 (23.0 %) 
Max4: 1 ,75 1 ( 1 4.0 %) 
'000 
Mean: 1 .74 
Standard Deviation: 1 .50 
SLEEP_OI 
Weight Changes 1 5) Weight Change 7000 
N = 1 2,205 
6000 
Min 0 :  5,8 1 0  (47.6 %) 
5000 1 :  1 ,375 ( 1 1 .3 %) 
'000 2 :  2,995 (24.5 %) 
3000 3 :  1 ,336  ( 1 0.9 %) 
2000 Max4: 689 (5.6 %) 
g Mean: 1 . 1 6  � 1000 
Standard Deviation : 5 .6 ! 0 
WEIGHT_C 
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Abdominal Pain Correlations 
AB ONSET AB DURAT AB FREQU AB I M PAI 
Pearson Correlation 1 .000 .763** .849" . 8 1 5" 
AB_ONSET Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .763" 1 .000 .835" .760" 
AB_DURAT Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .849" .835" 1 .000 .853" 
ABJREQ Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .81 5" .760" .853" 1 .000 
AB_IMPAI Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
** . Correlation IS significant at the 0.01 level (2-talled) 
Abdominal Pain Factor Analysis 
Descriptive Statistics Communalities 
Mean Std. Deviation Analysis N Initial Extraction 
AB_ONSET 1 .87 2 22 1 2205 AB_ONSET 1 .000 .854 
AB_DU RAT 1 .47 1 .99 1 2205 AB_DURAT 1 .000 .81 8 
ABJREQ 1 .9 1  1 . 1 2  1 2205 ABJREQ 1 .000 . 9 1 2  
A B  I M PAI .56 . 7 1  1 2205 AB I M PAI 1 .000 .855 
Extracllon Method: Principal Component Analysis 
T t l  V . o a  anance E I ·  d xplame 
Component 
Total % of Variance Cumulative % Total 
1 3.439 85.970 85.970 3.439 
2 .256 6.407 92.376 
3 . 1 85 4.622 96.998 
4 . 1 20 3.002 1 00.000 
Extraction Method: Principal Components AnalysIs. 
Component Matrix 
Component 
I 
AB_ONSET .924 
AB_DURAT .904 
ABJREQU .955 
AB I M PAI .925 
Extraction Method: Principal 
Components Analysis 
Component Score 
Coefficient Matrix 
Component 
I 
AB_ONSET .269 
AB_DURAT .263 
ABJREQU .278 
AB I M PAI .269 
Extraction Method: Principal 
Components Analysis 
% of Variance Cumu lative % 
85.970 
Component Score 
Covariance Matrix 
Component 1 
85.970 
I 1 .000 
Extraction Method: Principal 
Components Analysis 
BI d' G C ee Ing ums 
280 
orrelations 
BG ONSET BG DURAT BG FREQU BG I M PAI 
Pearson Correlation 1 .000 .765" .824-- .889" 
BG_ONSET Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .765" 1 .000 .857" .829" 
BG_DURAT Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .824-- .857" 1 .000 .888" 
BGJREQ Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .889" .829" .888" 1 .000 
BG_IMPAI Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
-- . Correlation IS sign ificant at the 0.01 level (2-tailed) 
Bleeding Gums Factor Analysis 
Descriptive Statistics Communal ities 
Mean Std. Deviation Analysis N Initial Extraction 
BG_ONSET 1 .28 2 . 02 1 2205 BG_ONSET 1 .000 .858 
BG_DURAT 1 .05 1 .80 1 2205 BG_DURAT 1 .000 .842 
BGJREQ .65 1 .04 1 2205 BGJREQ 1 .000 .904 
BG I M PAI .33 .49 1 2205 BG I M PAI 1 .000 .923 
Extraction Method: Principal Component Analysis 
Total Variance Explained 
Component 
Total % of Variance Cumulative % Total 
1 3.527 88. 1 80 88. 1 80 3.527 
2 .251 6.265 94.445 
3 . 1 33 3.31 4 97.759 
4 8.963E-02 2.241 1 00.000 
Extraction Method: Principal Components AnalysIs. 
Component Matrix 
Component 
1 
BG_ONSET .926 
BG_DURAT . 9 1 8  
BGJREQU .951 
BG I M PAI .961 
Extraction Method: Principal 
Components Analysis 
Component Score 
Coefficient Matrix 
Component 
1 
BG_ONSET .263 
BG_DURAT .260 
BGJREQU .270 
BG I M PAI .272 
Extraction Method: Principal 
Components Analysis 
% of Variance Cumulative % 
88. 1 80 
Component Score 
Covariance Matrix 
Component 1 
88. 1 80 
1 1 .000 
Extraction Method: Principal 
Components Analysis 
28 1 
Diarrhea Correlations 
DIA_ONSE DIA_DURA DIA FREQ DIA I M PA 
Pearson Correlation 1 .000 .667*- .799-- .787*-
DIA_ONSE Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .667** 1 .000 .781 -- .693--
DIA_DURA Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .779-- .781-- 1 .000 .827*-
DIAJREQ Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .787*- .693-- .827*- 1 .000 
DIA_IMPAI Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
-- . Correlation IS significant at the 0.01  level (2-talled) 
Diarrhea Factor Analysis 
Descriptive Statistics Communal ities 
Mean Std. Deviation Analysis N Initial Extraction 
DIA_ONSE 2 . 1 8  2 . 1 0  1 2205 DIA_ONSE 1 .000 .808 
DIA_DU RA 1 . 57 1 .9 1  1 2205 DIA_DURA 1 .000 .746 
DIA_FREQ 1 . 1 2  1 . 1 3  1 2205 DIAJREQ 1 .000 .889 
DIA I M PA .67 .68 1 2205 DIA I M PA 1 .000 .837 
Extraction Method: PrinCipal Component Analysis 
Total Variance Explained 
Component 
Total % of Variance Cumulative % Total 
1 3.280 82.001 82.001 3.280 
2 .357 8.923 90.923 
3 . 2 1 3 5.3 1 9  96.242 
4 . 1 50 3.758 1 00.000 
Extraction Method: PrinCipal Components AnalysIs. 
Component Matrix 
Component 
I 
DIA_ONSE .889 
DIA_DU RA .864 
DIAJREQ .943 
DIA I M PA .91 5 
Extraction Method: Principal 
Components Analysis 
Component Score 
Coefficient Matrix 
Component 
I 
DIA_ONSE .274 
DIA_DURA .263 
DIA_FREQ .287 
DIA I M PA .279 
Extraction Method: Principal 
Components Analysis 
% of Variance Cumulative % 
82.001 
Component Score 
Covariance Matrix 
Component 1 
82.001 
1 1 .000 
Extraction Method: Principal 
Components Analysis 
282 
F r a Igue C I r orre a Ions 
F _ONSET F DURAT F FREQU F I M PAI 
Pearson Correlation 1 .000 .71 3" .762" .69 1 - -
F _ONSET Sig.  (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .71 3-- 1 .000 .805-- .702--
F_DURATI Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .762-- .803-- 1 .000 .806--
FJREQUE Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .69 1 -- .702-- .806-- 1 .000 
F_I MPAIR Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
-- . Correlation IS significant at the 0 .01  level (2-talled) 
Fatigue Factor Analysis 
Descriptive Statistics Comm unal ities 
Mean Std. Deviation Analysis N Initial Extraction 
F _ONSET 3.30 2.01 1 2205 F_ONSET 1 .000 .771 
F_DURATI 2.94 2. 1 0  1 2205 F_DURATI 1 .000 .799 
FJREQUE 1 .99 1 .3 1  1 2205 FJREQUE 1 .000 .881 
F I M PAIR 1 .08 .78 1 2205 F I M PAIR 1 .000 .789 
Extraction Method: Principal Component Analysis 
Total Variance Explained 
Component 
Total % of Variance Cumulative % Total 
1 3.240 81 . 0 1 0  81 .01 0 3.240 
2 .31 5 7.879 88.889 
3 .287 7 . 1 83 96.072 
4 . 1 57 3.928 1 00.000 
Extraction Method: Principal Components AnalysIs. 
Component Matrix 
Component 
I 
F_ONSET .878 
F_DURATI .894 
FJREQUE .939 
F I M PAIR .888 
Extraction Method: Principal 
Components Analysis 
Component Score 
Coefficient Matrix 
Component 
I 
F_ONSET .271 
F_DURATI .276 
FJREQUE .290 
F I M PAIR .274 
Extraction Method: Principal 
Components Analysis 
% of Variance Cumulative % 
8 1 . 0 1 0  
Component Score 
Covariance Matrix 
Component 1 
8 1 .01 0 
1 1 .000 
Extraction Method: Principal 
Components Analysis 
283 
Hair Loss Correlations 
AB ONSET AB DURAT AB FREQU AB I M PAI 
Pearson Correlation 1 .000 .850** .798** .894** 
HL_ONSET Sig. (2-tai led) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .850** 1 .000 .887** .91 6** 
HL_DURAT Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .798** .887** 1 .000 .87 1 ** 
HLJREQU Sig.  (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .894** .91 6** .87 1 ** 1 .000 
H L_IMPAI Sig. (2-ta i led) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
** . Correlation IS sign ificant at the 0.01 level (2-tal led) 
Hair  Loss Factor Analysis 
Descriptive Statistics Communal ities 
Mean Std. Deviation Analysis N Initial Extraction 
HL_ONSET 1 . 30 2 . 02 1 2205 HL_ONSET 1 .000 .868 
H L_DU RAT 1 .38 2 . 1 0  1 2205 HL_DURAT 1 .000 .925 
HLJREQ .80 1 .28 1 2205 HLJREQ 1 .000 .876 
H L  I M PAI .33 .49 1 2205 HL I M PAI 1 .000 .940 
Extraction Method: Principal Component Analysis 
Total Variance Explained 
Component 
Total % of Variance Cumulative % Total 
1 3.609 90.223 90.223 3.609 
2 .209 5.228 95.451 
3 . 1 07 2.678 98 . 1 29 
4 7.484E-02 1 .871 1 00.000 
Extraction Method: Principal Components AnalysIs. 
Component Matrix 
Component 
I 
HL_ONSET .932 
HL_DURAT .962 
HLJREQU .936 
HL I M PAI .969 
Extraction Method: Principal 
Components Analysis 
Component Score 
Coefficient Matrix 
Component 
I 
HL_ONSET .258 
HL_DURAT .267 
HLJREQU .259 
HL I M PAI .269 
Extraction Method: Principal 
Components Analysis 
% of Variance Cumulative % 
90.223 
Component Score 
Covariance Matrix 
Component 1 
90.223 
1 1 .000 
Extraction Method: Principal 
Components Analysis 
284 
Headache Correlations 
HA ONSET HA DURAT HA FREQU HA I M PAI 
Pearson Correlation 1 .000 .659" .752-- .685" 
HA_ONSET Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .659" 1 .000 .754" .683" 
HA_DURAT Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .752" .754" 1 .000 .80r-
HAJREQU Sig. (2-tai led) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .685" .683" .807" 1 .000 
HA_I M PAI Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
-- . Correlation IS significant at the 0.01 level (2-talled) 
Headache Factor Analysis 
Descriptive Statistics Communal ities 
Mean Std. Deviation Analysis N Initial Extraction 
HA_ONSET 2.81  2 . 1 1 1 2205 HA_ONSET 1 .000 .752 
HA_DURAT 2.42 2 . 1 5  1 2205 HA_DURAT 1 .000 .753 
HAJREQU 1 .56 1 .2 1  1 2205 HAJREQU 1 .000 .871 
HA I M PAI .95 .80 1 2205 HA IMPAI 1 .000 .797 
Extraction Method: Principal Component Analysis 
Total Variance Explained 
Component 
Total % of Variance Cumulative % Total 
1 3 . 1 73 79.324 79.324 3. 1 73 
2 .341 8 . 5 1 4  87.838 
3 .31 5 7.879 95.7 1 8  
4 . 1 7 1 4.282 1 00.000 
Extraction Method: Principal Components AnalysIs. 
Component Matrix 
Component 
1 
HA_ONSET .867 
HA_DURAT .868 
HAJREQU .933 
HA I M PAI .893 
Extraction Method: Principal 
Components Analysis 
Component Score 
Coefficient Matrix 
Component 
1 
HA_ONSET .273 
HA_DURAT .273 
HAJREQU .294 
HA I M PAI .281 
Extraction Method: Principal 
Components Analysis 
% of Variance Cumulative % 
79.324 
Component Score 
Covariance Matrix 
Component 1 
79.324 
1 1 .000 
Extraction Method: Principal 
Components Analysis 
285 
Joint Pain Correlations 
JP _ONSET JP DURAT JP FREQU JP I M PAI 
Pearson Correlation 1 .000 .69 1 "  .71 2** .643** 
JP_ONSET Sig. (2-tai led) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .691 ** 1 . 000 .797** .692** 
J P  _DURAT Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation . 7 1 2** .797** 1 .000 .795** 
JPJREQ Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .643** .692** .795** 1 .000 
JP _IMPAI Sig. (2-tai led) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
** . Correlation I S  significant at the 0.01 level (2-talled) 
Joint Pain Factor Analysis 
Descriptive Statistics Communal ities 
Mean Std. Deviation Analysis N Initial Extraction 
JP_ONSET 3.37 2.00 1 2205 JP _ONSET 1 .000 .726 
J P  _DURAT 3.22 2.07 1 2205 JP _DU RAT 1 .000 .801 
JPJREQU 2.22 1 .39 1 2205 JPJREQU 1 .000 .868 
J P  I M PAI 1 . 20 .83 1 2205 JP I M PAI 1 .000 .774 
Extraction Method: Principal Component Analysis 
Total Variance Explained 
Component 
Total % of Variance Cumulative % Total 
1 3. 1 69 79.2 1 8  79.2 1 8  3 . 1 69 
2 .370 9.249 88.467 
3 .294 7.353 95.82 1 
4 . 1 67 4 . 1 79 1 00.000 
Extraction Method: Principal Components AnalysIs. 
Component Matrix 
Component 
I 
J P  _ONSET .852 
J P  _DURAT .895 
JPJREQU .932 
JP I M PAI .880 
Extraction Method: Principal 
Components Analysis 
Component Score 
Coefficient Matrix 
Component 
I 
JP_ONSET .269 
JP _DURAT .282 
JPJREQU .294 
JP I M PAI .278 
Extraction Method: Principal 
Components Analysis 
% of Variance Cumulative % 
79.21 8 
Component Score 
Covariance Matrix 
Component 1 
79.2 1 8  
1 1 .000 
Extraction Method: Principal 
Components Analysis 
286 
Muscle Pain Correlations 
MU_ONSET MU DURAT MU FREQU MU I M PAI 
Pearson Correlation 1 .000 .809** .829** .791 ** 
MU_ONSET Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .809** 1 .000 .854** .794** 
M U_DURAT Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .829** .854** 1 .000 .880** 
MUJREQU Sig.  (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .79 1 ** .794** .880** 1 .000 
MU_I M PAI Sig. (2-ta iled) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
** . Correlation I S  significant at the 0.01 level (2-talled) 
Muscle Pain Factor Analysis 
Descriptive Statistics Communal i ties 
Mean Std. Deviation Analysis N Initial Extraction 
MU_ONSET 2 . 38 2.28 1 2205 MU_ONSET 1 .000 .843 
MU_DU RAT 2 . 1 3  2 .21  1 2205 MU_DURAT 1 .000 .858 
MUJREQU 1 . 35 1 . 37 1 2205 MUJREQU 1 .000 . 9 1 4  
M U  I M PAI .79 .83 1 2205 MU I M PAI 1 .000 .863 
Extraction Method: Principal Component Analysis 
Total Variance Explained 
Component 
Total % of Variance Cumulative % Total 
1 3.479 86.975 86.975 3.479 
2 .223 5.578 92.553 
3 . 1 93 4.8 1 5  97.368 
4 . 1 05 2.632 1 00.000 
Extraction Method: Principal Components AnalysIs. 
Component Matrix 
Component 
I 
MU_ONSET .91 8 
MU_DURAT .926 
MUJREQU .956 
MU I M PAI .929 
Extraction Method: Principal 
Components Analysis 
Component Score 
Coefficient Matrix 
Component 
I 
MU_ONSET .264 
MU_DURAT .266 
MUJREQU .275 
MU I M PAI .267 
Extraction Method: Principal 
Components Analysis 
% of Variance Cumulative % 
86.975 
Component Score 
Covariance Matrix 
Component 1 
86.975 
1 1 .000 
Extraction Method: Principal 
Components Analysis 
287 
Rash Correlations 
RASH ONS RASH OUR RASH FRE RASH I M P  
Pearson Correlation 1 .000 .773** .782** .854** 
RASH_ONS Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .773** 1 .000 . 86 1 ** .783** 
RASH_OUR Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .782** .86 1 ** 1 .000 .806** 
RASHfRE Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .854** .783** .806** 1 .000 
RASH_I M P  S i g .  (2-tai led) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
** . Correlation IS significant at the 0.01 level (2-tailed) 
Rash Factor Analysis 
Descriptive Statistics Communalities 
Mean Std. Deviation Analysis N Initial Extraction 
RASH_ONS 2 . 08 2.1 9 1 2205 RASH_ONS 1 .000 .846 
RASH_OUR 1 . 79 2 . 1 2  1 2205 RASH_OUR 1 .000 .851 
RASHfRE 1 .2 1  1 .42 1 2205 RASHfRE 1 .000 .868 
RASH I M P  .55 .60 1 2205 RASH I M P I  1 .000 .865 
Extraction Method: Pnnclpal Component Analysis 
Total Variance Explained 
Component 
Total % of Variance Cumulative % Total 
1 3.429 85.735 85.735 3.429 
2 .287 7. 1 70 92.905 
3 . 1 51 3.770 96.675 
4 . 1 33 3.325 1 00.000 
Extraction Method: Pnnclpal Components AnalysIs. 
Component Matrix 
Component 
1 
RASH_ONS .920 
RASH_OUR .923 
RASHfRE .931 
RASH IMP .930 
Extraction Method: Principal 
Components Analysis 
Component Score 
Coefficient Matrix 
Component 
1 
RASH_ONS .268 
RASH_OUR .269 
RASHfRE .272 
RASH I M P  . 2 7 1  
Extraction Method: Principal 
Components Analysis 
% of Variance Cumulative % 
85.735 
Component Score 
Covariance Matrix 
Component 1 
85.735 
1 1 .000 
Extraction Method: Principal 
Components Analysis 
288 
Shortness of Breath Correlations 
SOB ONSE SOB DURA SOB FREQ SOB I M PA 
Pearson Correlation 1 .000 . 8 1 8" .837*- .81 7--
SOB_ONSE Sig.  (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation . 8 1 8-- 1 .000 .865-- . 8 1 5--
SOB_DURA Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .837*- .865-- 1 .000 .878--
SOB_FREQ Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .81 7-- .81 5-- .878-- 1 .000 
SOB_IMPA Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
--. Correlation IS significant at the 0.01 level (2-talled) 
Shortness of Breath Factor Analysis 
Descriptive Statistics Communalities 
Mean Std. Deviation Analysis N Initial Extraction 
SOB_ONSE 2 . 04 2.26 1 2205 SOB_ONSE 1 .000 .856 
SOB_DURA 1 . 80 2 . 1 7  1 2205 SOB_DURA 1 .000 .870 
SOBJREQ 1 .07 1 . 26 1 2205 SOB_FREQ 1 .000 . 9 1 3  
S O B  I M PA .64 .78 1 2205 SOB I M PA 1 .000 .876 
Extraction Method: Principal Component Analysis 
Total Variance Expla i ned 
Component 
Total % of Variance Cumulative % Total 
1 3 . 5 1 6  87.888 87.888 3 . 5 1 6  
2 . 1 92 4.800 92.688 
3 . 1 84 4.595 97.283 
4 . 1 09 2 .7 1 7  1 00.000 
Extraction Method: Principal Components AnalysIs. 
Component Matrix 
Component 
1 
SOB_ONSE .925 
SOB_DURA .933 
SOBJREQ .955 
SOB I M PA .936 
Extraction Method: Principal 
Components Analysis 
Component Score 
Coefficient Matrix 
Component 
1 
SOB_ONSE .263 
SOB_DURA .265 
SOB_FREQ .272 
SOB I M PA .266 
Extraction Method: Principal 
Components Analysis 
% of Variance Cumulative % 
87.888 
Component Score 
Covariance Matrix 
Component 1 
87.888 
1 1 .000 
Extraction Method: Principal 
Components Analysis 
289 
W . h C el�1 t hange Correlations 
WC ONSET WC DURAT WC FREQU WC I M PAI 
Pearson Correlation 1 .000 .867** .804** .846** 
WC_ONSET Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .867** 1 .000 .854** .839** 
WC_DURAT Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .804** .854** 1 .000 .827** 
WCJREQU Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .846** .839** .827** 1 .000 
WC_IMPAI Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
** . Correlation IS significant at the 0.01 level (2-talled) 
Weight Change Factor Analysis 
Descriptive Statistics Communal ities 
Mean Std. Deviation Analysis N Initial Extraction 
WC_ONSET 2 . 33 2 . 32 1 2205 WC_ONSET 1 . 000 .879 
WC_DU RAT 2.07 2 . 1 6  1 2205 WC_DU RAT 1 .000 .901 
WCJREQU 1 . 1 6  1 .28 1 2205 WC_FREQU 1 .000 .862 
WC I M PAI .59 .63 1 2205 WC I M PAI 1 .000 .876 
Extraction Method. PrinCipal Component Analysis 
Total Variance Explained 
Component 
Total % of Variance Cumulative % Total 
1 3 .5 1 8  87.961 87.961 3 . 5 1 8  
2 . 1 98 4.961 92.922 
3 . 1 67 4 . 1 64 97.086 
4 . 1 1 7  2 . 9 1 4  1 00.000 
Extraction Method: PrinCipal Components AnalysIs. 
Component Matrix 
Component 
1 
WC_ONSET .938 
WC_DURAT .949 
WCJREQU .928 
WC I M PAI .936 
Extraction Method: Principal 
Components Analysis 
Component Score 
Coefficient Matrix 
Component 
1 
WC_ONSET .267 
WC_DU RAT .270 
WCJREQU .264 
WC I M PAI .266 
Extraction Method: Principal 
Components Analysis 
% of Variance Cumulative % 
87.961 
Component Score 
Covariance Matrix 
Component 1 
87.961 
1 1 .000 
Extraction Method: Principal 
Components Analysis 
290 
D epressed Mood Correlations 
DM ONSET DM DURAT DM FREQU DM I M PAI 
Pearson Correlation 1 .000 . 7 1 2** .81 6** .789** 
DM_ONSET Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation . 7 1 2** 1 .000 .81 7** .757** 
DM_DU RAT Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation . 8 1 6** .81 7** 1 .000 .862** 
DMJREQU Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .789** .757** .862** 1 .000 
DM_I M PAI Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
** . Correlation IS sign ificant at the 0.01 level (2-talled) 
Depressed Mood Factor Analysis 
Descriptive Statistics Communal ities 
Mean Std. Deviation Analysis N Initial Extraction 
DM_ONSET 2.43 2.23 1 2205 DM_ONSET 1 .000 .81 3 
DM_DU RAT 1 .82 2 .01  1 2205 DM_DURAT 1 .000 .796 
DMJREQU 1 .22 1 . 1 8  1 2205 DMJREQ 1 .000 .907 
DM I M PAI .75 .75 1 2205 DM I M PAI 1 .000 .862 
Extraction Method: Principal Component Analysis 
Total Variance Explained 
Component 
Total % of Variance Cumulative % Total 
1 3.378 84.452 84.452 3.378 
2 .292 7.302 9 1 . 754 
3 .206 5. 1 59 96.9 1 3  
4 . 1 23 3.087 1 00.000 
Extraction Method: Principal Components AnalYSIS. 
Component Matrix 
Component 
I 
DM_ONSET .902 
DM_DU RAT .892 
DMJREQU .952 
DM I MPAI .928 
Extraction Method: Principal 
Components Analysis 
Component Score 
Coefficient Matrix 
Component 
I 
DM_ONSET .267 
DM_DURAT .264 
DM_FREQU .282 
DM I M PAI .275 
Extraction Method: Principal 
Components Analysis 
% of Variance Cumulative % 
84.452 
Component Score 
Covariance Matrix 
Component 1 
84.452 
1 1 .000 
Extraction Method: Principal 
Components Analysis 
2 9 1  
I ICU D'ff It C oncentratln� C I . orre atlons 
DC_ONSET DC_DURAT DCfREQU DC_IMPAI 
Pearson Correlation 1 .000 .795" .840** .788** 
DC_ONSET Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .795** 1 .000 .845** .777** 
DC_DURAT Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .840** .845** 1 .000 .869** 
DCfREQU Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .788** .777** .869** 1 .000 
DC_IMPAI Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
** . Correlation IS sign ificant at the 0.01 level (2-tailed) 
Difficulty Concentrating Factor Analysis 
Descriptive Statistics Communal ities 
Mean Std. Deviation Analysis N Initial Extraction 
DC_ONSET 2.71  2.25 1 2205 DC_ONSET 1 .000 .846 
DC_DURAT 2.37 2.22 1 2205 DC_DURAT 1 .000 .843 
DCfREQU 1 .47 1 .29 1 2205 DCfREQU 1 .000 .91 5 
DC_IMPAI .87 .81 1 2205 DC_IMPAI 1 .000 .853 
Extraction Method: Principal Component Analysis 
Total Variance Explained 
Component 
Total % of Variance Cumulative % Total 
1 3.458 86.443 86.443 3.458 
2 .227 5.684 92 . 1 27 
3 .204 5 . 1 1 0  97.236 
4 . 1 1 1  2.764 1 00.000 
Extraction Method: Principal Components AnalysIs. 
Component Matrix 
Component 
I 
DC_ONSET .920 
DC_DURAT . 9 1 8  
DCfREQU .957 
DC I M PAI .924 
Extraction Method: Principal 
Components Analysis 
Component Score 
Coefficient Matrix 
Component 
I 
DC_ONSET .266 
DC_DURAT .266 
DCfREQU .277 
DC I M PAI .267 
Extraction Method: Principal 
Components Analysis 
% of Variance Cumulative % 
86.443 
Component Score 
Covariance Matrix 
Component 1 
86.443 
1 1 .000 
Extraction Method: Principal 
Components Analysis 
292 
M emory P bl ro ems C orrelations 
MP_ONSET M P_DURAT MPJREQU MP_IMPAI 
Pearson Correlation 1 . 000 .828" .820" .782--
M P_ONSET Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .828** 1 . 000 .840" .780" 
MP_DURAT Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .820" .840" 1 .000 .860" 
M PJREQU Sig.  (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .782" .780" .860" 1 .000 
M P_IMPAI Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
** . Correlation IS significant at the 0.01 level (2-talled) 
Memory Problems Factor Analysis 
Descriptive Statistics Communal ities 
Mean Std. Deviation Analysis N I nitial Extraction 
MP_ONSET 2.86 2.25 1 2205 MP_ONSET 1 .000 .850 
MP_DU RAT 2.61 2.26 1 2205 M P_DURAT 1 .000 .860 
MPJREQU 1 .59 1 .38 1 2205 MPJREQU 1 .000 .898 
M P  I M PAI .90 .81  1 2205 MP I M PAI 1 .000 .847 
Extraction Method: Pnnclpal Component Analysis 
Total Variance Explained 
Component 
Total % of Variance Cumulative % Total 
1 3.455 86.385 86.385 3.455 
2 .244 6 . 1 09 92.494 
3 . 1 75 4.387 96.88 1 
4 . 1 25 3 . 1 1 9  1 00.000 
Extracllon Method: Pnnclpal Components AnalysIs. 
Component Matrix 
Component 
I 
MP_ONSET .922 
MP_DU RAT .928 
MPJREQU .948 
M P  I M PAI .920 
Extraction Method: Principal 
Components Analysis 
Component Score 
Coefficient Matrix 
Component 
I 
MP_ONSET .267 
MP_DURAT .268 
MP_FREQU .274 
M P  I M PAI .266 
Extraction Method: Principal 
Components Analysis 
% of Variance Cumulative % 
86.385 
Component Score 
Covariance Matrix 
Component 1 
86.385 
1 1 .000 
Extraction Method: Principal 
Components Analysis 
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SI eep D· t b IS ur ances C I . orre atlons 
SO ONSET SO DU RAT SO FREQU SO I M PAI 
Pearson Correlation 1 .000 .820" .809** .765** 
SO_ONSET Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .820** 1 .000 .876** .784** 
SD_DURAT Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .809** .876** 1 .000 .831**  
SD_FREQU Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
Pearson Correlation .765** .784** .83 1 ** 1 .000 
SD_IMPAI Sig. (2-tailed) .000 .000 .000 
N 1 2205 1 2205 1 2205 1 2205 
* *  . Correlation I S  significant a t  the 0 .01  level (2-talled) 
Sleep Disturbances Factor Analysis 
Descriptive Statistics Communalities 
Mean Std. Deviation Analysis N Initial Extraction 
SO_ONSET 2.63 2 . 1 7  1 2205 SO_ONSET 1 .000 .835 
SD_DURAT 2.66 2.28 1 2205 SD_DU RAT 1 .000 .881 
SDJREQU 1 . 74 1 .50 1 2205 SDJREQU 1 .000 .900 
SO I M PAI .83 .76 1 2205 SO I M PAI 1 .000 .828 
Extraction Method: Principal Component Analysis 
Total Variance Explained 
Component 
Total % of Variance Cumulative % Total 
1 3.444 86 . 1 00 86. 1 00 3.444 
2 .243 6.087 92 . 1 87 
3 . 1 97 4.935 97 . 1 22 
4 . 1 1 5  2.878 1 00.000 
Extraction Method: Principal Components AnalysIs. 
Component Matrix 
Component 
1 
SO_ONSET . 9 1 4  
SD_DU RAT .939 
SDJREQU .949 
SO I M PAI . 9 1 0  
Extraction Method: Principal 
Components Analysis 
Component Score 
Coefficient Matrix 
Component 
1 
SO_ONSET .265 
SD_DU RAT .273 
SDJREQU .275 
SO I M PAI .264 
Extraction Method: Principal 
Components Analysis 
% of Variance Cumulative % 
86. 1 00 
Component Score 
Covariance Matrix 
Component 1 
86. 1 00 
1 1 .000 
Extraction Method: Principal 
Components Analysis 
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